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The international system of units and units derived thereof have been used 
A domain adenylation domain 
A. fumigatus Aspergillus fumigatus 
A. nidulans Aspergillus nidulans 
A. terreus Aspergillus terreus 
aa amino acid 
ACP domain acyl carrier protein domain 
AT domain acyltransferase domain 
ATP adenosine triphosphate 
BGC biosynthetic gene cluster 
bp base pair 
br broad (NMR) 
C domain condensation domain 
CD3OD deuterated methanol 
CDCl3 deuterated chloroform 
cDNA copy deoxyribonucleic acid 
CoA coenzyme A 
COSY correlation spectroscopy 








D2O deuterium oxide 
Da dalton 
dd double doublet 
ddd double doublet of doublet 
DEBS 6-deoxyerythronolide B synthase  




DMAPP dimethylallyl diphosphate 
DMATS dimethylallyltryptophan synthase 
DMSO-d6 deuterated dimethyl sulfoxide 
DNA deoxyribonucleic acid 
dq double quartet 
dt double triplet 
E. coli Escherichia coli 
e.g. exempli gratia 
EIC extracted ion chromatogram 
ER domain enoyl reductase domain 
ESI electrospray ionization 
FAD flavin adenine dinucleotide 
FlC4a[OOH] flavin-C4a-hydroperoxide 
FlN5[O] flavin-N5-oxide 
Flox oxidized flavin 
Flred reduced flavin 
FMN flavin mononucleotide 
gDNA genomic DNA 
GMM glucose minimal medium 
GPP geranyl diphosphate 
GTP guanosine triphosphate 
HE heterologous expression 
His6 Hexahistidine six 
HMBC heteronuclear multiple bond correlation 
HPLC high performance liquid chromatography 
hph hygromycin B phosphotransferase gene 
HRMS high resolution mass spectrometry 
HR-PKS highly-reducing polyketide synthase 
HSQC heteronuclear single quantum coherence 
Hz hertz 
i.e. id est 
J coupling constant 
kbp kilo base pairs 
ABBREVIATIONS 
XI 
kcat turnover number 
kDa kilodaltons 
KM Michaelis-Menten constant 
KR domain β-ketoreductase domain 
KS domain β-ketoacyl synthase domain 
LC-MS liquid chromatography–mass spectrometry 
m/z mass-to-charge ratio 
MAT doamin malonyl-CoA-ACP transacylase 
mAU milli absorbance unit 
Mb mega base pairs 
MHz mega hertz 
MOS 3-methylorcinaldehyde synthase 
mRNA messenger ribonucleic acid 
MeT methyltransferase 
MS mass spectroscopy 
multi multiplicity 
NADH nicotinamide adenine dinucleotide 
NADPH nicotinamide adenine dinucleotide phosphate 
N. fischeri Neosartorya fischeri 
NMR nuclear magnetic resonance 
NP natural product 
NR-PKS non-reducing polyketide synthase 
nonheme FeII/2-OG nonheme FeII/2-oxoglutarate 
Opa cluster Oxepinamide cluster 
NRPS nonribosomal peptide synthetase 
P450 cytochrome P450 
P. crustosum Penicillium crustosum 
P. citrinum Penicillium citrinum 
PCP domain peptidyl carrier protein domain 
PCR polymerase chain reaction 
PD potato dextrose 
PDA potato dextrose agar 
PDB potato dextrose broth 
PEG polyethylene glycol 
ABBREVIATIONS 
XII 
PKS polyketide synthase 
ppm parts per million 
PR-PKS partially-reducing polyketide synthase 
PT prenyltransferase 
PT domain Product template domain 
q quartet 
R domain reductase domain 
RNA ribonucleic acid 
rpm revolutions per minute 
s singlet 
S. cerevisiae Saccharomyces cerevisiae 
SAT domain starter unit acyltransferase domain 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SM secondary metabolite 
t Triplet 
T domain thiolation domain 
TB terrific broth 
td triple doublet 
TE domain thioesterase domain 
Tris tris(hydroxymethyl)aminomethane 
UV ultraviolet 
utt cluster ustethylin cluster 
v/v volume per volume 
WT wild type 
α-KG α-ketoglutarate 
δC chemical shift of 13C 










Secondary metabolites, especially those from microorganisms like bacteria and fungi, play an important 
role in defending the host against natural enemies, competitors or environmental pressure. These 
ecological functions provide the microbial natural products with a significant role in drug discovery, 
determination of new enzyme reaction mechanisms and interactions between species. Plentiful microbial 
secondary metabolites, including polyketides (PKs), nonribosomal peptides (NRPs), alkaloids and 
terpenes have been isolated and identified in the last decades. The progress in sequencing technologies 
and bioinformatics analysis provide a huge advantage of studying the biosynthesis of these metabolites. 
Polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs) follow logical assembly 
lines and are the most studied enzymes in the last years. Together with the versatile tailoring enzymes 
like prenyltransferases (PTs), flavin-dependent monooxygenases, nonheme FeII/2-oxoglutarate 
dependent monooxygenases, and cytochrome P450 enzymes, these enzymes are responsible for the 
formation of a large number of secondary metabolites. 
The biosynthetic pathways of many fungal metabolites have special features. For example, nonreducing 
polyketide synthetases are merely found to assemble fungal polyketides and their multiple domains can 
be iteratively utilized. Compared to bacteria, less fungi were sequenced and the genetic manipulation in 
fungi is usually more complex and difficult. Thus, the biosynthesis of many intriguing fungal secondary 
metabolites still remains unclear.  
In cooperation with Haowen Wang and Yiling Yang, biosynthetic pathways of three metabolites from 
Aspergillus ustus were elucidated in this thesis. Ustethylin A, a highly oxygenated aryl aldehyde 
containing a common phenethyl residue, was isolated and identified from this fungus. Isotopic labelling 
experiments proved that the backbone of ustethylin A is derived from malonyl-CoA, the methyl group in 
the phenethyl residue, the phenyl methyl group, and the O-methyl group from L-methionine. 
Transcriptome analysis, gene deletion and expression as well as isotopic labelling experiments confirmed 
that ustethylin A is biosynthesized via a PKS-related pathway. The PKS UttA as a key enzyme is 
responsible for the formation of the phenethyl backbone with methylation as essential steps. Consecutive 
and coordinated modifications by three different types of oxidoreductases and one O-MeT lead to the 
formation of ustethylin A. The Utt biosynthetic gene cluster (BGC) is the first reported cluster for a 
phenethyl-containing fungal metabolite.  
30 years ago, two benzoyl esters were identified after feeding an Aspergillus ustus culture with EtOH and 




ustethylin A biosynthetic pathway, with the UttA-bound thioesters as precursors for the methyl and ethyl 
ester formation. The fed alcohols hijack the polyketide acyl intermediates from the ustethylin A pathway. 
Besides ustethylin A, oxepinamides D, E, and F were isolated and identified in A. ustus. Two similar 
NRPS-containing gene clusters, opa and opa2, were identified by bioinformatics analysis. Enzymes from 
the opa cluster are responsible for the biosynthesis of oxepinamides E and F and those from the opa2 
cluster are involved in the formation of oxepinamide D. In the biosynthetic pathway of oxepinamide F, the 
NRPS enzyme OpaA with a domain structure of A-T-C-A-T-E-C-A-T-CT, activates Ant, L-Ile, and L-Phe, 
changes the configuration of L-Phe to D-Phe by an epimerase domain, and assembles the quinazolinone 
derivative protuboxepin K. Afterwards, the P450 enzyme OpaB catalyzes the expansion of the benzene 
to oxepin ring in the Ant residue of protuboxepin K. Subsequently, the flavin-dependent oxidase OpaC 
catalyzes the regio- and stereospecific hydroxylation accompanied by double bond migration, which 
leads to the conversion of a 1H-oxepin to a 3H-oxepin system. The epimerase OpaE catalyzes the D-
Phe residue back to L-Phe, which is essential for the final 12-OH methylation by the O-MeT OpaF to 
produce oxepinamide F.  
For the biosynthesis of oxepinamide D, a similar NRPS OpaA2 in the opa2 cluster utilizes Ant, L-Phe, 
and L-Ala to assemble a fused quinazolinone core structure. In analogy to OpaB, the P450 enzyme 
OpaB2 is responsible for the oxepin formation via a specific and stereoselective manner to form the 1H-
oxepin oxepinamide. Subsequently, OpaC2 installs a hydroxyl group at C-3 position to produce the final 
product oxepinamide D. 
Prenylation is one of the most important enzymatic modifications of natural products. FgaPT2 from 
Aspergillus fumigatus had been identified as a regular C4-prenyltransferase of L-Trp. Previous studies 
showed that mutation on key residues Lys174 and Arg244 led to the enhanced acceptance of the 
cyclodipeptides (CDPs) for C4-prenylation. However, the FgaPT2_K174F mutant shows only low activity 
for reverse C3-prenylation of six cyclodipeptides. The combinational mutations on Lys174 and Arg244 
was demonstrated to increase the catalytic activity of these cyclodipeptides. Except for cyclo-L-Trp-L-Trp, 
FgaPT2_K174F_R244X (X=L, N, Q, Y) show much better acceptance, with an increase of two- to six-
fold activity, to the tested cyclodipeptides than that of FgaPT2. More importantly, compared to 
FgaPT2_K174F, even two- to ten-fold conversion yields were calculated for the double mutants. These 
results proved that site-directed mutagenesis is an effective method to modify the enzyme function, which 





Sekundärmetabolite, insbesondere solche aus Bakterien und Pilzen, spielen eine wichtige Rolle bei der 
Verteidigung gegen natürliche Feinde, Konkurrenten oder Umweltbelastungen. Diese ökologischen 
Funktionen verleihen den mikrobiellen Naturstoffen eine wichtige Rolle bei der Wirkstoffentdeckung, 
Erforschung von Enzymen und Artenwechselwirkungen. Zahlreiche mikrobielle Sekundärmetabolite, 
einschließlich Polyketide, nichtribosomale Peptide, Alkaloide und Terpene wurden isoliert und identifiziert. 
Fortschritte bei Sequenzierungstechnologien und der Bioinformatik-Analyse ermöglichen es, die 
Biosynthese dieser Metabolite zu untersuchen und aufzuklären. Polyketidsyntasen und nichtribosomalen 
Peptidsynthasen folgen einer logischen Kettenverlängerungsstrategie und sind die am besten 
untersuchten Enzyme der letzten Jahrzehnte. Zusammen mit Modifikationsenzymen wie 
Prenyltransferasen, FAD-abhängigen Oxidoreduktasen, nicht-Häm-FeII / 2-Oxoglutarat-abhängigen 
Monooxygenasen und Cytochrom P450-Enzymen sind sie für die Entstehung einer großen Anzahl an 
Sekundärmetabolite verantwortlich. 
Die Biosynthesewege vieler Pilzmetabolite weisen besondere Merkmale auf. Zum Beispiel wurden 
nichtreduzierende Polyketidsyntasen lediglich in Pilzen gefunden und ihre Domänen können wiederholt 
durchlaufen werden. Im Vergleich zu Bakterien wurden bisher weniger Pilze sequenziert und die 
genetische Manipulation bei Pilzen ist normalerweise komplexer und schwieriger. Daher bleibt die 
Biosynthese vieler faszinierender sekundärer Pilzmetabolite noch ungeklärt. 
In Zusammenarbeit mit Haowen Wang und Yiling Yang wurden in dieser Arbeit Biosynthesewege von 
drei Metaboliten aus Aspergillus ustus aufgeklärt. Aus diesem Pilz wurde zuerst Ustethylin A, ein stark 
hydroxyliertes Arylaldehyd mit einem Phenethylrest isoliert und identifiziert. 
Isotopenmarkierungsexperimente zeigten, dass das Grundgerüst von Ustethylin A aus Malonyl-CoA und 
die Methylgruppen im Phenethylrest und Phenylmethyl sowie die O-Methylgruppe aus L-Methionin 
stammen. Transkriptomanalyse, Gendeletion und -expression sowie Isotopenmarkierungsexperimente 
bestätigten, dass Ustethylin A über einen PKS-Biosyntheseweg entsteht. Das PKS-Enzym UttA ist ein 
Schlüsselenzym für die Bildung des Phenethylgerüsts mit Methylierung als Schlüsselschritten. 
Aufeinanderfolgende und koordinierte Modifikationen durch drei verschiedene Arten von 
Oxidoreduktasen und eine O-MeT führen zur Bildung von Ustethylin A. Das Utt-Biosynthesegencluster 
ist das erste bekannte Cluster, das für einen Phenethyl-haltigen Pilzmetaboliten codiert. 
Vor 30 Jahren wurden zwei Benzoylester nach EtOH- und MeOH-Fütterungen in einer Aspergillus ustus-
Kultur identifiziert. Die Experimente wurden von diesem Doktoranden reproduziert und erwiesen sich als 




Vorläufer für die Methyl- und Ethylesterbildung dienen. Die zugeführten Alkohole entführen die 
Polyketidacyl-Zwischenprodukte aus dem Ustethylin A-Weg. 
Neben Ustethylin A wurden Oxepinamide D, E und F aus A. ustus isoliert und identifiziert. Zwei ähnliche 
NRPS-haltige Gencluster, opa und opa2, wurden durch bioinformatische Analyse identifiziert. Enzyme 
aus dem opa-Cluster sind für die Biosynthese der Oxepinamide E und F und solche aus dem opa2-
Cluster für die Bildung von Oxepinamid D verantwortlich. Im Biosyntheseweg von Oxepinamid F aktiviert 
das NRPS-Enzym OpaA mit einer Domänenstruktur von A-T-C-A-T-E-C-A-T-CT Ant, L-Ile und L-Phe, 
ändert die Konfiguration von L-Phe zu D-Phe durch eine Epimerasedomäne und baut das 
Chinazolinonderivat Protuboxepin K zusammen. Das P450-Enzym OpaB katalysiert anschließend die 
Expansion des Benzolrings zum Oxepinring im Ant-Rest von Protuboxepin K. Anschließend katalysiert 
die flavin-abhängige Oxidase OpaC die regio- und stereospezifische Hydroxylierung, begleitet von einer 
Doppelbindungsmigration, die zur Umwandlung eines 1H-Oxepin in ein 3H-Oxepin-System führt. Die 
Epimerase OpaE verändert den D-Phe-Rest zurück zu L-Phe, was für die endgültige 12-OH-Methylierung 
durch das O-MeT-OpaF zur Herstellung von Oxepinamid F essentiell ist. 
Für die Biosynthese von Oxepinamid D verwendet ein ähnliches NRPS OpaA2 im opa2-Cluster Ant, L-
Phe und L-Ala, um eine kondensierte Chinazolinon-Kernstruktur aufzubauen. In Analogie zu OpaB ist 
das P450-Enzym OpaB2 auf spezifische und stereoselektive Weise für die Oxepinbildung verantwortlich, 
um das 1H-Oxepinoxepinamid zu bilden. Anschließend führt OpaC2 eine Hydroxylgruppe an der C3-
Position ein, wodurch das Endprodukt Oxepinamid D herzustellen. 
Die Prenylierung ist eine der wichtigsten enzymatischen Modifikationen von Naturstoffen. FgaPT2 aus 
Aspergillus fumigatus wurde als reguläre C4-Prenyltransferase von L-Trp identifiziert. Frühere Studien 
zeigten, dass die Mutation an den Schlüsselpositionen Lys174 und Arg244 zu einer erhöhten Akzeptanz 
der cyclischen Dipeptide für die C4-Prenylierung führt. Die FgaPT2_K174F-Mutante zeigt jedoch nur eine 
geringe Aktivität für die reverse C3-Prenylierung von sechs Cyclodipeptiden. Es wurde in dieser Arbeit 
gezeigt, dass die kombinierten Mutationen an Lys174 und Arg244 die katalytische Aktivität dieser 
cyclischen Dipeptide erhöhen. Mit Ausnahme von Cyclo-L-Trp-L-Trp zeigt FgaPT2_K174F_R244X (X = 
L, N, Q, Y) eine viel bessere Akzeptanz, mit einer zwei- bis sechsfachen Aktivität, für die getesteten 
Dipeptide als FgaPT2. Noch wichtiger ist, dass im Vergleich zu FgaPT2_K174F für die Doppelmutanten 
sogar zwei- bis zehnfache Umwandlungsausbeuten berechnet wurden. Diese Ergebnisse zeigen, dass 
ortsgerichtete Mutagenese eine wirksame Methode zur Modifizierung der Enzymfunktion ist, die die 






   
   
 
   
  
 
    
  
   




 1.1 Natural products as important source for drug discovery. 
 2020 was a special year to all of us, because of the nightmare of Coronavirus (SARS-Covid19). Until now, 
 just a few vaccines have been approved for improving the immune system and no drug is effective against 
 this virus. New drugs to combat  viruses or other multidrug-resistant pathogens are  urgently needed, 
 because we do not know when  similar  viruses or other “super bacteria” will  be brought into our live 
 suddenly. 
 Based on the statistics from 01/1981 to 09/2019, 1881 new drugs including vaccines, biologicals, and 
 small molecules  were  approved by  the  FDA for clinical use.1 85 (4.5%) of them are unaltered natural 
 products, 346 (18.4%) are biological macromolecules, 356 (18.9%) are natural product derivatives, and 
 272 (14.5%) are natural product pharmacophore or mimics of natural products (Figure 1). More than sixty 
 percent of the approved drugs are natural product relevant, proving the essential role of natural products 
 in drug discovery. Natural products offer the best choices for finding agents/active templates, which 
 provide the potential to discover the leading agents in a variety of human diseases in conjunction with 
 synthetic chemistry and biology.1 Elucidation of the biosynthetic pathway largely extends our knowledge 



























1.1.1.1 Clinically used polyketides from bacteria and fungi 
Polyketides (PKs), which have been isolated and identified from plants, fungi, and bacteria, are a large 
group of natural products.2 Some of them are important drugs for clinical use. Outstanding examples from 
bacteria are tetracyclines isolated from Streptomyces aureofaciens and erythromycins obtained from 
Saccharopolyspora erythraea for the treatment of a number of bacterial infections3 as well as ivermectin 
produced by Streptomyces avermectinius against parasite infestations.3 While α-zearalanol as an 
anabolic agent isolated from FusariumI sp, lovastatin produced by Aspergillus terreus is used as a blood 
cholesterol lowing agent. Griseofulvin as antifungal medication from Penicillium sp. is also an excellent 
fungal example (Figure 2).4 These market drugs are just small numbers of PKs or their derivatives. The 
versatile scaffolds and functional groups of PKs provide many active templates or leading agents for drug 
discovery.  




1.1.1.2 Phenyethyl polyketides and their origins 
Phenethyl-containing PKs, with multiple biological activities, are frequently identified microbial SMs 
(Figure 3). Gilvocarcin E5 and tiacumicin B6 occur in Streptomyces, while barnol7 and marilone A8 are 
examples from fungi. Isotopic feeding experiments and genetic studies proved that the phenethyl units 
are products of PKS biosynthetic gene clusters (BGCs).5,6,9 The ethyl groups in the phenethyl residue of 
bacterial SMs are mostly originated from propionate as a starter unit of PKSs.5,6 In fungi, it can be derived 
from acetate as in the cases of LL-D253α10 and O-methylasparvenone,11 which was confirmed by feeding 
with [1, 2-13C] acetate. However, most methyl groups of the phenethyl residue in fungal metabolites are 
derived from S-adenosyl methionine (SAM), which has been proven by feeding experiments with [methyl-
13C]-L-methionine (Figure 3).8,12 Methyltransferases (MeTs) for the methylation and the biosynthetic 
pathways for such metabolites in fungi have not been described before. 
1.1.2 Nonribosomal peptides  
1.1.2.1 Clinically utilized bacterial and fungal nonribosomal peptides  
Nonribosomal peptides (NRPs) belong to another important group of natural products, which are mainly 
found in bacteria and fungi. Similar to PKs, NRPs used as clinical drugs are evident. Around 30 NRP 
(core) structures are found in the marketed drugs currently, contributing to sales of billions Euros in the 
chemical and pharmaceutical industry.13 Examples of bacterial NRPs used clinically as antibiotics are 
vancomycins from Amycolatopsis orientalis, daptomycin from Streptomyces roseosporus and lincomycin 
from Streptomyces lincolnensis.13 Well-known cases in fungal NRPs are β-lactam antibiotics like 
penicillins from Penicillium chrysogenum and cephalosporins from Acremonium chrysogenum. 
Ergotamine from Claviceps purpurea, is used for treatment of migraine (Figure 4).13 The various core 
structures of peptides together with multiple tailoring enzymatic modifications extensively increase the 
structural diversity of NRPs, which have huge potential for drug discovery. 




1.1.2.2 Oxepinamides, a rare class of NRP derivatives in nature  
Oxepinamides with an Oxepine-Pyrimidinone-Ketopiperazine (OPK) backbone are a rarely observed 
class of fungal NRP derivatives with a broad range of biological activities, which are mainly found in 
Aspergillus and Penicillium species. Since 1988, more than thirty seven OPK derivatives were isolated 
and identified (Figure 5).14,15 Some of them show high affinity to liver X receptors (LXRs) and are potential 
agents for the treatment of Alzheimer’s disease, atherosclerosis, diabetes, and inflammation.16,17 
Oxepinamides are usually derived from quinazolinones with anthranilyl (Ant) residue in common. They 
differ from each other by incorporation of two other varying amino acids and additional modifications. The 
natural oxepinamides can basically be divided into two classes: 1H-oxepins with three C=C in the oxepin 
ring including oxepinamide D, versicoloid A/B, circumdatin A/B and dihydrocineain and 3H-oxepin core 
structure with two C=C in the ring and one exo C=N bond, such as varioxepine A, varioloid A, 
oxepinamide F and oxepinamide G.16-19 20,21 22 23  




1.2 Natural product producers 
1.2.1. Fungi as important sources for natural products and their genetic potentials 
Microorganisms including bacteria and fungi produce plentiful secondary metabolites and therefore are 
recognized as important natural product producers. Recently, a high-throughput sequencing analysis 
revealed that about 5.1 million fungal species live on earth, about 6 times of the number of all plant 
species.24 Filamentous fungi are notable for producing huge numbers of secondary metabolites, which 
have ecological fitness roles for fungi.25 Melanin, for example, protects hosts from UV damage, phenazine 
acts as a weapon for defense in Aspergillus,24,26-28 and several secondary metabolites are proven to 
protect host from toxic natural products.25 More importantly, many fungal SMs including the 
aforementioned antibiotics, immunosuppressants, anti-osteoporosis agents, and cholesterol-lowering 
drugs, have benefitted human health.29 These examples offer the confidence and motivation for a deeper 
understanding of fungal secondary metabolites. 
Recent advances achieved in sequencing technologies and bioinformatics analysis revealed that fugal 
genomes are usually larger than those of bacteria. Genes for fungal SMs are usually clustered in a 
chromosome presented as BGCs.29 However, under laboratory culture conditions, most BGCs are only 
lowly expressed or even not expressed. Therefore, only a small number of BGCs have been accurately 
assigned to the corresponding SMs.25,29 Since last decades, genetic tools like modification of regulators 




including pathway-specific transcription factors, global regulators, epigenetic regulators, and other 
regulators largely increased the diversity of fungal SMs.29 PKs, NRPs, terpenes, indole alkaloids as well 
as ribosomally synthesized and post-translationally modified peptides are important classes of fungal 
SMs.4 In this thesis, polyketides synthases (PKSs) and nonribosomal peptides synthases (NRPSs) will 
be discussed in details.  
1.2.2. Aspergillus ustus and its secondary metabolites 
Aspergillus ustus, a member of the division Ascomycota, is usually found in indoor environments and 
soil.30 Colonies of this species appear greyish brown or dark brown.31 Since more than 20 invasive 
aspergillosis cases have been reported for this species, A. ustus is considered as a rare human pathogen 
that can cause invasive infection in immunocompromised hosts.31 Molecular data, including random 
amplification of polymorphic DNA analysis, indicate that A. ustus is highly variable.31  Phylogenetic 
analysis shows that A. ustus is close to Aspegillus puniceus and Aspergillus granulosus.31  




Aspergillus ustus has been proven to be a good producer for SMs. Until now, versatile natural products 
(Figure 6) including PKs such as austdinol, austocystin A, and sterigmatocystin, NRPs like austamide, 
phenylahistin, and prolyl-2-(1',1'-dimethylallyl)-tryptophyldiketopiperazine (Figure 6) as well as terpenes 
e.g. austin, have been obtained from different isolates of this fungus.32-34 It is noteworthy that alcohol 
feeding into the culture of an A. ustus strain led to the accumulation of benzoic esters. The molecular 
mechanism for this phenomenon has not been elucidated prior to this thesis.  
Aspergillus ustus 3.3904 was purchased from the China General Microbiological Culture Collection 
Center (Beijing, China) and used in this thesis. In 2015, this strain was sequenced and a total of 38.3 
Mbp length scaffolds were assembled.35 Bioinformatics analysis revealed the presence of more than 52 
BGCs of secondary metabolites. 28 of these BGCs contain genes coding for PKSs and 18 for NRPSs or 
NRPS-like enzymes. Some of these BGCs show considerable similarity to those of known compounds 
such as sterigmatocystin and viridicatumtoxin.35 However, neither genetic manipulation in A. ustus 3.3904, 
nor investigations on the biosynthesis of its metabolites has been reported, prior to our studies. In this 
thesis, this PhD candidate mainly focuses on the genetic manipulation in A. ustus 3.3904 to elucidate the 
biosynthetic pathways of several SMs. 
1.3 Biosynthesis of natural products 
1.3.1 Polyketide synthases 
Polyketide synthase (PKS) is one of the most abundant enzyme class attributed in microorganisms for 
natural product biosynthesis. On the basis of their structural composition, PKSs can basically be divided 
into three classes. Type I PKSs are large multidomain megaenzymes with distinct modules. Type II PKSs, 
are enzyme complexes with mono functional proteins. Type III PKSs have no acyl carrier protein domain. 
The polyketide backbone is formed by condensation of starter units such as acetyl-CoA, propionyl-CoA, 
or benzoyl-CoA with extender units via Claisen condensation.2,36,37 The type I and type II PKSs will be 
discussed in this section. 
1.3.1.1 Modular type I polyketide synthases 
Type I PKSs have been discovered in both bacteria and fungi. Type I PKSs can be basically classified 
into two subdivisions, i.e. modular and iterative type I PKSs.36 Modular type I PKSs are commonly found 
in bacteria36 and are usually large enzymes containing multi-domains including β-ketoacyl synthase (KS), 
acyl transferase (AT), and acyl carrier protein (ACP), keto reductase (KR), dehydratase (DH), enoyl 




typical modular type I PKS is the 6-deoxyerythronolide B synthase (DEBS) from Saccharopolyspora erythraea, 
assembling the core structure 6-deoxyerythronolide B. Subsequent modifications by tailoring enzymes lead to 
the production of erythromycin A (Figure 7A).38 





1.3.1.2 Iterative type I polyketide synthases 
Iterative type I PKSs are usually found in fungi. The multiple domain enzymes can be basically divided 
into three classes by the reduction level of their products: nonreducing PKS (NR-PKS), partially reducing 
PKS (PR-PKS), and highly reducing PKS (HR-PKS). All of them contain the minimal PKS domains (KS, 
AT, and ACP), the NR-PKSs lack the β-keto processing domains including KR, DH, and ER domains 
present in the HR-PKSs or PR-PKS. On the other hand, there are additional functional domains that are 
unique to the NR-PKSs, including the starter unit acyl transferase (SAT) domain, product template 
domain (PT domain), and thioesterase–Claisen cyclase (TE–CLC) domain (Figure 7Bii).39,40  
The fungal NR-PKSs are usually responsible for the production of aromatic PKs. Norsolorinic acid, a 
precursor in the biosynthesis of aflatoxin, for example, is a typical NR-PKS product. The PksA utilizes 
hexanoyl-CoA as starter unit by SAT domain and elongates with 7 malonyl-CoA catalyzed by KS, MAT 
(malonyl-CoA-ACP transacylase), and ACP to form the polyketide chain. Cyclization of the intermediate 
is catalyzed by the product template domain and the aromatic intermediate is released by TE–CLC 
domain to form the end product norsolorinic acid.41 This is an example of the simplest NR-PKS systems 
(Figure 7Bi).  
In some cases, NR-PKSs contain a reductive (R) domain at the C-terminal as release domain (Figure 
7Bi). In addition, a methyltransferase (MeT) domain is usually located between the ACP and the R domain. 
The products of such NR-PKSs are usually found to be aldehydes. For example, the 3-
methylorcinaldehyde synthase (MOS) with a SAT-KS-MAT-PT-ACP-MeT-R domain structure from 
Acremonium strictum is responsible for the production of 3-methylorcinaldehyde. Instead of releasing the 
intermediate by TE domain, the R domain was identified as a releasing domain.42,43 
Another significant difference between fungal and bacterial PKS systems is the mode of methylation 
(Figure 7Bii). Bacterial PKSs can utilize methyl-malonate as an extender unit. However, the fungal PKSs 
usually methylate growing chains at the β-dicarbonyl position by a C-methyltransferase (C-MeT) domain 
with SAM as cosubstrate.36 Mutation of key residues in the C-MeT domain of a PKS led to complete 
abolishment of polyketide production, indicating the essential role of the C-MeT domain in PKS assembly 
line.44 Recently, the crystal structure of the C-MeT in the biosynthesis of citrinin from Monascus purpureus 
was elucidated with a 1.5 Å resolution, which largely extended the knowledge of the catalytic 
mechanism.45 The conserved motif GxGxGG (residues 1,992–1,997) and the key catalytic residue H2067 
for enolization was verified in the structure. Biochemical investigation proved that the C-MeT domain can 




1.3.1.3 Type II polyketide synthases 
Type II PKSs are usually found in bacteria and responsible for the biosynthesis of aromatic core 
structure.2 An outstanding example is the oxy BGC coding the enzymes in the biosynthesis of 
oxytetracycline, which has been identified in several Streptomyces strains (Figure 8).46,47 The minimal 
PKSs containing KS-α, KS-β, and ACP, employ malonamyl-CoA as starter unit to assemble eight 
malonyl-CoA extender units into a poly-β-carbonyl intermediate. The intermediate is then cyclized and 
modified to the core structure 1,6-methylpretetramid, which can be further converted to oxytetracycline 
by diverse tailoring enzymes.46,47 
1.3.2 Nonribosomal peptide synthetases  
NRPSs are ribosomally independent enzymes that form modular templates to assemble specific peptide 
derivatives. Usually, the NRPSs are large modular complexes (Type I NRPS).48 Recently, some 
standalone NRPSs or di-domains that coordinate to form unique amino acid derivatives were also 
reported (Type II NRPS).48 In this part, the assembly line for the Type I NRPSs is discussed. 
1.3.2.1 Assembly logics of nonribosomal peptide synthetases 
As aforementioned, NRPs from microorganisms are important sources for drug discovery and many 
market drugs are from NRPs. Excellent examples are ergotamine for migraine (Figure 4), tyrothricin, 
vancommycin, capreomycin, lincomycin and daptomycin as antibiotics, and cyclosporine as an 
immunosuppressive drug.13 The backbones of NRPs are biosynthesized by the well-known NRPSs. 




The core NRPS domains consist of adenylation (A) domain, thiolation or peptidyl carrier protein (T or 
PCP) domain, and condensation (C) domain (Figure 9). Firstly, A domains recognize and activate their 
cognate amino acids by selectively binding the amino acids and converting them to high-energy 
aminoacyl-AMPs at the expense of ATP molecules. Secondly, the A domain protects the high-energy 
intermediate from bulk water to subsequently catalyze its loading onto the Ppant arm of the holo-T domain. 
Then, the C domain catalyzes peptide bond formation between the activated amino acids or nascent 
peptide which is attached to the upstream T domain. After aforementioned three steps, the oligopeptidyl-
enzyme intermediate is formed. Usually, a conserved serine residue in TE domain forms an ester bond 
with the C terminus of the oligopeptide. Hydrolysis or intramolecular attack of a nucleophilic moiety of the 
intermediate leads to the formation of a linear or macrocyclic product, respectively (Figure 9).13,49,50  
Additional domains of NRPSs 
TE domain. After NRP assembly line is finalized, the T domain located in the termination module 
transfers the mature peptide to the TE domain for releasing the peptide from the NRPS. The TE domain 
contains a conserved catalytic triad of Ser residue that links the mature peptidyl intermediates. Product 
release from the TE domain follows either by hydrolysis (water as a nucleophile) or aminolysis (amine as 
a nucleophile), thereby liberating linear products. In addition, TE domains often acts as cyclases by 
constraining the substrate’s conformation to form a lactone or lactam. Both head-to-tail, e.g. gramicidin 
S,51 and side-chain-to-tail, e.g. daptomycin,52 exist in numerous NRPs. 




Epimerization domain. Most of NRPs are equipped with D-amino acids which confer beneficial 
properties, e.g. predetermining bioactive conformations or protecting against peptidase and protease 
attacks.53 The epimerization in NRPS is usually catalyzed by an epimerization (E) domains, embedded 
within the assembly line (Figure 10). It acts on T domain-bound aminoacyl substrates and plays an 
essential role in NRPS assembly line.50 In tyrocidine biosynthesis in Bacillus brevis, the C5 domain only 
utilizes D-Phe-L-Pro-L-Phe-D-Phe-PCP, a product of E4 domain, as a substrate for condensation.54 In the 
biosynthesis of acetylaszonalenin from the fungus Neosartorya fischeri, compared with the amount of the 
cyclodipeptide with Ant and D-Trp produced by the wild-type, less than 1% of cyclo-Ant-L-Trp was 
detected as product after inactivation of the E domain.  
Bioinformatics analysis indicated that E domain is descendant of the C domain. A common acid-base 
catalytic mechanism of E domains with exogenous cofactors was proposed.13 For example, in the TycA 
assembly line, the Glu882 residue abstracts the α-proton, while the His743 residue and the dipole 
moment of α-helix 4 possibly stabilize the transient enolated intermediates.55 
Methyltransferase domain. Most of methylations in NRP biosynthetic pathways are performed by MeT 
domains which are integrated into the A domain (Figure 10). A MeT domain transfers the methyl group 
from its co-substrate SAM to the growing peptide chain. Until now, N-methylation of the peptide backbone 
is the most abundant type. O-, S-, and C-methylations have also been reported.13 
Reductase domain. The R domain catalyzes the reduction of the tethered peptidyl thioester to aldehyde 
or primary alcohol (Figure 10). It has been proven biochemically that the R domain acts as a NAD(P)H-
dependent reductase and replaces the TE domain of a termination module.56 Similar to TE domains, R 
domains do not essentially need tethered substrates to be provided by their upstream T domains. 




Other tailoring domains. Besides the aforementioned domains, other features like communication 
domains for the interactions between the C-terminal domain of the first modular and the N-terminal 
domain of the second modular, formylation domain for N-formylation, halogenase domain, cyclization 
domain and oxidation domain for the five-membered ring formation (thiazoline to thiazole), and 
monooxygenase domain have also been reported.13 Even the typical PKS domains KR and DH were 
found in NRPSs, which largely expand the NRPS diversity.13 
1.3.2.2 Biosynthesis of quinazolinone derivatives in fungi 
As described in sections 1.1.2, fungal peptidyl alkaloids, especially those biosynthesized by NRPSs are 
structurally diverse natural products with high affinity for various biological targets. Unlike bacterial 
NRPSs employing TE domains to perform cyclization, many fungal NRPSs use a terminal 
condensation-like domain (CT domain) as the terminal domain to produce peptidyl products.57 
Bioinformatics analysis of the CT domain from several fungi revealed the highly conserved HXXXDXXS 
motif in the active sites. Point mutation of the His residue led the inactivation of the CT domain, proving 
its essential role for the NRP cyclization (Figure 11).58 
It has been proven that quinazolinone-related cyclic tripeptide derivatives are natural products assembled 
by a tri-modular NRPS containing three A-T-C modules, which use anthranilate as a common residue for 
the backbone formation.59 Normally, the macrocycle of NRPs is formed via an ester bond catalyzed by a 
TE domain, which leads to the production of the most cyclized peptides.13 However, for the biosynthesis 
of the quinozalinone NRPs, a two-step cyclization mechanism was speculated.58,60 The first step is the 
formation of a ten-membered macro ring from the tripeptidyl thioester, followed by spontaneous 
intramolecular annulation as second step to form the quinazolinone core (Figure 11). 
Figure 11. Quinazolinone backbone formation catalyzed by a terminal condensation-like 




Despite the structural diversity of quinazolinone peptidyl products, only a few NRPSs for quinazolinone 
tripeptides have been reported previously. These are FmqA from Aspergillus fumigatus for the 
fumiquinazoline C biosynthesis,61 TqaA from Penicillium aethiopicum for the tryptoquialanine formation,62 
AldpA from Penicillium janthinellum for alanditrypinone, and CtqA from Neosartorya fischeri NRRL181 
for the biosynthesis of cottoquinazolies.63 The NRPS AspA from Aspergillus alliaceus, which coordinates 
Ant, Ant, and Trp to form asperlicins, shares similar domain structure with FmqA, TqaA, AldpA, and 
CtqA.64 The NRPSs together with their tailing redox enzymes, mostly flavin-dependent- and nonheme 
FeII/2-oxoglutarate-dependent monooxygenases (FeII/2-OG-dependent oxygenases), increase the 
structural complexity in quinazolinone peptidyl products (Figure 12). Comparison of the structures of 
oxepinamides with that of the quinozalinone backbone revealed the only difference in the Ant residue. 
While quinozalinones contain a benzene ring in quinozalinone backbone, oxepinamides carry an oxepin 
ring. It can be speculated that the oxepinamides might also be trimodular NRPS derivatives. 
1.3.3 Tailoring enzymes 
As introduced in section 1.3.1 and 1.3.2, PKSs and NRPSs synthesize different backbones of numerous 
SMs. For the most natural products, they are further modified in an enzymatic or nonenzymatic manner. 
As the rapid development in studies on the natural product biosynthesis, plentiful enzymes for backbone 
modifications have been identified biochemically, e.g. oxidoreductases, transferases like. MeTs, 
glycosyltransferases, acyltransferases, and prenyltransferases.65,66 In this section, four important enzyme 




classes including cytochrome P450 enzymes, flavin-dependent and FeII/2-OG-dependent oxygenases, 
as well as fungal prenyltransferases will be introduced briefly. 
1.3.3.1 Cytochrome P450 enzymes 
Cytochrome P450 enzymes (P450s) are the most common biological biocatalysts in natural product 
biosynthesis. Generally, P450s function as monooxygenases catalyzing the hydroxylation and 
epoxidation steps. Recently, increased cases demonstrated other intriguing functions of P450s, e.g. 
intramolecular and intermolecular aromatic ring coupling, C–C bond cleavage, ring formation or 
expansion.67 Here, the general catalytic mechanism of hydroxylation and epoxidation by P450s will be 
discussed. 





Based on amino acid sequences, P450s can be basically divided into ten classes.68 In fungi, the diversity 
of P450s is tremendous, and they are involved in the biosynthesis of a wide range of metabolites including 
primary and secondary metabolites as well as in the environmental pollutant degradation process.69 The 
majority of the fungal P450s are membrane-bound proteins belonging to class II P450s and catalyze 
extremely diverse oxidations. Basically, fungal P450s perform the monooxygenase reaction by inserting 
one atom of oxygen molecular into the substrate, and reducing the second oxygen atom into water.70  
P450-catalyzed hydroxylation undergoes a general nine-stage catalytic mechanism (Figure 13): (a) the 
formation of the ferric heme-iron (FeIII) complex with six ligands that contain four nitrogen atoms of the 
porphyrin (Por) ring, the absolutely conserved cysteine (Cys), and one water molecule. (b) The substrate 
(SH) enters the active site and binds to the FeIII complex with the replacement of the water ligand, which 
is in the oxidized state. (c) Cytochrome P450 reductase (CPR) using FAD and FMN as cofactor transfers 
one electron to from NAD(P)H to FeIII complex leading to the production of FeII complex as the ‘first 
reduction step. (d) By binding of one molecular oxygen, the ferrous heme-iron (FeII) converts to the 
dioxygen adduct [Cys–FeII–O2]. (e) The CPR (or cytochrome b5) transfers the second electron to [Cys–
FeII–O2] leading to the production of ferric peroxo intermediate [Cys–FeIII–OO]-. (f) The negatively 
charged intermediate can be quickly protonated to ferric hydroperoxo intermediate [Cys–FeIII–OOH]. (g) 
Subsequently, the second protonation and heterolytic cleavage of the O–O bond gives the reactive ferryl-
oxo intermediate [Cys–FeIV=O]+ with concurrent loss of a water molecule (porphyrin π-cation radical). (h) 
This extremely reactive species abstracts a hydrogen atom from the substrate, yielding a substrate 
radical and the ferryl-hydroxo compound. (i) The radical rebound to the hydroxyl group of intermediate 
results in the insertion of an oxygen atom into the substrate leading to the formation of the hydroxylated 
product (SOH) or epoxidation products. The product is then released from the active site and rebounding 
a water molecule to the ferric heme-iron (FeIII) complex restores the resting state (a). An alternative route 
is binding of H2O2 to the ferric heme-iron (stage b), which leads to the peroxide stage f.67,70,71 
1.3.3.2 Flavin-dependent oxygenases 
Flavin cofactors are mostly used as redox catalysts by enzymes and are originated from riboflavin 
(vitamin B2) that is converted to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) in 
the cells. The majority of flavin-dependent enzymes catalyzes oxidations. However, reactions such as 
halogenation by the brominase Bmp2,72 pyrrolizine ring reconstruction via intramolecular C–N bond 




the catalytic mechanisms of flavin-dependent oxygenases using NAD(P)H as cofactor will be discussed 
briefly.  
Based on protein sequence motifs, structural features, electron donors, and oxygenation types, flavin-
dependent monooxygenases can be basically divided into eight classes. Most flavin-dependent 
monooxygenases, which utilize NAD(P)H as electron donor, belong to the classes A and B.77 Despite of 
the fact that various flavin-dependent monooxygenases have been discovered, just two catalytic 
mechanisms with C4a-hydroperoxy and N5-oxide as reactive oxygenating species were reported (Figure 
14).78 
Usually, the flavins including FAD and FMN exist commonly in their oxidized form Flox under aerobic 
conditions. After transferring two electrons from the donor NAD(P)H, the Flox intermediate is converted to 
its reduced form Flred. O2 as electron acceptor reacts with Flred in two ways, which produces oxygenating 
species in form of flavin-C4a-hydroperoxide (FlC4a[OOH]) or flavin-N5-oxide (FlN5[O]). These two 
Figure 14. FlC4a[OOH] and FlN5[O] catalytic mechanisms of flavin-dependent enzymes with AspB 




intermediates can serve as nucleophilic oxygenating agents for their substrates.76 The produced C4a-
hydroflavin will be dehydrated to Flox for the next reaction cycle (Figure 14). 
Most reactions catalyzed by flavin-dependent monooxygenases including hydroxylation, epoxidation, and 
Baeyer-Villiger oxidation follow the typical FlC4a[OOH] mechanism.76 The fungus-derived flavin-dependent 
monooxygenase AspB converts an indole to a 2-keto indoline ring via a postulated arene oxide 
intermediate, which was proven to utilize FlC4a[OOH as a key intermediate.79 The typical FlN5[O] 
monooxygenase is EncM in the biosynthesis of enterocin from several Streptomyces strains.80,80-82 EncM 
harbors the FlN5[O] as oxygenating species and the poly-β-carbonyl intermediate acts as electrophilic 
substrate that triggers the Favorskii-like rearrangement of the polyketide carbon backbone and multiple 
cyclization reactions to form the final product enterocin (Figure 14).80,80-82  
1.3.3.3 Nonheme FeII/2-oxoglutarate-dependent monooxygenases 
Nonheme FeII/2-oxoglutarate (FeII/2-OG)-dependent monooxygenases are widely distributed in 
microorganisms and catalyze numerous types of reactions. For example, CitB acts as a hydroxylase, 
AmbO5 as a halogenase, and CODM as an O-demethylase.83 In this section, the general catalyzed 
mechanism of FeII/2-OG-dependent monooxygenases is briefly introduced.  
Figure 15. Catalytic mechanisms of FeII/2-OG-dependent enzymes. A: The catalytic cycle of 
hydroxylation by FeII/2-OG-dependent enzymes. B: FeII/2-OG-dependent enzyme ClaD in the 




For the most of previously reported FeII/2-OG-dependent monooxygenases, the catalysis is initiated by 
coordination of FeII to three water molecules and the conserved 2-His-1-Asp facial triad ligands (stage a) 
(Figure 15A). 84,85 The intermediate of stage b is produced via the displacement of two water molecules 
with the keto and carboxyl groups of 2-oxoglutarate in the FeII center. The replacement of the third water 
molecule of the FeII center with one O2 molecule leads to the production of the FeIII-superoxo intermediate 
(stage c). A peroxohemiketal bicyclic intermediate (stage d) is generated after attacking the keto group 
in the 2-oxoglutarate by the distal oxygen atom of the FeIII-superoxo species. A subsequently oxidative 
decarboxylation yields the high valence FeIV=O (ferryl) intermediate (stage e). Similar to that of P450s, 
this very reactive species abstracts a hydrogen atom from the substrate (SH) to reduce the iron to the 
FeIII-OH form accompanied by the substrate radical (S•) formation (stage f). The rebounding of hydroxyl 
radical with the substrate radical leads to the production of the hydroxylated product (S-OH) as well as 
the FeII species binding with one succinate (stage g). The release of the succinate and the attachment 
of three water molecules regenerate the initial state a for the next catalytic cycle (Figure 15A).86 
An outstanding example of the fungal FeII/2-OG-dependent monooxygenase is ClaD in the biosynthetic 
pathway of peniphenones and penilactones in Penicillium crustosum. ClaD utilizes FeII and 2-
oxoglutarate as cofactors to hydroxylate the methyl group of clavatol. After spontaneous dehydration to 
an ortho-quinone methide, the intermediate undergoes a nonenzymatic 1,4-Michael addition, which is 
essential for the backbone formation in the final products (Figure 15B).87 
1.3.3.4 Prenyltransferases 
Prenyltransferases  belong to one of the most important modifying enzymes of natural products and 
catalyze the transfer reactions of prenyl units (n x C5, n=1, 2, 3, 4 etc.) from prenyl diphosphates to 
different aliphatic and aromatic acceptors, which largely increases the diversity of natural products.88 
Members of the mostly biochemically and structurally investigated PT group share significant sequence 
identities with the dimethylallyltryptophan synthase in the biosynthesis of ergot alkaloids and are therefore 
termed DMATS enzymes.57,88-90 Most PTs of the DMATS superfamily use dimethylallyl diphosphate 
(DMAPP) as donor and L-tryptophan or tryptophan-containing cyclodipeptides as acceptors and are 
involved in the biosynthesis of diverse indole alkaloids.57,88 The dimethylallyl moieties are attached to N-
1, C-2, C-3, C-4, C-5, C-6, or C-7 of the indole ring in a regular or reverse manner (Figure 16A). For the 
regular prenylation, DMAPP was proposed to form a dimethylallyl cation/pyrophosphate ion pair. The 
primary center of DMAPP is attacked by the electron-rich aromatic ring with a concerted displacement of 
pyrophosphate to form the arenium ion intermediate, which re-aromatizes by deprotonation to form the 
final product.91-93 For the reverse prenylation, the nucleophilic attack takes place at the tertiary center 




mainly place at C-2 and C-3 of the cyclodipeptides, like those of cyclo-L-Trp-L-Pro catalyzed by NotF and 
BrePT,94,95 cyclo-L-Trp-L-Ala by EchPT1,96 cyclo-D-Trp-Ant by AnaPT,97 and cyclo-L-Trp-L-Leu by 
CdpC3PT.98 L-tryptophan is usually regularly prenylated at C-4, C-5, C-6, and C-7 positions, as 
demonstrated for FgaPT2,99 5-DMATS,100 6-DMATS,101 and 7-DMATS, respectively.102 
FgaPT2 from Aspergillus fumigatus was identified as a C4-DMATS, which initiates the biosynthesis of 
the ergot alkaloids fumigaclavines.99 The crystal structure of FgaPT2 contains a rare ß/α fold (PT barrel) 
and serves as a basis for understanding the prenylation mechanism and for enzyme design.92,93 
Structure-based molecular modelling and site-directed mutagenesis revealed that Lys174 facilitates the 
entrance of substrates in the reactive center and Ile80, Leu81, Tyr191, and Arg244 anchor the polar side 
chain of L-tryptophan.93 Mutation of Lys174 to Phe switches FgaPT2 to a tyrosine C3-prenyltransferase 
FgaPT2_K174F.103 Arg244 mutants significantly enhance the catalytic ability of FgaPT2 towards 
tryptophan-containing CDPs and keep the prenylation position at C-4.104 Luk et al105 demonstrated that 
FgaPT2_K174A can prenylate L-tryptophan at both C-3 and C-4 position and proposed the C4-prenylated 
derivative to be the result of Cope rearrangement of a C3-prenylated derivative. Acceptance of 
tryptophan-containing CDPs by FgaPT2_K174A has not been tested before, while FgaPT2 was also 
demonstrated to prenylate these compounds at C-4, i.e. the same position as for the natural substrate L-
tryptophan (Figure 16B). All these results proved FgaPT2 as an excellent model for enzyme design by 
site-directed mutagenesis.
Figure 16. A Enzymatic N1, C2, C4, C5, C6 and C7 prenylation of indole ring. B multifunction 
of FgaPT2 after site-directed mutation 
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2. AIM OF THIS THESIS 
 
2. Aim of this thesis 
In this thesis, the following issues have been addressed: 
(1). Biosynthesis of ustethylins and the formation of benzoyl esters 
Despite the abundant secondary metabolites from Aspergillus ustus, biosynthesis of only few natural 
products were reported. Cultivation of the fungus Aspergillus ustus 3.3904 in PD media led to the 
detection of a dominant unknown product. Feeding alcohols to the three-day old culture led to significant 
decrease of this peak and the formation of benzoyl esters. The biosynthesis of these esters has not been 
reported before. The aim of this project is to identify the structure of the unknown dominant peak and to 
elucidate its biosynthetic pathway as well as the molecular basis for the ester formation after feeding with 
alcohols. 
The following experiments were carried out: 
➢ Isolation and structural identification of the dominant peak ustethylin A from Aspergillus ustus 
culture in PD media. 
➢ Elucidation of the origin of ustethylin A by feeding with different isotopic precursors 
➢ Identification of the putative utt BGC by bioinformatics analysis 
➢ Verification of the gene function of utt BGC in the biosynthesis of ustethylin A by gene deletion, 
feeding experiments, and heterologous expression 
➢ proving the relationship of ester formation to the ustethylin A biosynthesis 
The designed experiments of this project have been successfully finished in cooperation with Yiling Yang. 
She isolated and identified the metabolites and also carried out isotopic feeding experiments. 
(2). Elucidation of two oxepinamide biosynthetic pathways 
Oxepinamides D, E, and F are rare bioactive fungal metabolites derived from Oxepine-Pyrimidinone-
Ketopiperazine (OPK) backbone and were isolated from rice cultures of Aspergillus ustus. Based on their 
structures, it can be deduced that oxepinamides are products of NRPSs. The biosynthesis of the 
oxepinamides, especially the formation of the oxepin ring was still unclear before this study. Furthermore, 
elucidation of the tailoring enzymes will largely contribute to our understanding on the structural diversity 
of the oxepinamide family. The aim of this project is to identify the biosynthetic gene clusters of 
oxepinamides D, E, and F, to elucidate the formation of the oxepin ring, and the tailoring modifications 
afterward.  
The following experiments were carried out: 
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➢ Isolation and identification of oxepinamides D, E, and F from the rice culture of Aspergillus 
ustus 3.3904. 
➢ Identification of the opa BGC for the biosynthesis of oxepinamides E and F and opa2 BGC for 
oxepinamide D. 
➢ Verification of the putative NRPSs OpaA and OpaA2 for assembling the quinazolinone core 
structures. 
➢ Identification of OpaB and OpaB2 as oxepinases for the oxepin formation and proof of their 
substrate specificity.  
➢ Biochemical characterization of the flavin-dependent oxegenases OpaC and OpaC2 for 
hydroxylation at different positions of OPK backbone. 
➢ Biochemical investigation of the epimerase OpaE catalyzing the configuration change of Phe 
residue from D- back to L- form during the biosynthesis of oxepinamides E and F. 
The designed experiments of this project have been successfully finished in cooperation with Haowen 
Wang. She isolated and identified the oxepinamides and the biosynthetic intermediates. 
(3). Switch the catalytic activity of a tryptophan prenyltransferases by protein design. 
PTs belong to one of the most important modification enzymes of cyclodipeptides (CDPs) and are key 
enzymes to increase the structural diversity and biological activity of secondary metabolites. FgaPT2 has 
been characterized as a regular C4-prenyltransferase of L-Trp. Mutation of Lys174 and Arg244 can 
change the function of the enzyme and enhance its acceptance for CDPs as substance. The aim of this 
project is to explore the additional function of FgaPT2 and its mutants towards L-Trp containing CDPs. 
The following experiments were carried out: 
➢ Construction of mutants FgaPT2_K174A, FgaPT2_K174F, and FgaPT2_K174F_R244X (X= L, 
N, Q, Y) via sequential site-directed mutagenesis. 
➢ Overexpression of the obtained mutants in Ecoli BL21 (DE3). 
➢ Purification of the recombinant proteins  
➢ Activity tests of the obtained variants toward L-tryptophan-containing CDPs. 
➢ Isolation and structural elucidation of the products. 
➢ Determination of the kinetic parameters. 
The designed experiments of this project have been successfully finished in cooperation with Dr. Peter 
Mai. He constructed several mutants and verified by sequencing.
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3. Results and discussion 
3.1 Biosynthesis of ustethylins in Aspergillus ustus and the shunted pathway after alcoholic feeding 
As described in section 1.1.1.2, phenethyl-containing natural products are common microbial metabolites. 
The ethyl groups in phenethyl residue of bacterial metabolites are mostly originated from propionate as 
starter unit of PKSs.5,6 In fungi, the methyl group of the phenethyl residue is generally derived from 
SAM.8,12 However, the responsible genes/enzymes for the methylation have not been reported previously.  
HPLC analysis of the EtOAc extract of an A. ustus 3.3904 culture in PD media revealed that ustethylin A 
(1) was almost the only product peak in the chromatogram. During isolation, the amount of ustethylin A 
(1) decreased evidently. Dissolving the finally isolated 7 mg sample in DMSO-d6 led to precipitation 
immediately. The 1H NMR spectrum of the supernatant was very complex, so that an interpretation was 
impossible. To overcome the instability, 1 in the fungal extract was immediately converted with Ac2O 
NaOAc at room temperature 106 by Haowen Wang to its triacetate 2 for structural elucidation (Figure 17). 
To elucidate the origin of ustethylin A (1), we carried out feeding experiments with sodium [1,2-13C] 
acetate, sodium [1-13C] acetate, sodium [2-13C] acetate and [2-13C] malonic acid. The 13C NMR results 
proved that C-1/C-7, C-2/C-3, C-4/C-5, and C-6/C-9 are from four intact units originating from 
Figure 17. The structures of ustethylin A (1) and its triacetate (2) 
Figure 18. Labelling pattern of compound 2 after feeding different precursors.  
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acetate/malonate (Figure 18). The 13C NMR spectrum of 2 after feeding with [methyl-13C]-L-methionine 
showed enhanced signals for C-8, C-10 and C-11, proving that the methyl group of the phenethyl residue 
is also from SAM. To figure out whether A. ustus utilizes propionate as starter unit, sodium [2-13C] 
propionate was fed into the culture. To our surprise, the labelling pattern of 2 is very similar to that with 
[1-13C] acetate. No enrichment for C-9 at 31.5 ppm was observed. These results proved unequivocally 
that sodium [2-13C] propionate was not directly utilized for incorporation, but was degraded to acetyl-CoA 
likely via pyruvate by α-oxidation (Figure 18).107 
From the structure of 1, it can be deduced that a NR-PKS would be responsible for the formation of its 
backbone.108 Based on the bioinformatics and transcriptome analyses, the PKS gene uttA coding for 
KIA75596 (Figure 19) was one of the eighty best expressed genes under our culture conditions. HPLC 
analysis of the culture extract of a ΔuttA mutant showed complete loss of 1 production, proving its 
involvement in the biosynthesis of 1. Heterologous expression of uttA in A. nidulans LO8030109 leading 
to the production of three benzoic acid derivatives 3 – 5 (Figure 20). They differ from each other just in 
the methyl group at C-3 and the ethyl group at C-6 of the benzene ring, indicating multi-methylation steps 
during 5 formation.  
Bioinformatics analysis revealed that UttA is a NR-PKS with a domain architecture of KS-MAT-PT-ACP-
ACP-MeT-TE (Figure 20).39 It can be speculated that the methyl groups in 3 are transferred by the MeT 
domain from SAM. Creation of the mutants at the key catalytic residues, UttA_G1778V and UttA_H1850A, 
and expression in A. nidulans LO8030 resulted in the abolishment of the PKS products 3 – 5. Feeding 
propionate to the two mutants did not lead to any detectable product formation, confirming that UttA 
cannot directly utilize propionate as starter as described above. These results indicated that the 
methylation step is essential for the polyketide assembling by UttA. However, it cannot be excluded that 
mutation at G1778 and H1850 had influences on the transcription, translation process or protein stability. 
We proposed that malonyl-CoA is loaded onto the MAT domain and transferred to the ACP domain. The 








PKS oxidoreductase regulator O-MeT transporter unknown 
function
NRPS-Like
Figure 19. Putative BGC (utt BGC) for ustethylin A (1).  
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two malonyl-CoA molecules, the MeT domain attaches the second methyl group. Condensation with 
another malonyl-CoA molecule leads to the production of a polyketide chain, which is subsequent 
cyclized by the PT domain and released by the TE domain, resulting in the formation of the predominant 
product 5 (Figure 20). 
1 differs structurally from 5 in oxidation states of the functional groups at C-1, C-3 and C-6 as well as O-
methylation at OH-4. The conversion of 5 to 1 would require three oxidoreductases and an O-MeT. 
Deletion of the NRPS_like gene uttJ abolished the formation of 1 and accumulation of 3 – 5 with almost 
the same product profile of the A. nidulans uttA expression strain. This proved unambiguously its role in 
the reduction of carboxyl group to aldehyde. Feeding 5 into the A. nidulans uttJ overexpression strain led 
to the detection of ustethylin D (6), confirming UttJ as an aryl acid reductase. Deletion of the putative 
nonheme FeII/2-oxoglutarate dependent oxygenase UttH led to the accumulation of UttJ product 6, 
proving the reaction order of both enzymes. Deletion of uttC coding for a cytochrome P450 enzyme 
abolished the formation of 1 and the production of 7 (ustethylin B), which differs from 1 just in the oxidation 
state of the ethyl group. This proved that UttC catalyzed the last step in the biosynthesis of 1. One 
predominant peak ustethylin C (8) was observed in the ΔuttF mutant. Similar to 1, 8 was also found to 
be unstable and could not be obtained in pure form for structure elucidation. However, its structure could 
be elucidated after conversion to its diacetylated derivative. Deletion of uttD coding for a regulator 
completely abolished product formation, proving its role in the utt BGC. The biosynthetic pathway of 
ustethylin A is illustrated in Figure 20. 
In 1987, a study reported the accumulation of 2,4-dihydroxy-3-methyl-6-ethyl benzoyl methyl and ethyl 
ester after feeding an Aspergillus ustus culture with MeOH and EtOH, respectively. Isotope incorporation 
was observed for both methyl groups of the aryl acid after feeding with [methyl-13C]-L-methionine, 
indicating their origin from SAM. Isotope labelling experiments also proved that other carbons are derived 
from acetate.12 However, the biosynthetic process for these compounds was unclear. We repeated the 
feeding experiments with MeOH and EtOH into three-day-old cultures of A. ustus 3.3904. In the extracts 
of the cultures with externally fed MeOH and EtOH, three benzoyl esters each, 9 – 11 and 12 – 14, were 
detected, respectively, with 11 and 14 as the major products. These results are in good consistence with 
those reported previously.12 Compared the structures, the products of the PKS enzyme UttA 3 – 5 are 
the acyl moieties of 9 − 11 and 12 – 14. Thus, we speculated that compounds 9 – 14 are also derived 
from the ustethylin pathway (Figure 20). 
To prove this hypothesis, MeOH was fed into ΔuttA mutant, which did not lead to an accumulation of 9 – 
11. Similar results were also observed after feeding the ΔuttA mutant with EtOH. This clearly proved the 
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involvement of UttA in the formation of compounds 9 – 14. To figure out whether the ester formation 
utilizes free acids in A. ustus, 5 dissolved in MeOH was fed to the culture of ΔuttA mutant. No trace of 11 
was detected in the HPLC result. Alternatively, 5 was converted to the corresponding benzaldehyde 6 
(ustethylin D). Additionally, 11 was not detected after incubation of 5 with MeOH at 37℃ for 16 h. These 
results proved that the ester formation in 9 – 14 requires activation of the acidic precursors 
As mentioned above, we proposed that malonyl-CoA is utilized as both the starter and extension units 
for the PKS UttA. Two methylation steps, at C-3 of the benzene ring and the C6-methyl group, are 
involved in the formation of the aryl acyl-ACP molecules (Figure 20), which are then released as free aryl 
acids and modified by tailoring enzymes. The UttA bound acyl component can also be hijacked by 
alcohols to form the esters (Figure 20). The production of the trace products 9, 10, 12, and 13 after 
feeding with alcohols confirmed the incomplete methylation by UttA. The reduction of the acid 5 to the 
benzaldehyde 6 by the NRPS-like enzyme UttJ is a prerequisite for further modification. Therefore, the 
esters 9 – 14 cannot be further metabolized by the tailoring enzymes in the Utt pathway and were 
accumulated as artificial products. Ester bonds are universally present in natural products and are usually 
formed during chain release in the PKS 110 or NRPS and by Baeyer–Villiger monooxygenases.111 
However, spontaneous ester formation has also been reported for carboxylic acids by incubation in 
alcoholic solvents at room temperature.112 Therefore, the enzymatic or nonenzymatic formation of 9 – 14 
still needs further exploration (Figure 20). 
Figure 20. Proposed biosynthetic pathway of ustethylin A and the shunt products after feeding 
with MeOH and EtOH 
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In conclusion, we verified the biosynthetic gene cluster of the highly oxygenated aryl-aldehyde derivative 
ustethylin A and elucidated its biosynthetic pathway by gene deletion and expression as well as isotopic 
labelling experiments. The PKS UttA as a key enzyme is responsible for the formation of the phenethyl 
core structure with methylation as key reactions. Consecutive and coordinated modifications by three 
different kinds of oxidoreductases and one O-MeT lead to the final product. Alternatively, this pathway 
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3.2 Biosynthesis of oxepinamides D, E, and F in Aspergillus ustus 
Oxepinamides including 1H-oxepins with three C=C double bonds in the oxepin ring and 3H-oxepins with 
two C=C double bonds in the ring and one exo C=N bond are fungal natural products with a fused 
pyrimidinone ring system. Despite the intriguing structural features and biological activities, studies on 
the biosynthesis of oxepinamides, especially the formation of the oxepin ring, have not been reported 
before. Oxepinamide F (15) and E (16) were isolated from A. ustus 3.3904 after cultivation in rice media. 
The NMR signals at δH 6.7 (d, 7.3 Hz), δH 5.5 (t, 7.1 Hz), δH 6.2 (dd, 10.0, 7.0Hz), and δH 5.8 ppm (d, 
10.1 Hz) as well as δC 144, 104, 130, and 128 ppm were observed in their spectra and indicate the 
existence of 3H-oxepins. Their structures were identified by comparison with the reported data.16,17  
To investigate the biosynthesis of 15, we sequenced the A. ustus 3.3904 genome with the help of Prof. 
Aili Fan in Beijing, predicted the putative BGCs by using AntiSMASH,113 and compared them with the 
published data.35 The core structure of 15 is likely assembled from Ant, Phe, and Ile by a NRPS containing 
at least three A-T-C modules.114 15 differs from 16 only in the methyl group at OH-12, indicating that an 
O-methyltransferase (O-MeT) should be involved in the biosynthesis. Bioinformatics analysis of the A. 
ustus genome revealed two NRPSs, KIA75458 and KIA75688, containing three A-T-C modules. In 
addition, a gene coding for a putative O-MeT (KIA75453) was only found neighboring to the gene for 
KIA75458. Thus, the KIA75458-related BGC was the best candidate for the biosynthesis of 15 and 16. 
Inspecting the genomic neighborhood of opaA, coding for KIA75458, revealed the presence of a putative 
BGC comprising six genes opaA – opaF (Figure 21), coding for the putative proteins KIA75458 – 
KIA75453 in the NCBI database. Sequence analysis and comparison indicated their putative functions 
Figure 21. Putative biosynthetic gene clusters of oxepinamide F (opa) and oxepinamide D 
(opa2) 
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as cytochrome P450 enzyme (OpaB, KIA75457), flavin-dependent oxygenase (OpaC, KIA75456), 
transporter (OpaD, KIA75455), epimerase (OpaE, KIA75454), and O-MeT (OpaF, KIA75453). . 
To prove their roles in the biosynthesis of 15, we carried out gene deletion experiments with hygromycin 
as selection marker. HPLC analysis of a rice culture extract of the opaA deletion mutant revealed the 
abolishment of the production of both 15 and 16, proving its involvement in their biosynthesis. Deletion 
Figure 22. Comparative illustration of the biosynthetic pathways for oxepinamides D and F in 
Aspergillus ustus 
Figure 23. Quinozalinone core formation by NRPSs OpaA (A) and OpaA2 (B) 
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of opaF coding for a methyltransferase abolished the production of 15, but not that of 16, proving OpaF 
is responsible for the conversion of 16 to 15 (Figure 22). Heterologous expression of opaA in A. nidulans 
LO8030115,116 117 led to the production of the tripeptide  protuboxepin K (17)118 119 proving its function for 
assembling the quinazolinone core (Figure 23). These results proved unequivocally that the opaA-related 
BGC is involved in the biosynthesis of 15 and 16.  
Deletion of opaB coding for a P450 enzyme abolished the production of 15 and 16, accompanied by 
accumulation of compound 17. Heterologous expression of opaB in A. nidulans LO8030115,116 117 was 
carried out to figure out its function. Protuboxepin A (18 )120 was detected as sole product after feeding 
17 in the obtained overexpression strain. This proved that the P450 enzyme OpaB alone catalyzes the 
oxepin ring formation (Figure 24). Phylogenetic analysis of P450 enzymes indicated that OpaB is located 
near to the epoxidase AtaY, but far away from the oxepinase AtaF in Aspergillus terreus,121 providing 
additional evidence for identification of a new class of oxepinases. Sequence alignments revealed that 
the conserved P450 motif ExxR is present as ETMR in OpaB.122-124 Similar to the alkane hydroxylations 
and alkene epoxidations catalyzed by P450 enzyme,125,126 the electrophilic oxoferryliron (FeIV=O) is 
speculated to be the active oxygen intermediate in the OpaB reaction. An arene oxide was formed after 
attacking of the oxoferryliron species by the nucleophilic benzene double bond in 17. Such arene oxide 
is in rapid spontaneous equilibrium with the oxepin 18 through 6π electrocyclic ring opening (Figure 
24).127,128 
Figure 24. Oxepin ring formation catalyzed by oxepinases OpaB (A) and OpaB2 (B) 
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Deletion of opaC from the A. ustus genome led to the accumulation of 19 (Figure 25). NMR and CD 
analyses revealed that 19 (termed 15-epi-oxepinamide E) and 16 are diastereomers and differ from each 
other merely in the configuration at C15. To figure out the catalytic role, opaC was amplified from cDNA 
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and cloned into pET28a (+) for overexpression in Escherichia coli. The recombinant N-terminally His6-
tagged protein was purified to near homogeneity with a yield of 3.5 mg per liter culture [Figure 25A(i)]. As 
expected, one product peak 19 was detected in the incubation mixture of 18 with the purified OpaC in 
the presence of NADPH. In the incubation mixture of 17 and OpaC, no substrate consumption was 
observed, proving the prerequisite of the oxepin ring for an acceptance by OpaC. The reaction of OpaC 
with 18 in the presence of NADPH follows a typical substrate inhibition equation. An apparent KM value 
at 0.15 ± 0.006 mM and a turnover number (kcat) at 0.25 ± 0.003 s−1 were calculated [Figure 25A(ii)]. 
Phylogenetic analysis revealed that OpaC belongs to the well-studied class A flavin-dependent 
monooxygenases.77 Thus, a mechanism with a C4a-hydroperoxyflavin intermediate75 was postulated for 
the OpaC reaction. The oxidized flavin Flox is converted to Flred by external electron donor NADPH. The 
Flred then reacts with O2, leading to the production of the electrophilic reagent C4a-hydroperoxyflavin. 
Elimination of the proton at C3 in 18 results in the double bond migration and attack on the C4a-
hydroperoxyflavin, leads to the formation of 19 and C4a-hydroxyflavin. The C4a-hydroxyflavin is then 
regenerated to Flox by elimination of one water molecule for the next reaction cycle. 
As aforementioned, 16 differs from 19 only in the configuration at C15. Conversion of 19 to 16 would 
need an epimerase like OpaE. Deletion of opaE indeed abolished the production of 15 and 16 and mainly 
accumulated 19 as well as a trace amount of a methylated product 15-epi-oxepinamide F. opaE was 
subsequently cloned and overexpressed as described for OpaC (Figure 26A). HPLC analysis of the 
reaction mixture of 19 with the recombinant OpaE revealed 16 as the mere product peak, proving 
unequivocally its function as an epimerase. Epimerization at C15 is essential for further methylation to 
the final product 15, because only trace amounts of 19 were converted to its methylated product in the 
ΔopaE mutant. Incubation of OpaE and 19 in Tris-HCl buffer containing D2O/H2O (9:1) and subsequent 
analysis on LC-MS led to detection of the shifted [M + H]+ isotopic pattern of 16 (m/z 395.184), which is 
1 Da larger than that in H2O (m/z 394.177). Incubation of 16 in Tris-HCl buffer containing D2O/H2O (9:1) 
without OpaE did not change the isotopic pattern. These results confirmed the involvement of an enol 
intermediate in the OpaE-catalyzed epimerization (Figure 26C).129 The kinetics of OpaE reaction with 19 
followed the typical Michaelis-Menten equation and gave a KM value of 0.46 ± 0.03 mM and a turnover 
number (kcat) of 1.67 ± 0.09 s−1 (Figure 26B). 
Taken together, oxepinamide F has been proven to be the final product of the opa cluster. OpaA is 
responsible for assembling the quinazolinone 17. The P450 enzyme OpaB catalyzes the ring expansion 
of the benzene ring in the Ant residue of 17 to form the oxepin ring in 18. The regio- and stereospecific 
hydroxylation of 18 catalyzed by the flavin-dependent enzyme OpaC was accompanied by double bond 
migration from C4-N5 and C6-C12 in 18 to C3-C4 and N5-C6 in 19, converting 1H-oxepin to 3H-oxepin 
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system. The R-configuration in 19 was converted to S-configuration by the epimerase OpaE, which is 
essential for the final methylation of the OH-12 by the O-methyltransferase OpaF to form the end product 
15 (Figure 22).  
In addition to ustethylin A, oxepinamides E and F, HPLC analysis of the EtOAc extract of an A. ustus rice 
culture also revealed the presence of an additional peak 20. The NMR data of the isolated compound 20 
correspond well to those of oxepinamide D, which has been isolated from Aspergillus puniceus.17 Based 
on the structure, it can be speculated that 20 is derived from Ant, Ala, and Phe.  
The aforementioned opaA deletion mutant did not produce 15 and 16, but still 20, proving the involvement 
of another biosynthetic pathway for 20. As mentioned above, NRPS KIA75688 (termed OpaA2 in this 
study) also contained the domain architecture of A-T-C-A-T-E-C-A-T-C and shares a sequence identity 
of 48% with OpaA on the amino acid level. Bioinformatics analysis of opaA2 indicated the presence of a 
putative BGC containing three additional genes opaB2 – opaD2, corresponding to a putative cytochrome 
P450 enzyme (OpaB2, KIA75687), a flavin-dependent oxygenase (OpaC2, KIA75686), and a transporter 
(OpaD2, KIA75689) (Figure 21). HPLC-MS analysis of the cultural extract of ΔopaA2 confirmed the 
abolishment of 20 production, but not that of 15 and 16. Heterologous expression of opaA2 in Aspergillus 
Figure 26. A SDS-PAGE analysis of OpaE, B kinetics of OpaE reacted with compound 19. C 


























6 0 0 K M  =  1 .4 1  ±  0 .0 5  m M
k c a t = 0 .2 8  ±  0 .0 1  s
- 1























L in e w e a v e r-B u rk
37 
3. RESULTS AND DISCUSSION 
 
nidulans led to the production of compounds 21 and 22. Detailed spectroscopic analysis proved that 21 
and 22 are diastereomeric quinazolinones derived from Ant, Ala, and Phe. They just carry different 
configurations at C-3 position (Figure 27).  
In parallel, opaA was also heterologously expressed in A. nidulans, leading to the accumulation of 
protuboxepin K (18) with a D-Phe residue and proving the function of E domain in the second module of 
OpaA for the epimerization of L-phenylalanine. The presence of D-Ala residue in 21 and 22 can be 
explained by the existence of the E domain in the second module in OpaA2. However, for the D-Phe 
residue in 22, no redundant epimerization domain in OpaA2 was predicted. HPLC analysis of 21 and 22 
after incubation at 37°C and different pH values showed that 22 is a nonenzymatic product of 21 via a 
keto-enol tautomeric event with involvement of a two double bond migration mechanism in the fused 
quinazolinone ring (Figure 27).  
Deletion of opaB2 from A. ustus genome abolished the production of 20 accompanied by the 
accumulation of two tripeptide derivatives 21 and 22, the same products after heterologous expression 
of opaA2 in A. nidulans. To figure out its catalytic role, opaB2 was amplified from genomic DNA and 
expressed in A. nidulans. Feeding 21 in the A. nidulans opaB2 transformant led to the production of 
compound 23, which was not observed in a negative control. 23 was identified as an OPK derivative by 
intensive interpretation of NMR spectra including 1H, 13C, HMQC and HMBC. Feeding 22 into the A. 
nidulans opaB2 culture did not lead to any conversion, indicating the stereochemistry at C-3 position of 
the quinazolinone core is essential for the OpaB2 reaction. As described before, the E domain of OpaA 
changes the configuration of Phe residue from L- to D-form during the formation of the quinazolinone 
derivative (14R) protuboxepin K (17), the substrate of another oxapinase OpaB. To figure out whether 
this configuration change is essential for the oxepin ring formation catalyzed by OpaB, (14S)-epi-
protuboxepin K was chemically synthesized by Lena Ludwig-Radtke130,131 and fed into the culture of an 
A. nidulans opaB transformant. No product was detected by HPLC analysis. In contrast, almost complete 
Figure 27. Nonenzymatic keto-enol tautomerization of compounds 21 and 22 
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conversion of the natural substrate protuboxepin K (17) to protuboxepin A (18) was observed after 
feeding into the A. nidulans opaB culture. Feeding 21 and 22 into the A. nidulans opaB transformant did 
not lead to any consumption. Similar results were also obtained after feeding of 17 and (14S)-epi-
protuboxepin K into the A. nidulans opaB2 transformant. These results proved the high substrate 
specificity and stereoselectivity of the ring expansion reactions catalyzed by the two oxepinases OpaB 
and OpaB2 and the necessity of the configuration change during the NRPS assembly line (Figure 24). 
In comparison to 23, 20 bears an additional hydroxyl group at C-3 position of the OPK backbone. 
Bioinformatics analysis results suggested OpaC2 to be a FAD-containing monooxygenase. OpaC2 
shares a sequence identity of 61% with OpaC and might also function as a hydroxylase. Deletion of 
opaC2 from the A. ustus genome led indeed to the abolishment of 20 production and the accumulation 
of 23. opaC2 was then amplified from cDNA of A. ustus and cloned into pET28a (+) for overexpression 
in Escherichia coli to characterize its catalytic role (Figure 25). The recombinant N- terminally His6-tagged 
protein was purified to near homogeneity with a yield of 1.6 mg per liter culture. After incubation of 23 
with the purified OpaC2 in the presence of NADPH, 20 was detected as the sole product. 23 and 20 show 
apparently different CD spectra, indicating the change of the orientation of the phenyl ring at C-3 position. 
These results proved that OpaC2 catalyzed the regio- and stereospecific C3-hydroxylation of 23 with 
retaining the 1H-oxpin system (Figure 25B). Similar to OpaC, OpaC2 also utilized NADH as a cofactor, 
but with an observably reduced activity. The kinetic data of the OpaC2 reaction with 23 in the presence 
of NADPH fits well to a velocity equation of Michaelis-Menten. An apparent KM value at 0.14 ± 0.01 mM, 
a turnover number (kcat) at 0.085 ± 0.002 s−1 and the catalytic efficiency (kcat/KM) at 607 M-1 s-1 were 
calculated [Figure 25B(ii)]. To prove the substrate flexibility for the flavin-dependent enzymes, 23 and 18 
were incubated with OpaC2 and OpaC, respectively. No product formation was detected on HPLC in 
both cases, which are consisted with the in vivo results of the ΔopaC and ΔopaC2 mutants and 
demonstrating their high substrate specificity. Together with the abovementioned feeding results in the 
opaB and opaB2 transformants, it can be concluded that there is no crosstalk between the two BGCs. 
In conclusion, the second oxepinamide BGC opa2 in A. ustus is responsible for the biosynthesis of the 
1H-oxepin oxepinamide D carrying a C3-hydroxyl group. Both oxepinamide clusters share a NRPS 
(OpaA and OpaA2) for quinazolinone skeleton and P450 (OpaB and OpaB2) for the oxepin formation. 
The two flavin-dependent monooxygenases OpaC and OpaC2 install hydroxyl groups at different 
positions in OPK backbones. In the biosynthesis of oxepinamide F, two additional enzymes (an O-Met 
and an epimerase) are involved in the pathway. Additionally, the E domains in OpaA and OpaA2 are 
responsible for the epimerization of phenylalanine and alanine, respectively, which is a prerequisite for 
the ring expansion catalyzed by the oxepinases OpaB and OpaB2 (Figure 22). 
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For details on this work, please see the publication (sections 4.3 and 4.4) 
Liujuan Zheng,# Haowen Wang,# Aili Fan, and Shu-Ming Li (2020). Oxepinamide F biosynthesis involves 
enzymatic D-aminoacyl epimerization, 3H-oxepin formation, and hydroxylation induced double bond 
migration. Nature Communications 11: 4914 doi: 10.1038/s41467-020-18713-0. (# equal contribution) 
Liujuan Zheng,# Haowen Wang,# Lena Ludwig-Radtke, and Shu-Ming Li (2021). Oxepin formation in 
fungi implies specific and stereoselective ring expansion. Organic Letters. 23, 6, 2024–2028. 
doi.org/10.1021/acs.orglett.1c00166. (# equal contribution) 
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3.3 Switching a regular tryptophan C4-prenyltransferase to a reverse tryptophan-containing 
cyclodipeptide C3-prenyltransferase by sequential site-directed mutagenesis 
As mentioned in the introduction, enzymatic prenylation plays a significant role in structure modification 
of CDPs,57,132-134 and FgaPT2 from Aspergillus fumigatus has been proven to be an excellent example of 
a multiple functional enzyme, especially for regular C4-prenylation of tryptophan derivatives and CDPs 
as well as reverse C3-prenylation of tryptophan103-105. However, a reverse C3-prenylation of tryptophan-
containing CDPs has not been reported before.  
Based on the results with FgaPT2_R244 mutants, which significantly enhance the catalytic ability for C4-
prenylation towards the tryptophan-containing CDPs104, as well as FgaPT2_K174A, which can prenylate 
L-tryptophan at both C-3 and C-4 positions of the indole ring, we were inspired to test the two step-
mutations on Lys174 and Arg244 of FgaPT2 to create a reverse C3-prenyltransferase of tryptophan-
containing CDPs. The general working flow is illustrated in Figure 28.  
To test the activity to tryptophan-containing CDPs, the plasmid pLZ1 for overproduction of 
FgaPT2_K174A was constructed. From the SDS-PAGE analysis, an apparent protein band at 53 
kDa was detected for the purified FgaPT2_K174A (Figure 29). After incubation with L-tryptophan 
and DMAPP, two product peaks with the same [M+H]+ ion were detected on LC-MS, which were 
identified as C4-prenylated (UV λmax 278nm) and C3-prenylated derivative (UV λmax at 240 and 
294nm), respectively.105 
FgaPT2_K174A was incubated afterward with six L-tryptophan-containing CDPs, i.e. cyclo-L-Trp-
L-Ala (24), cyclo-L-Trp-L-Trp (25), cyclo-L-Trp-Gly (26), cyclo-L-Trp-L-Phe (27), cyclo-L-Trp-L-Pro 
Figure 28. Working flow for switching FgaPT2 to a C3-prenyltransferase by sequential site-
directed mutagenesis 
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(28), and cyclo-L-Trp-L-Tyr (29) in the presence of DMAPP at 37°C for 3 h. No product was 
detected on LC-MS in all enzyme assays under the tested conditions. For the wild type FgaPT2, 
the cyclodipeptides 24 – 29 showed product yields in the range from 6.6 to 29.5 %. With the 
exception for 25, one product peak each (24a or 26a – 29a) was detected. The products show 
the typical UV λmax at 278 nm for indole system and 68 daltons higher [M + H]+ ion, indicating the 
presence of an indole chromophore and the prenylation of the cyclodipeptides by FgaPT2.135 For 
compound 25, two products 25a and 25a* were detected, with [M+H]+ ions, which are 68 and 136 
daltons larger than that of 25, indicating a mono- and diprenylation, respectively.  
As described above, the key residue Lys174 was proven to be essential for aromatic substrate 
selection. Compared with FgaPT2, the activity of FgaPT2_K174F to L-tryptophan decrease 
evidently.103 Similarly, all six CDPs were accepted by FgaPT2_K174F, but with very low product 
yields, ranging from 2.5 to 6.5 %. The clearly different UV spectra (λmax at 240 and 294nm) of the 
products indicated that 24b - 29b were C3-prenylated derivatives of 24 – 29, respectively.105,136 
For compound 25, a diprenylated product 25b* with the similar UV spectrum to that of 25b was 
also detected by LC-MS analysis. The previous study proved that Arg244 mutants, especially 
R244N, R244Q, R244Y, and R244L, showed evidently increased activities to tryptophan-
containing CDPs, which led to the production of regular C4-prenylated products compared with 
Figure 29. SDS-PAGE analysis of the purified FgaPT2 and its mutants. The proteins were 
separated on a 12% polyacrylamide gel and stained with Coomassie brilliant blue R-250. 
M-maeker, 1: FgaPT2, 2: FgaPT2_K174A, 3: FgaPT2_K174F, 4: FgaPT2_K174F_R244L, 
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those of wild type FgaPT2.104 In analogy, double mutants of Lys174 to Phe and Arg244 to Leu, 
Asn, Gln, and Tyr were constructed by site-directed mutagenesis and overexpressed in E. coli, 
creating the four double mutants FgaPT2_K174F_R244L, FgaPT2_K174F_R244N, 
FgaPT2_K174F_R244Q, and FgaPT2_K174F_R244Y (Figure 29).  
HPLC analysis of the reaction mixtures of the obtained mutants showed that all double mutants 
exhibited increased activities towards the six CDPs. Total product yields of 20.3 to 41.4 % were 
calculated for the best mutant with a given substrate, i.e. FgaPT2_K174F_R244N for 24 – 27 and 
FgaPT2_K174F_R244L for 28 and 29, which showed an activity increase of two to ten-fold 
compared to those of FgaPT2_K174F. The products showed same retention times and UV 
spectra as those of the FgaPT2_K174F for a given substrate (24b – 29b) and the corresponding 
products also have the same [M+H]+ ions with those of FgaPT2_K174F by LC-MS analysis. For 
compound 25, the additional peak 25b* with a [M+H]+ ion for a diprenylated derivative was also 
detected. All these data proved the successful mutational combinations for acceptance of 
tryptophan-containing CDPs (Figure 30).  
To get NMR spectra, the enzyme products of 25 – 27 were isolated from incubation mixtures with 
FgaPT2_K174F_R244N and those of 28 and 29 with FgaPT2_K174F_R244L in 10 mL scale. 
The typical signals for a reverse prenyl moiety each at δH 4.97-5.13 (dd, 1H), 5.05-5.09 (dd, 1H), 
5.76-5.98 (dd, 1H), 0.93-1.11 (s, 3H), and 0.79-1.01 (s, 3H) ppm were clearly present in the 1H 
NMR spectra of 24b – 29b. The signals of H-2 at the original indole rings are apparently shifted 
up-field to 5.32 – 5.55 ppm, indicating the disruption of the indole and formation of a 
hexahydropyrroloindole system caused by a C3-prenylation.98,136 The signals of H-11 appear as 
double doublets with coupling constants of approximate 11, 6.0, and 2.0 Hz, proving the 3ß-
prenylation of L-configured tryptophanyl moiety, i.e. syn-cis configuration (3R, 2S, 11S).136 For 
the product 25b*, the structure could not be confirmed by NMR analysis, due to the low quantity. 
Here, we speculated here C3-prenylation at both indole rings, as observed for other C3-
prenyltransferases with cyclo-L-Trp-L-Trp.88  
Kinetic parameters including Michaelis-Menten constants (KM) and turnover numbers (kcat) were 
determined at pH 7.5 for the two best mutants in the presence of DMAPP, i.e. 
FgaPT2_K174F_R244N with 25 – 27 as well as FgaPT2_K174F_R244L with 28 and 29. The 
reactions catalyzed by both mutants followed the typical Michaelis-Menten kinetics. With the 
exception for 27, KM values in the range of 0.15 to 0.79 mM were determined.  
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Taken together, the variant FgaPT2_K174F can utilize cyclo-L-Trp-L-Ala, cyclo-L-Trp-L-Trp, cyclo-
L-Trp-Gly, cyclo-L-Trp-L-Phe, cyclo-L-Trp-L-Pro, and cyclo-L-Trp-L-Tyr as substrates for reverse 
C3-prenylation, but only with low activity. Compared with the wild-type FgaPT2, the combinational 
mutations on Lys174 and Arg244 significantly increases the catalytic activity for these 
cyclodipeptides. With the exception for cyclo-L-Trp-L-Trp, FgaPT2_K174F_R244X (X=L, N, Q, Y) 
show much better acceptance, with an increase of two- to six-fold activity, to the tested 
cyclodipeptides than that of FgaPT2. More importantly, compared to FgaPT2_K174F, even two- 




Figure 30. Prenylations of six tested CDPs catalyzed by FgaPT2 and its double mutants. 
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For details on this work, please see the publication (section 4.5) 
Liujuan Zheng,# Peter Mai,# Aili Fan, and Shu-Ming Li (2018). Switching a regular tryptophan C4-
prenyltransferase to a reverse tryptophan-containing cyclic dipeptide C3-prenyltransferase by sequential 
site-directed mutagenesis. Organic & Biomolecular Chemistry 16: 6688-94. doi: 10.1039/C8OB01735B. 
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ABSTRACT: A highly oxygenated phenethyl derivative ustethylin
A was isolated from Aspergillus ustus. Gene deletion, isotope
labeling, and heterologous expression proved that the phenethyl
core structure is assembled from malonyl-CoA by a polyketide
synthase harboring a methyltransferase domain. Propionate was
converted via acetyl-CoA to malonyl-CoA and incorporated into
the molecule. Modifications on the core structure by three different
oxidoreductases and one O-methyltransferase lead to the final product, ustethylin A.
Phenethyl-containing natural products are common micro-bial metabolites. Barnol1 and marilone A2 are examples
from fungi, while gilvocarcin E3 and tiacumicin B4 occur in
Streptomyces (Figure 1). Feeding experiments and genetic
studies proved that the phenethyl units are products of
polyketide synthases (PKSs).3−5 The ethyl groups in phenethyl
residue of bacterial metabolites are mostly originated from
propionate as starter unit of PKSs.3,4 In fungi, it can be derived
from acetate, as in the cases of LL-D253α6 and O-
methylasparvenone,7 which was confirmed by feeding with
[1,2-13C] acetate. However, the most methyl groups of the
phenethyl residue in fungal metabolites are derived from S-
adenosyl L-methionine (SAM), which has been proven by
feeding experiments with [methyl-13C]-L-methionine.2,8 The
responsible enzymes for the methylation and the biosynthetic
pathways for such metabolites have not been reported prior to
this study.
HPLC analysis of the EtOAc extract of an A. ustus culture in
PD media revealed the presence of one predominant peak 1
(Figure 2B(i)) with a [M + Na]+ ion at m/z 249.0732 and a
deduced molecular formula of C11H14O5 (see Figure S7 in the
Supporting Information). Attempts to get interpretable 1H
NMR spectrum for 1 from a large-scale fermentation failed,
although it was almost the only product peak in the HPLC
chromatogram. During isolation, the amount of 1 decreased
evidently. Dissolving the finally isolated 7 mg sample in
DMSO-d6 led to precipitation immediately. The
1H NMR
spectrum of the supernatant was very complex, so that an
interpretation was impossible (data not shown). To overcome
the instability, 1 in the fungal extract was immediately
converted to its triacetate 2 for structural elucidation (see
Table S5, Figure S19, and Figures S21−S25 in the Supporting
Information), which confirmed 1 to be 2-hydroxy-3-hydrox-
ymethyl-4-methoxy-6-hydroxyenthylbenzaldhyde, termed uste-
thylin A (Scheme 1).
To elucidate the origin of 1, we performed a feeding
experiment with sodium [1,2-13C] acetate in A. ustus. In the
13C NMR spectrum of the acetylated product 2 (Figure 3),
four signal pairs of coupling carbons, C-1/C-7, C-2/C-3, C-4/
C-5, and C-6/C-9, were detected, proving unequivocally the
incorporation of four intact acetate units. Feeding with sodium
Received: August 14, 2020
Published: October 2, 2020
Figure 1. Origins of ethyl groups in phenethyl-containing natural
products.
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[1-13C] acetate revealed that C-2 at δC 152.5, C-4 at 162.1, C-6
at 144.9, and C-7 at 189.0 ppm are from the carbonyl group of
acetate, with 3.8−6.1-fold enrichments (see Table S11 in the
Supporting Information). Correspondingly, significantly in-
creased intensity was observed for the signals at δC 119.8 (C-
1), 116.0 (C-3), 112.1 (C-5), and 31.5 ppm (C-9), with 4.9−
8.9-fold of those of the unlabeled 2 after feeding with sodium
[2-13C] acetate and [2-13C] malonic acid (see Table S11). This
confirmed the methyl/methylene group of acetate/malonate as
their origin.
To determine whether A. ustus utilizes propionate as a
starter unit, sodium [2-13C] propionate was fed into the
culture. To our surprise, the labeling pattern of 2 is very similar
to that with [1-13C] acetate (Figure 3), with 3.6−6.1-fold
enrichments for C-2, C-4, C-6, and C-7 (see Table S11). No
enrichment for C-9 at 31.5 ppm was observed. These results
proved unequivocally that sodium [2-13C] propionate was not
directly utilized for incorporation, but was degraded to acetyl-
CoA likely via pyruvate by α-oxidation.9 Acetyl-CoA was
converted to malonyl-CoA and incorporated in 1.
In the 13C NMR spectrum of 2 after feeding with
[methyl-13C]-L-methionine (Figure 3), the three signals at δC
54.1 (C-8), 63.9 (C-10), and 56.6 ppm (C-11) were enhanced
to 13.1−15.9-fold of those of the unlabeled 2 (see Table S11),
proving that the methyl group of the phenethyl residue is also
from SAM.
The genome of A. ustus 3.3904 was sequenced and published
in 2015.10 For our biosynthetic studies, we resequenced it and
used both sequences for prediction of putative gene clusters by
AntiSMASH.11 Our sequence correlated very well with the
published data, at least for the cluster described in this study.
From the structure of 1, it can be deduced that a PKS would be
responsible for the formation of its backbone.12 Genome
mining indicated the presence of more than 20 putative PKS
genes. Transcriptome analysis revealed that the PKS gene
coding for KIA75596, termed uttA in this study (recall Figure
2A), was one of the 80 best expressed genes under our culture
conditions (data not included).
To prove its function, uttA was replaced with a hygromycin
B resistance cassette by using a split marker gene replacement
protocol.13 The potential mutants were verified by PCR
(Figure S1 in the Supporting Information) and cultivated in
PD medium for secondary metabolite production. HPLC
analysis of the culture extract of a ΔuttA mutant showed
complete loss of 1 production (recall Figure 2B(ii)).
Afterward, uttA was cloned into pYH-gpdA-pyrG via homol-
ogous recombination in yeast14 for heterologous expression.15
The obtained plasmid pLZ51 was linearized by SmaI and
integrated into the genome of A. nidulans LO8030 (Figure S2
in the Supporting Information).16 In comparison to that of the
negative control, three additional products 3−5 were detected
in the uttA overexpression transformant with 3 as the
predominant peak (98%) (see Figure 4B). The UttA products
3−5 were identified as benzoic acid derivatives by NMR
analysis and comparison with published data17,18 (see Tables
S6 and S7 in the Supporting Information, as well as Figure 4C
and Figures S26−S31 in the Supporting Information). They
differ from each other only in the methyl group at C-3 and the
ethyl group at C-6 of the benzene ring (Figure 4C), indicating
multimethylation steps during the formation of 3.
Figure 2. (A) Schematic representation of the utt cluster in A. ustus
and (B) HPLC analysis of the fungal extracts.
Scheme 1. Biosynthetic Pathway of Ustethylins in A. ustusa
aThe red bonds indicate SAM-associated methylation.
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Feeding 3 into the ΔuttA mutant led to detection of one
additional major peak 6 and one minor peak 7 (see Figure 5A).
Structure elucidation confirmed 6 to be the corresponding
aldehyde of 3 (ustethylin D; see Scheme 1, as well as Table S7
and Figure S32 in the Supporting Information) and the minor
peak 7 as a dimerization product (see Table S8 and Figures
S33−S37 in the Supporting Information). Trace amounts of 1
were also detected in this culture (Figure 5A), proving 3 to be
a precursor of 1. It can be speculated that the metabolism of 6
is a limited step in the biosynthesis. Interestingly, 3 was not
detected in the ΔuttA mutant after feeding with 4 (Figure S18
in the Supporting Information), excluding the direct
methylation of the C6-methyl group in 4.
Bioinformatics analysis revealed that UttA is a nonreducing
PKS with a domain architecture of KS-MAT-PT-ACP-ACP-
MeT-TE (β-ketoacyl synthase, KS; malonyl-CoA-ACP trans-
acylase, MAT; product template, PT; acyl carrier protein,
ACP; methyltransferase, MeT; thiolesterase, TE) (Figure
4C).19 The PT domain was deduced by phylogenetic analysis
with 30 known PKS PTs (see Figure S3 in the Supporting
Information).20 It can be speculated that the methyl groups in
3 are transferred by the MeT domain from S-adenosyl L-
methionine. UttA shares a sequence identity of 37.8% with the
citrinin synthase PksCT from Monascus purpureus.21 The
sequence identity of their MeT domains is found to be 39.7%.
Therefore, a model of UttA-MeT was built, using PksCT-MeT
as a template with SWISS-MODEL.22 Meanwhile, 96 MeT
domains in PKSs were analyzed and presented with Weblogo
(Figure 4A).23,24 The highly conserved residues of the SAM
binding motif ExGxGxGx were identified at residues 1772−
1779 in UttA. His1850 acting as a key catalytic residue for
enolization is also highly conserved (see Figure S4 in the
Supporting Information). To delete MeT activity from UttA,
the UttA_G1778 V and UttA_H1850A mutants were
constructed and expressed in A. nidulans LO8030. HPLC
results showed the abolishment of the PKS products 3−5
Figure 3. 13C NMR spectra of the labeled and unlabeled 2. [Legend:
solid blue circles represent the labeled carbons after feeding with
sodium [1-13C] acetate, solid green circles represent sodium [2-13C]
propionate, solid blue squares represent sodium [2-13C] acetate, solid
black squares represent [2-13C] malonic acid, bold bonds represent
sodium [1,2-13C] acetate for the intact acetate unit, and solid pink
circles represent [methyl-13C]-L-methionine.]
Figure 4. (A) Structural model of UttA-MeT with conserved motifs
by alignments of 96 MeT domains in PKSs; (B) HPLC results of A.
nidulans heterologous expression strains; and (C) the reactions
catalyzed by UttA.
Figure 5. HPLC analysis of culture extracts of (A) A. ustus ΔuttA and
(B) A. nidulans uttJ overexpression mutant after feeding with 3.
Organic Letters pubs.acs.org/OrgLett Letter
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without accumulation of any other products, indicating the
essential role of MeT domain for the functionality of UttA.
Feeding propionate to the two mutants did not resulted in any
detectable product formation, confirming that UttA cannot
directly utilize propionate as starter as described above (Figure
4B(ii)−(v). These results indicated that the methylation step is
essential for the polyketide assembling by UttA. We propose
that malonyl-CoA is loaded onto the MAT domain and
transferred to the ACP domain. The propionyl-ACP complex
is formed by methylation via SAM and decarboxylation. After
condensation with two malonyl-CoA molecules, the MeT
domain attaches the second methyl group. Condensation with
another malonyl-CoA molecule led to the production of a
polyketide chain, which is subsequent cyclized by the PT
domain and released by the TE domain, resulting in the
formation of the predominant product 3 (98%; see Figures 2B
and 4B). However, it cannot be excluded that mutation at
G1778 and H1850 had influence on the transcription,
translation process, or protein stability. Attempts to get
recombination protein of the MeT domain failed, so that no
in vitro study was possible. The reaction catalyzed by UttA
with involvement of two methylation steps is closely related to
that of 3-methylorcinaldehye synthase MOS from Acremonium
strictum. However, MOS contains a terminal reductase domain
for direct release of an aldehyde,25 while the UttA product, an
aryl acid, is afterward reduced to an aldehyde.
1 differs structurally from 3 in oxidation states of the
functional groups at C-1, C-3, and C-6, as well as O-
methylation at OH-4. The conversion of 3 to 1 would require
three oxidoreductases and an O-MeT. Inspection of the
genomic neighborhood of uttA in A. ustus revealed the
presence of a putative biosynthetic gene cluster (uttA−uttJ,
coding for the putative proteins KIA75596−KIA75587 in the
database; see Figure 2A) containing such genes as well as those
coding for regulator and transporter (Table S1 in the
Supporting Information). UttJ coding for an NRPS-like
enzyme with an A-T-R domain architecture is 1 of the 10
highly expressed genes in A. ustus under our culture conditions
(data not included). Given such enzymes from different fungal
strains for aryl acid reduction to aldehydes,26,27 UttJ is likely
involved in the conversion of 3 to 6. Indeed, deletion of uttJ
abolished the formation of 1 and accumulation of 3−5 with
almost the same product profile of the A. nidulans uttA
overexpression strain (see Figures 2B(viii) and 4B(i), as well as
Figure S16 in the Supporting Information). This unambigu-
ously proved its role in the reduction of the carboxyl group to
an aldehyde. Feeding 3 into the A. nidulans uttJ overexpression
strain led to the detection of 6 (see Figure 5B(ii)), proving
UttJ as an aryl acid reductase (Scheme 1). Further sequence
comparison and analysis revealed UttH to be a putative
nonheme FeII/2-oxoglutarate dependent oxygenase and shares
58% and 52% sequence identities with CitB from Monascus
ruber28 and ClaD from Penicillium crustosum,29 respectively
(see Table S1 and Figure S5 in the Supporting Information).
Both known enzymes catalyze hydroxylations of aryl methyl
groups. Deletion of uttH led to the accumulation of UttJ
product 6, proving the reaction order of both enzymes (see
Figure 2B(vii), as well as Figure S15 in the Supporting
Information). Deletion of uttC coding for a cytochrome P450
enzyme abolished the formation of 1 and production of 8
(ustethylin B; see Table S9 in the Supporting Information,
Figure 2B(iii), and Figures S9 and S38−S41 in the Supporting
Information), which differs from 1 just in the oxidation state of
the ethyl group. This proved that UttC catalyzed the last step
in the biosynthesis of 1. Bioinformatics analysis showed that
UttC contains the conserved motifs ExxR (EAGR, 349−352)
and CxG (CLG, 434−436) of P450 enzymes (see Figure S6 in
the Supporting Information).30 Usually, the hydroxylation of
phenyethyl group occurs at the α-position (−CH2−), e.g., in
the biosynthesis of marilone A.31 Here, we present an unusual
β-hydroxylation of the phenyethyl group by the cytochrome
P450 UttC. Detection of 8 with a methoxy group in ΔuttC
mutant indicates that the methylation of the C4-hydroxyl
group occurs before UttC and after UttH reactions and could
be catalyzed by the putative O-MeT UttF. Indeed, one
predominant peak 9 (ustethylin C) with a [M + Na]+ ion at
m/z 219.0626, which is 14 Da less than that of 8, was observed
in the ΔuttF mutant (see Figure 2B(v), as well as Figure S13 in
the Supporting Information). Similar to 1, 9 was also found to
be unstable and could not be obtained in pure form for
structure elucidation. However, its structure can be elucidated
after conversion to its diacetylated derivative 10 (see Table
S10 and Figures S42−S45 in the Supporting Information).
Gene deletion results revealed the reaction sequence of the
tailoring enzymes for 3 conversion to 1. Extracted ion
chromatograms of the culture proved the presence of 1 as
almost the only pathway product (see Figure S7 in the
Supporting Information), indicating the high efficiency of the
involved enzymes in wildtype A. ustus. The utt cluster is
positively regulated by a DNA binding enzyme UttD. Deletion
of uttD completely abolished product formation (see Figure
2B(iv), as well as Figure S11 in the Supporting Information).
Even feeding 3 to the ΔuttD deletion mutant did not lead to
any conversion (see Figure S17 in the Supporting Informa-
tion). Deletion of uttG coding for an MFS transporter reduced
1 production to 30.8% of that of the wildtype A. ustus (see
Figures 2B(vi), as well as Figure S14 in the Supporting
Information). 1 was still detected in the deletion mutants of
the two oxidoreductase genes uttB and uttE (see Figures S9
and S12 in the Supporting Information). They very likely are
not involved in the formation of ustethylin A.
In summary, in this study, we have identified the
biosynthetic gene cluster of the highly oxygenated aryl-
aldehyde derivative ustethylin A and elucidated its biosynthetic
pathway by transcriptome analysis, gene deletion, and
expression, as well as isotopic labeling experiments. The PKS
UttA, as a key enzyme, is responsible for the formation of the
phenethyl core structure with methylation as key reactions.
Consecutive and coordinated modifications by three different
types of oxidoreductases and one O-MeT lead to the final
product. To the best of our knowledge, this is the first report
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Sodium [1-13C] acetate, sodium [2-13C] acetate, and sodium [2-13C] propionate were purchased from Cambridge 
Isotope Laboratories. Sodium [1,2-13C] acetate, [2-13C] malonic acid, and [methyl-13C]-L-methionine were obtained 
from Sigma-Aldrich. Other reagents were from Fisher scientific, VWR or Sigma-Aldrich. 
2. Strains, media, and growth conditions 
Escherichia coli DH5α cells were grown in LB medium (1% NaCl, 1% tryptone, and 0.5% yeast extract). 50 mg/mL 
ampicillin were supplemented for cultivation of recombinant E. coli strains.  
Saccharomyces cerevisiae HOD114-2B cells were grown in YPD medium (1% yeast extract, 2% peptone and 2% 
glucose). 1.5% agarose was used for plates. The SC-uracil medium (6.7 g/L yeast nitrogen base with ammonium 
sulfate, 650 mg/L CSM-His-Leu-Ura (MP Biomedicals), 20 mg/L His and 60 mg/L Leu, 2% glucose, pH 6.2 − 6.3, 
1.5% agarose was used for plates) was used for selection.  
Fungal strains used in this study are summarized in Table S2. Aspergillus ustus (A. ustus) 3.3904  was purchased 
from China General Microbiological Culture Collection Center (Beijing, China) and cultivated in PD (potato 
dextrose broth, Sigma) or ISP3 (6% oat) medium at 230 rpm and 30 °C for secondary metabolite (SM) production.  
Aspergillus nidulans strains were grown at 37 °C on GMM medium (1.0% glucose, 50 mL/L salt solution, 1 mL/L 
trace element solution, 1.6% agar) for sporulation and transformation with appropriate nutrition as required. The 
salt solution comprises (w/v) 12% NaNO3, 1.04% KCl, 1.04% MgSO4∙7H2O, and 3.04% KH2PO4. The trace 
element solution contains (w/v) 2.2% ZnSO4∙7H2O, 1.1% H3BO3, 0.5% MnCl2∙4H2O, 0.16% FeSO4∙7H2O, 0.16% 
CoCl2∙5H2O, 0.16% CuSO4∙5H2O, 0.11% (NH4)6Mo7O24∙4H2O, and 5% Na4EDTA.  
3. Genomic DNA isolation 
The mycelia of A. ustus 3.3904 and A. nidulans were dried on filter paper and collected in 2 mL Eppendorf tubes. 
Four glass beads (2.85 mm in diameter) and 400 μL of LETS buffer (10 mM Tris-HCl pH 8.0, 20 mM EDTA pH 
8.0, 0.5% SDS, and 0.1 M LiCl) were added to the tubes. After vigorous mixing for 4 min, 300 μL LETS buffer 
were added. The solution was then treated with 700 μL phenol: chloroform: isoamyl alcohol (25: 24: 1). Genomic 
DNA was precipitated by addition of 900 μL of absolute EtOH. After centrifugation at 13,000 rpm for 30 min and 
washing with 70% EtOH, the obtained DNA was dissolved in 50 ‒ 100 μL distilled H2O. 
4. Genome sequencing and sequence analysis 
The genome of A. ustus 3.3904 was sequenced by Genewiz (Suzhou, China) using Nova-seq6000/X-ten 





Prediction of the enzyme function was performed with the online BLAST tools (http://blast.ncbi.nlm.nih.gov). 
The genes uttA-J in the utt cluster are summarized in Table S1. The genomic DNA sequence of the utt cluster 
reported in this study corresponds to that depicted at GenBank under accession numbers JOMC01000079.1. 
5. PCR amplification, gene cloning and plasmid construction 
Plasmids and primers used in this study are listed in Table S3 and Table S4, respectively. Primers were synthesized 
by Seqlab GmbH (Göttingen, Germany). PCR amplification was carried out by using Phusion® High-Fidelity DNA 
polymerase from New England Biolabs (NEB) on a T100TM Thermal cycler from Bio-Rad. PCR thermal profiles 
were set as recommended by the manufacturer´s instruction. The plasmids for gene deletion and heterologous 
expression were constructed via homologous recombination in Escherichia coli DH5α or Saccharomyces 
cerevisiae HOD114-2B by using primers listed Table S4. 
6. Molecular modeling for UttA_MeT 
Homolog modelling for 300 amino acids of UttA_MeT was carried out by using SWISS-MODEL.2 S-Adenosyl-
L-homocysteine (SAH) was manually positioned by using Coot.3 The illustration was created with Pymol (DeLano 
Scientific LLC, Version 1.3.x.). 
7. Genetic manipulation in A. ustus 3.3904 and cultivation of deletion mutants 
Fresh spores of A. ustus 3.3904 were inoculated into 50 mL LMM medium in 250 mL flask and incubated at 230 
rpm and 30 °C for germination. The germlings were harvested after 11 h by centrifugation at 5,000 rpm and 4 °C 
for 10 min and washed with distilled H2O. The mycelia were then transferred into a 25 mL flask with 10 mL of 
osmotic buffer (1.2 M MgSO4 in 10 mM sodium phosphate, pH 5.8) containing 40 mg lysing enzyme from 
Trichoderma harzianum (Sigma) and 30 mg yatalase from Corynebacterium sp. OZ-21 (OZEKI Co., Ltd.). After 
shaking at 100 rpm and 30 °C for 10 h, the mixture was transferred into a 50 mL falcon tube and overlaid gently 
with 10 mL of trapping buffer (0.6 M sorbitol in 0.1 M Tris-HCI, pH 7.0). After centrifugation at 5,000 rpm and 
4 °C for 10 min, the protoplasts were collected from the interface of the two buffer systems. The collected 
protoplasts were then transferred to a sterile 15 mL falcon tube and resuspended in 100 μL of STC buffer (1.2 M 
sorbitol, 10 mM CaCl2 in 10 mM Tris-HCI, pH 7.5) for transformation. 
The DNA fragments (2 ‒ 3 μg in 8 ‒ 10 μL) were mixed with 100 μL of the protoplasts and incubated for 50 min 
on ice. 1.25 mL of PEG solution (60% polyethylene glycol 4000, 50 mM CaCl2, 50 mM Tris-HCI, pH 7.5) was 
then added and gently mixed. After incubation at room temperature for 30 min, 5 mL STC buffer was added into 
the mixture and spread on plates with SMM bottom medium (1.0% glucose, 50 mL/L salt solution, 1 mL/L trace 
element solution, 1.2 M sorbitol, and 1.6% agar) containing 100 µg/mL hygromycin B. SMM top medium (1.0% 
glucose, 50 mL/L salt solution, 1 mL/L trace element solution, 1.2 M sorbitol, and 0.8% agar) containing 50 µg/mL 





plates (PD medium with 3% agar) containing 100 µg/mL hygromycin B for selection. The obtained transformants 
were inoculated in PD medium for isolation of genomic DNA to verify the integrity via PCR amplification (Figure 
S2). After cultivation in PD liquid medium at 230 rpm and 30 °C for 7 days, the cultures were extracted with EtOAc, 
dissolved in DMSO and subjected to HPLC and LC-MS for analysis. 
8. Heterologous expression in A. nidulans 
A. nidulans LO80304 was used as the recipient host. The protoplast preparation and transformation were performed 
as described previously.5 PLZ51 ‒ 54 containing the PKS gene uttA, uttA-G1778V and uttA-H1850A as well as the 
NRPS-like gene uttJ were transformed into A. nidulans LO8030 to create expression strain LZ51, LZ52, LZ53 and 
LZ54, respectively. The transformants were verified by PCR (Figures S2 and S4).  
9. Site-directed mutagenesis of UttA 
The fragments containing the point mutation were constructed via fusion PCR. The mutated and non-mutated 
fragments of uttA were then integrated into pYH-gpdA-pyrG following the same procedure for pLZ51 to produce 
pLZ53 (UttA_G1778V) and pLZ54 (UttA_H1850A). The primers used for plasmids constructing were listed in 
Table S3 ‒ S4. 
10. HPLC equipment for analysis and metabolite isolation  
EtOAc extracts of fungal strains were analyzed on an Agilent HPLC series 1200 (Agilent Technologies) equipped 
with an Agilent Eclipse XDB-C18 column (5 μm, 4.6 × 150 mm). A linear gradient from 10 to 90% ACN in H2O 
in 20 min was used. The column was then washed with 100% ACN for 5 min and equilibrated with 10% ACN in 
H2O for another 5 min. Detection was carried out with a photodiode array detector from 190 to 400 nm. 
The same HPLC system was also used for product isolation with a Multospher 120 RP-18 column (5 μm, 10 × 250 
mm). The products were eluted with different solvent gradients of ACN in H2O, with or without HCOOH, at a flow 
rate of 2 mL/min.  
11. Large-scale fermentation, extraction and isolation of secondary metabolites  
For metabolite extraction after large-scale fermentation, the supernatant was separated from mycelia by filtration 
and extracted with equal volume of EtOAc for three times. The mycelia were extracted with acetone and 
concentrated under reduced pressure to afford an aqueous solution and then extracted with EtOAc for three times. 
Both EtOAc extracts were evaporated under reduced pressure to afford the crude extracts for further purification. 
To isolate compound 1, A. ustus spores were cultivated in 10 x 250 mL flasks containing 50 mL PDB liquid medium 
for 2 days, then transferred to 10 x 2 L flasks containing 500 mL PDB liquid medium each. The cultures were 





mentioned above to give 0.4 g crude extract. The crude extract was subjected to silica gel column chromatography 
by using stepwise gradient elution with mixtures of petroleum ether/EtOAc (20:1 to 0:1, v/v) to give five fractions 
(1 – 5). Fraction 2 was further purified on the HPLC system mentioned above by using ACN/H2O (40:60) as elution 
solvents, resulting in 7.0mg of 1. 
To identify the structure of 1, we used the previously published acetylation method.6 A. ustus spores were inoculated 
into 40 x 250 mL flasks containing 50 mL PDB liquid medium each and incubated on a rotary shaker at 230 rpm 
and 30 °C for 6 days. 400 mg of the obtained crude extracts were immediately acetylated with acetic anhydride 
(21.24 mmol) and NaOAcꞏ3H2O (0.3 mmol) at room temperature for 16 h. The mixture was extracted with 15 mL 
EtOAc and washed with 15 mL saturated solution of NaHCO3 for three times. After evaporation of the solvent, 
11.4 mg of 2 were isolated by isocratic elution with ACN/H2O (55:45) on the aforementioned HPLC system for 
MS and NMR analyses.  
To isolate compounds 3 ‒ 5 from the A. nidulans-pYH-gpdA-uttA-pryG transformant, the strain was cultivated in 
ISP3 medium at 30 °C for 8 days. After extraction, 4.7 g crude extract was obtained from 5 L culture and subjected 
to silica gel column chromatography. Petroleum ether/EtOAc (50:1 to 0:1, v/v) were used as elution solvents to 
give 17 fractions (1 ‒ 17). Fraction 6 was purified on the HPLC by isocratic elution with ACN/H2O (40:60, 0.1% 
HCOOH) to get 3 (26.0 mg). 4 (14.6 mg) was obtained from fraction 8, which was purified on the HPLC system 
by isocratic elution with ACN/H2O (25:75) containing 0.1% HCOOH. 5 (10.6 mg) was obtained from fraction 9 
under the same conditions as for 4. 3 ‒ 5 were also isolated from the A. ustus ΔuttJ mutant in a similar procedure. 
To isolate compound 6, the ΔuttH mutant was cultivated in PDB medium at 30 °C for 7 days. After extraction, 
0.1 g crude extract was obtained from 5 L culture and subjected to silica gel column chromatography by using 
petroleum ether/EtOAc (50:1 to 0:1, v/v) as elution solvents to give 11 fractions (1 ‒ 11). 6 (1.0 mg) was obtained 
from fraction 2 after purification on HPLC using isocratic elution with ACN/H2O (53:47) containing 0.1% 
HCOOH). 
To isolate compound 8 from ΔuttC mutant, the mutant was cultivated in ISP3 medium at 30 °C for 8 days. After 
extraction, 8.2 g crude extract was obtained from 5 L culture and subjected to silica gel column chromatography 
by using petroleum ether/EtOAc (50:1 to 0:1, v/v) as elution solvents to give 13 fractions (1 ‒ 13). Fraction 5 was 
purified on the HPLC with a linear gradient from 10 to 100% ACN containing 0.1% HCOOH in H2O containing 
0.1% HCOOH in 22 min. The column was then washed with 100% ACN containing 0.1% HCOOH for 5 min, 
followed by 5 min equilibration with 10% ACN containing 0.1% HCOOH. 9.3 mg of 8 were obtained for MS and 
NMR analyses.  
To identify compound 9, spores of ΔuttF mutant were inoculated into 40 x 250 mL flasks containing 50 mL PDB 
medium each and incubated on a rotary shaker at 230 rpm and 30 °C for 6 days. After extraction, the crude extract 





10 was obtained after purification on the HPLC by isocratic elution with ACN/H2O (46:54) for MS and NMR 
analyses. 
12. Feeding experiments  
Feeding with 13C-labeled precursors 
For labeling experiments, appropriate amounts of A. ustus spores were transferred from plates into 250 mL flasks 
containing 50 mL PDB medium and cultivated on a rotary shaker at 230 rpm and 30 °C. Aqueous stock solution of 
the respective precursor was fed after 30 h cultivation, followed by a second feeding 24 h later. After cultivation 
for another 60 h, the fungal cultures were extracted with EtOAc for three times. The EtOAc extracts were 
evaporated at 30 °C to dryness and acetylated as mentioned above. The acetylated product was further purified on 
the HPLC system and subjected to NMR analysis. The culture size, precursor amounts and product yields are given 
below.  
250 and 125 mg of sodium [1-13C] acetate were used for the first and second feeding of the cultures in 25 flasks, 
leading to 0.5 mg of 2. The feeding experiments with sodium [2-13C] acetate and sodium [1,2-13C] acetate followed 
the same procedure, resulting in 1.5 and 1.0 mg of 2, respectively. 
293 and 147 mg of [2-13C] malonic acid were used for the first and second feeding of the cultures in 22 flasks, 
yielding 2.5 mg of 2. 
200 and 100 mg of sodium [2-13C] propionate were used for the first and second feeding of the cultures in 12 flasks, 
giving 0.6 mg of 2. 
180 and 120 mg of [methyl-13C]-L-methionin were used for the first and second feeding of the cultures in 40 flasks, 
leading to 6.0 mg of 2.  
Feeding experiments in A. nidulans expression mutants with UttA_G1778V and UttA_H1850A  
A. nidulans with empty vector, UttA_G1778V or UttA_H1850A mutant was cultivated as duplicate in 250 mL 
flask containing 50 mL PDB medium at 230 rpm and 30 °C. 3 mL propionic acid (3 g) were diluted with NaOH 
solution to 6 ml stock solution (pH 7). 650 μL (0.325 g propionic acid) of this solution were added into each of the 
two days-old cultures. Another 350 μL (0.175 g propionic acid) solution were added one day later. After cultivation 
in PD liquid medium at 230 rpm and 30 °C for 4 days, the cultures were extracted with EtOAc, dissolved in ACN 
and subjected to LC-MS analysis. 





Compound 3 was dissolved in DMSO to a concentration of 18 mg/mL. 277 μL (5 mg) of this solution was added 
into A. ustus ∆uttA cultures in 250 mL flasks containing 50 mL PDB medium each after fermentation at 230 rpm 
and 30 °C for three days. 2 L total culture in 40 flasks were used for this experiment and harvested after 7 days. 1.0 
mg of 7 and 1.0 mg of 8 were obtained and subjected to NMR and MS analyses. Feeding compound 3 into A. 
nidulans-pYH-gpdA-uttJ-pyrG transformant led to the isolation of 12.4 mg of 6 for NMR and MS analyses. 
Compound 3 was also fed to A. ustus ∆uttD mutant. 
1.0 mg (100 μL) of 4 was administered to a 100 mL flask containing 10 mL A. ustus ∆uttA culture after 3 days 
fermentation at 230 rpm and 30 °C. 1 mL culture was extracted for LC-MS analysis.  
13. LC-MS analysis 
LC-MS analysis was carried out on an Agilent HPLC 1260 series system equipped with a Bruker microTOF QIII 
mass spectrometer by using an Agilent Eclipse XDB C18 column (5 μm, 4.6 × 150 mm). Separation was performed 
at a flow rate of 0.25 mL/min with a 40 min linear gradient from 5 to 100% ACN in H2O, both containing 0.1% 
(v/v) HCOOH. The column was then washed with 100% ACN for 5 min and equilibrated for 5 min. The parameters 
of the spectrometer were set as the following: electrospray positive ion mode for ionization, capillary voltage with 
4.5 kV, collision energy with 8.0 eV. Sodium formate was used in each run for mass calibration. The masses were 
scanned in the range of m/z 100 ‒ 1500. Data were evaluated with the Compass DataAnalysis 4.2 software (Bruker 
Daltonik, Bremen, Germany).  
14. NMR analysis 
NMR spectra of the isolated products were recorded at room temperature on a JEOL ECA-500 spectrometer (JEOL, 
Akishima, Tokyo, Japan). The samples were dissolved in DMSO-d6 or CDCl3. All spectra were processed with 
MestReNov.9.0.0 (Mestrelab Research, Santiago de Compostella, Spain).  
The 13C enrichments were calculated by comparison of the integrals of the 13C signals in the 13C NMR spectra of 
2. The integrals of the C-12 signal at δC 169.1 ppm in both labeled and unlabeled samples were chosen as reference 
and set as 1.0. The integrals of other signals were normalized and expressed as relative values to this signal. For a 
given carbon, the enrichment is the ratio of the normalized value of the labeled to unlabeled sample. 
15. Physiochemical properties of the compounds described in this study  
2: yellow power; 1H and 13C NMR data given in Table S5; UV spectrum in Figure S21; HRMS (ESI) m/z: [M + 
Na]+ calcd. for C17H20NaO8 375.1050; found 375.1057. 
3: white power; 1H and 13C NMR data given in Table S6; UV spectrum in Figure S21; HRMS (ESI) m/z: [M + H]+ 





4: white power; 1H NMR data given in Table S7; UV spectrum in Figure S21; HRMS (ESI) m/z: [M + H]+ calcd. 
for C9H11O4 183.0652; found 183.0652.  
5: white power; 1H NMR data given in Table S7; UV spectrum in Figure S21; HRMS (ESI) m/z: [M + H]+ calcd. 
for C9H11O4 183.0652; found 183.0656. 
6: white power; 1H NMR data given in Table S7; UV spectrum in Figure S21; HRMS (ESI) m/z: [M + H]+ calcd. 
for C10H13O3 181.0859; found 181.0862. 
7: yellow power; 1H and 13C NMR data given in Table S8; UV spectrum in Figure S21; HRMS (ESI) m/z: [M + 
H]+ calcd. for C19H23O5 331.1540; found 331.1544. 
8: yellow power; 1H and 13C NMR data given in Table S9; UV spectrum in Figure S21; HRMS (ESI) m/z: [M + 
Na]+ calcd. for C11H14NaO4 233.0784; found 233.0784. 
10: yellow oil; 1H and 13C NMR data given in Table S10; UV spectrum in Figure S21; HRMS (ESI) m/z: [M + 
Na]+ calcd. for C14H16NaO6 303.0839; found 303.0845. 
16. Structural elucidation 
The structures of the isolated products were elucidated by comprehensive interpretation of their MS and NMR 
data (Figures S21 ‒ S45). By comparison with the literature data, 4,7 58 and 69 were identified as known 
compounds. 
The molecular formula of 2 was deduced from its HRMS as C17H20O8. 2 was obtained as a triacetylated derivative 
of 1 after acetylation of the crude extract from the wild type, which was confirmed by detection of the difference 
of their [M + Na]+ ions and by the presence of the corresponding signals for three acetyl groups in the NMR spectra 
of 2 (δC 169.1 ppm, C-12, δH 2.32 and δC 20.4 ppm, CH3-13; δC 170.1 ppm, C-14, δH 1.96 and δC 20.6 ppm, CH3-
15; δC 170.0 ppm, C-16, δH 1.96 and δC 20.4 ppm, CH3-17, Table S5). The 1H NMR data of 2 suggested also the 
presence of an aldehyde group (δH 10.10 ppm), a five-substituted benzene ring (δH 7.05 ppm), an aromatic methoxy 
group (δH 3.94 ppm), and three methylene groups (δH 5.02, 3.33 and 4.22 ppm). This was also proven by 
interpretation of its 13C NMR data. HMBC correlations revealed that two of the methylene groups are corrected to 
each other (Table S5 and Figure S25). Elucidation of the structure of 2 proved 1 to be 2-hydroxy-6-(2-
hydroxyethyl)-3-(hydroxymethyl)-4-methoxybenzaldehyde. 
The molecular formula of 3 was deduced from its HRMS data to be C10H12O4. Interpretation of its NMR spectra 






The molecular formula of 8 was deduced from the HRMS data to be C11H14O4 with five degrees of unsaturation. 
Comparison of its NMR data with those of 2 revealed the presence of signals for two instead of three methylene 
groups. One of them couples with a methyl group, i.e. as an ethyl group as observed in 3 and 5. The signals of an 
aromatic methoxy group are still detectable (δH 3.93 and δC 56.1 ppm). This proved the structure of 8 to be 6-ethyl-
2-hydroxy-3-(hydroxymethyl)-4-methoxybenzaldehyde. 
9 was unstable and its structure was elucidated after acetylation. The molecular formula of the diacetylated 
derivative 10 was deduced from the HRMS data to be C14H16O6, one oxygen more than that of 6. The existence of 
OH at C-2 was verified by the signal at δH 12.62 ppm. Comparison of the 1H NMR spectrum of 10 with that of 6 
indicated the hydroxylation of the methyl group at C-3. Differing from those in 2 and 8, no signal for an aromatic 
methoxy group was detected in the spectra of 6 and 10. This proved 9 as the hydroxylation product of C3-methyl 






















  Table S1. Putative functions of the genes from
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Table S2. Strains used in this study 
Stains Genotype 
Wild type A. ustus 3.3904 
ΔuttA ΔuttA::hph in A. ustus 3.3904 
ΔuttB ΔuttB::hph in A. ustus 3.3904 
ΔuttC ΔuttC::hph in A. ustus 3.3904 
ΔuttD ΔuttD::hph in A. ustus 3.3904 
ΔuttE ΔuttE::hph in A. ustus 3.3904 
ΔuttF ΔuttF::hph in A. ustus 3.3904 
ΔuttG ΔuttG::hph in A. ustus 3.3904 
ΔuttH ΔuttH::hph in A. ustus 3.3904 
ΔuttJ ΔuttJ::hph in A. ustus 3.3904 
A.nidulans  
LO8030  pyroA4, riboB2, pyrG89, nkuA::argB 
 
sterigmatocystin cluster (AN7804-AN7825)Δ, 
emericellamide cluster (AN2545-AN2549)Δ, 
 asperfuranone cluster (AN1039-AN1029)Δ, 
 monodictyphenone cluster (AN10023-AN10021)Δ, 
 terrequinone cluster (AN8512-AN8520)Δ, 
 austinol cluster part 1 (AN8379-AN8384)Δ, 
 austinol cluster part 2 (AN9246-AN9259)Δ, 
 F9775 cluster (AN7906-AN7915)Δ, 
 asperthecin cluster (AN6000-AN6002)Δ 
LZ51 gpdA::uttA::AfpyrG in A. nidulans LO8030 
LZ52 gpdA:: uttJ:::AfpyrG in A. nidulans LO8030 
LZ53 gpdA:: uttA_G1778V::AfpyrG in A. nidulans LO8030 






Table S3. Plasmids used and constructed in this study 
Plasmids Description 
p5HY Two-third of the hph resistance gene at the 5´-end, originated from the pUChph and inserted into pESC-URA. For gene replacement using hph as selection marker. 
p3YG Two-third of the hph resistance gene at the 3´-end, originated from the pUChph and inserted into pESC-URA. For gene replacement using hph as selection marker. 
pLZ101(p5HY-uttA) a 1171 bp US PCR fragment of uttA from genomic DNA of A. ustus 3.3904 inserted in p5HY. 
pLZ102(p3YG-uttA) a 1170 bp DS PCR fragment of uttA from genomic DNA of A. ustus 3.3904 inserted in p3YG. 
pLZ103(p5HY-uttB) a 1535 bp US PCR fragment of uttB from genomic DNA of A. ustus 3.3904 inserted in p5HY. 
pLZ104(p3YG-uttB) a 1486 bp DS PCR fragment of uttB from genomic DNA of A. ustus 3.3904 inserted in p3YG. 
pLZ105(p5HY-uttC) a 1476 bp US PCR fragment of uttC from genomic DNA of A. ustus 3.3904 inserted in p5HY. 
pLZ106(p3YG-uttC) a 1463 bp DS PCR fragment of uttC from genomic DNA of A. ustus 3.3904 inserted in p3YG. 
pLZ107(p5HY-uttD) a 1477 bp US PCR fragment of uttD from genomic DNA of A. ustus 3.3904 inserted in p5HY. 
pLZ108(p3YG-uttD) a 1492 bp DS PCR fragment of uttD from genomic DNA of A. ustus 3.3904 inserted in p3YG. 
pLZ109(p5HY-uttE) a 1527 bp US PCR fragment of uttE from genomic DNA of A. ustus 3.3904 inserted in p5HY. 
pLZ110(p3YG-uttE) a 1410 bp DS PCR fragment of uttE from genomic DNA of A. ustus 3.3904 inserted in p3YG. 
pLZ111(p5HY-uttF) a 1580 bp US PCR fragment of uttF from genomic DNA of A. ustus 3.3904 inserted in p5HY. 
pLZ112(p3YG-uttF) a 1523 bp DS PCR fragment of uttF from genomic DNA of A. ustus 3.3904 inserted in p3YG. 
pLZ113(p5HY-uttG) a 1480 bp US PCR fragment of uttG from genomic DNA of A. ustus 3.3904 inserted in p5HY. 
pLZ114(p3YG-uttG) a 1449 bp DS PCR fragment of uttG from genomic DNA of A. ustus 3.3904 inserted in p3YG. 
pLZ115(p5HY-uttH) a 1479 bp US PCR fragment of uttH from genomic DNA of A. ustus 3.3904 inserted in p5HY. 
pLZ116(p3YG-uttH) a 1426 bp DS PCR fragment of uttH from genomic DNA of A. ustus 3.3904 inserted in p3YG. 
pLZ117(p5HY-uttJ) a 1416 bp US PCR fragment of uttJ from genomic DNA of A. ustus 3.3904 inserted in p5HY. 
pLZ118(p3YG-uttJ) a 1505 bp DS PCR fragment of uttJ from genomic DNA of A. ustus 3.3904 inserted in p3YG. 
pYH-gpdA-pyrG URA3, wA flanking, gpdA, AfpyrG, Amp 
pLZ51 pYH-gpdA-uttA-pyrG; a 7836 bp fragment of uttA with its terminator from genomic DNA of A. ustus 3.3904 inserted in pYH-gpdA-pyrG 
pLZ52 pYH-gpdA- uttJ -dMeT-pyrG; a 177 bp fragment of uttA was removed in pYH-gpdA-pyrG.  
pLZ53 pYH-gpdA-uttA_G1778V-pyrG; mutation at Gly1778 to Val in pLZ51. 
pLZ54 pYH-gpdA-uttA_H1850A-pyrG; mutation at His1778 to Ala in pLZ51. 






















 Table S4. Prim
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Table S5. NMR data of compound 2 in DMSO-d6 (500 MHz, δ in ppm, J in Hz) 
 
Position δC δH (multi. J) HMBC 
1 119.8 (C) ‒ ‒ 
2 152.5 (C) ‒ ‒ 
3 116.0 (C) ‒ ‒ 
4 162.1 (C) ‒ ‒ 
5 112.1 (CH) 7.05 (s) C-1, C-3, C-4, C-9 
6 144.9 (C) ‒ ‒ 
7 189.0 (CH) 10.10 (s) C-1, C-2, C-6 
8 54.1 (CH2) 5.02 (s) C-2, C-3, C-4, C-14 
9 31.5 (CH2) 3.33 (t, J = 6.6 Hz) C-1, C-5, C-6, C-10 
10 63.9 (CH2) 4.22 (t, J = 6.6 Hz)) C-1, C-9,C-16 
11 56.6 (OCH3) 3.94 (s) C-4 
12 169.1 (C) ‒ ‒ 
13 20.4 (CH3) 2.32 (s) C-12 
14 170.1 (C) ‒ ‒ 
15 20.6 (CH3) 1.96 (s) C-14 
16 170.0 (C) ‒ ‒ 





Table S6. NMR data of compound 3 in DMSO-d6 (500 MHz, δ in ppm, J in Hz)  
 
Position δC δH (multi. J) HMBC 
1 103.0 (C) ‒ ‒ 
2 162.1 (C) ‒ ‒ 
3 108.0 (C) ‒ ‒ 
4 160.1 (C) ‒ ‒ 
5 108.9 (CH) 6.28 (s) C-1, C-4, C-6, C-9 
6 145.8 (C) ‒ ‒ 
7 173.8 (COOH) 9.97 (s) ‒ 
8 8.0 (CH3) 1.93 (s) C-2, C-3, C-4 
9 28.8 (CH2) 2.81 (q, J = 7.4 Hz) C-5, C-6, C-10 
10 16.1 (CH3) 1.10 (t, J = 7.4 Hz) C-6, C-9 
4-OH ‒ 13.33 (s) ‒ 










Position δH (multi., J) δH (multi., J) δH (multi., J) 
3 ‒ 6.13 (d, J = 2.4 Hz) ‒ 
5 6.25 (s) 6.18 (d, J = 2.4 Hz) 6.33 (s) 
7 ‒ ‒ 10.63 (s) 
8 1.93 (s) 2.78 (q, J = 7.4 Hz) 1.92 (s) 
9 2.39 (s) 1.11 (t, J = 7.4 Hz) 2.83 (q, J = 7.5 Hz) 
10 ‒ ‒ 1.17 (t, J = 7.5 Hz) 
2-OH 12.94 (s) 12.42 (s) 12.77 (s) 
4-OH 12.94 (s) 12.42 (s) 10.02 (s) 
7-OH 9.99 (s) 10.02 (s) ‒ 
 






Table S8. NMR data of compound 7 in DMSO-d6 (500 MHz, δ in ppm, J in Hz) 
 
Position δC δH (multi., J) HMBC 
1 111.5 (C) ‒ ‒ 
2 163.8 (C) ‒ ‒ 
3 112.7 (C) ‒ ‒ 
4 154.3 (C) ‒ ‒ 
5 109.4 (CH) 6.28 (s) C-1, C-3, C-9 
6 148.8 (C) ‒ ‒ 
7 194.1 (CH) 10.00 (s) C-2, C-3 
8 18.9 (CH2) 3.71 (s) C-2, C-3, C-4, C-1ʹ, C-2ʹ, C-6ʹ 
9 24.3 (CH2) 2.82 (q, J = 7.5 Hz) C-5, C-6, C-10 
10 17.0 (CH3) 1.15 (t, J = 7.5 Hz) C-6, C-9 
1ʹ 115.6 (C) ‒ ‒ 
2ʹ 163.8 (C) ‒ ‒ 
3ʹ 108.7 (C) ‒ ‒ 
4ʹ 154.4 (C) ‒ ‒ 
5ʹ 107.5 (CH) 6.16 (s) C-1ʹ, C-3ʹ, C-4ʹ, C-8ʹ 
6ʹ 141.2 (C) ‒ ‒ 
7ʹ 9.6 (CH3) 1.92 (s)  C-3ʹ, C-4ʹ 
8ʹ 25.9 (CH2) 2.63 (q, J = 7.5 Hz) C-1ʹ, C-5ʹ, C-6ʹ, C-9ʹ 
9ʹ 16.1 (CH3) 0.98 (t, J = 7.5 Hz) C-6ʹ, C-8ʹ 
4ʹ-OH ‒ 8.72 (s) C-3ʹ, C-4ʹ 






Table S9. NMR data of compound 8 in CDCl3 (500 MHz, δ in ppm, J in Hz) 
 
Position δC δH (multi., J) HMBC 
1 151.2 (C) ‒ ‒ 
2 163.5 (C) ‒ ‒ 
3 114.2 (C) ‒ ‒ 
4 164.3 (C) ‒ ‒ 
5 104.0 (CH) 6.34 (s) C-3, C-4, C-6, C-9 
6 112.7 (C) ‒ ‒ 
7 193.3 (CH) 10.14 (s) C-2, C-3 
8 53.9 (CH2) 4.76 (s) C-2, C-3, C-4 
9 25.7 (CH2) 2.93 (q, J = 7.6 Hz) C-5, C-6, C-10 
10 17.3 (CH3) 1.31 (t, J = 7.6 Hz)) C-1, C-9 
4-OCH3 56.1 (OCH3) 3.93 (s) C-4 







Table S10. NMR data of compound 10 in DMSO-d6 (500 MHz, δ in ppm, J in Hz) 
 
 
Position δC δH (multi., J) HMBC 
1 114.3 (C)   
2 162.6 (C)   
3 115.6 (C)   
4 155.9 (C)   
5 115.0 (CH) 6.72 (s) C-4, C-6, C-9 
6 150.9 (C)   
7 196.1 (CH) 10.28 (s) C-1, C-2 
8 53.9 (CH2) 5.02 (s) C-2, C-3, C-4, C-12 
9 24.0 (CH2) 2.99 (q, J = 7.6 Hz) C-5, C-6, C-1, C-10 
10 16.2 (CH2) 1.21 (t, J = 7.6 Hz)) C-6, C-9 
11 170.0 (C)   
12 20.4 (CH3) 1.96 (s) C-11 
13 168.4 (C)   
14 20.6 (CH3) 2.29 (s) C-13 
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Figure S1. PCR verification of deletion mutants of A. ustus 3.3904. 
PCR amplification for three different fragments from genomic DNA of WT and deletion mutants was used to prove the presence/absence of the 























Figure S2. PCR verification of heterologous expression transformants. 
A. nidulans-pYH-gpdA-uttA-pyrG (HE-uttA) (A),A. nidulans-pYH-gpdA-uttJ-pyrG (HE-uttJ) (B), and marker reference (C). A fragment of 1.5 kb 
















Figure S4. Point mutation in UttA and analysis of the obtained mutants. 







Figure S5. Sequence alignments of 2-OG-dependent oxygenases. 
CitB (ALI92653)10, ClaD (QBK15042), and ANS (Q96323) are from Monascus ruber M7, Penicillium crustosum and Arabidopsis thaliana, 
respectively. UttH contains the typical conserved 2-His-1-Asp ion-binding triad of non-heme FeII/2-oxoglutarate-dependent oxygenases (His228, 
His296 and Asp296) (marked with *) compared with the crystal structure of ANS11. Protein sequence alignments were carried out by using the 
sequence alignment function of Multiple Sequence Alignment by CLUSTALW (https://www.genome.jp/tools-bin/clustalw) and visualized with 















Figure S6. Weblogo illustration for the conserved ExxR and CxG motifs in UttC by using 96 P450 enzyme in fungi. 
EAGR (349-352) in UttC (A); CLG (434-436) in UttC (B) 
 
The amino acids in the following enzymes (accession number are listed) were used for analysis. UttC (KIA75594) is highlighted in red. 
XP_664053.1_10-490, XP_033674816.1_17-507, XP_033595470.1_20-516, XP_033430050.1_21-509, XP_033391313.1_19-508, 
XP_026608368.1_1-495, XP_025573321.1_5-496, XP_025464315.1_5-498, XP_024692041.1_6-487, XP_016600678.1_16-516, 
XP_016589218.1_27-507, XP_016221951.1_24-495, XP_007806251.1_26-498, XP_007805323.1_1-429, XP_003234761.1_17-497, 
XP_003170503.1_31-508, XP_003071602.1_35-507, XP_002848393.1_22-522, XP_002145722.1_1-497,XP_001911463.1_5-497, 
XP_001905657.1_14-503, XP_001245240.2_35-507, XP_001228060.1_35-520, VBB75775.1_5-497, TVY58386.1_20-510, SLM38802.1_31-
474, RYP92946.1_1-423, RYP43872.1_19-502, RVX74072.1_1-443,RMZ76241.1_762-1242, RMD39760.1_78-530, RAO64728.1_1-365, 
QGA14808.1_1-497, Q0CRQ3.2_13-480, PVH96859.1_19-500, POS74238.1_21-516, PLN86963.1_21-508, PCG99300.1_13-489, 
OXV11655.1_4-509, OTB02447.1_24-516, OTA92375.1_13-516, OTA64244.1_13-516, OSS44053.1_30-509, OJJ68595.1_1-492, 
OCK75412.1_40-531, KUL85074.1_3-484, KMP04844.1_28-510, KMM70176.1_35-510, KKY30492.1_16-525, KIH90520.1_27-527, 
KIA75594.1_1-506, KGO38587.1_16-495, KFY99026.1_1-431, KFY63720.1_19-514, KFH44065.1_16-507, KFA68360.1_26-512, 
KFA60546.1_25-483, KEY71920.1_31-483, KEY71720.1_26-512, KAF4779182.1_34-507, KAF4310737.1_17-496, KAF4228494.1_6-502, 
KAF3895032.1_17-525, KAF3406269.1_34-522, KAF3023069.1_9-517, KAF3012828.1_17-494, KAF2994041.1_1-422, KAF2847821.1_21-
515, KAF2678715.1_16-511, KAF2258967.1_9-501, KAF2205452.1_8-503, KAF2189392.1_14-523, KAF2004773.1_15-520, 
KAE8553912.1_1-497, KAB8343000.1_743-1215, KAB5575480.1_31-514, KAA6412416.1_75-547, GFF93090.1_21-527, GFF54863.1_21-
527, GFF23783.1_21-510, GES61355.1_13-512, GAW17174.1_5-514, GAO84805.1_21-527, GAM43297.1_34-522, EZF36180.1_17-525, 
EZF23312.1_17-525, ERS97303.1_27-525, EPE10457.1_18-502, EKG19934.1_1-426, EGE04287.1_17-525, EGD97508.1_17-525, 











Figure S7. LC-MS analysis of the metabolite profile of the A. ustus wild type 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated (i). EICs with a tolerance range of ± 0.005 







Figure S8. LC-MS analysis of the metabolite profile of the A. ustus ΔuttA mutant 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated (i). EICs with a tolerance range of ± 0.005 







Figure S9. LC-MS analysis of the metabolite profile of the A. ustus ΔuttB mutant 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated (i). EICs with a tolerance range of ± 0.005 







Figure S10. LC-MS analysis of the metabolite profile of the A. ustus ΔuttC mutant 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated (i). EICs with a tolerance range of ± 0.005 







Figure S11. LC-MS analysis of the metabolite profile of the A. ustus ΔuttD mutant 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated. (i). EICs with a tolerance range of ± 0.005 







Figure S12. LC-MS analysis of the metabolite profile of the A. ustus ΔuttE mutant 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated. (i). EICs with a tolerance range of ± 0.005 







Figure S13. LC-MS analysis of the metabolite profile of the A. ustus ΔuttF mutant 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated. (i). EICs with a tolerance range of ± 0.005 







Figure S14. LC-MS analysis of the metabolite profile of the A. ustus ΔuttG mutant 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated. (i). EICs with a tolerance range of ± 0.005 







Figure S15. LC-MS analysis of the metabolite profile of the A. ustus ΔuttH mutant 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated. (i). EICs with a tolerance range of ± 0.005 







Figure S16. LC-MS analysis of the metabolite profile of the A. ustus ΔuttJ mutant 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated. (i). EICs with a tolerance range of ± 0.005 






Figure S17. LC-MS analysis of the metabolite profile of the A.ustus ΔuttD after feeding with 3. 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated (i). EICs with a tolerance range of ± 0.005 






Figure S18. LC-MS analysis of the metabolite profile of the A. ustus ΔuttA after feeding with 4. 
UV detection was carried out on a diode array detector and absorptions at 292 nm are illustrated (i). EICs with a tolerance range of ± 0.005 








Figure S19. LC-MS analysis of the acetylated EtOAc extract from A. ustus. 
 




Figure S20. LC-MS analysis of the acetylated EtOAc extract from ΔuttF of A. ustus. 
 












Figure S22. 1H NMR spectrum of compound 2 in DMSO-d6 (500 MHz) 
 






Figure S24. HSQC spectrum of compound 2 in DMSO-d6 
 













Figure S26. 1H NMR spectrum of compound 3 in DMSO-d6 (500 MHz) 
 







Figure S28. HSQC spectrum of compound 3 in DMSO-d6 
 







Figure S30. 1H NMR spectrum of compound 4 in DMSO-d6 (500 MHz) 
 







Figure S32. 1H NMR spectrum of compound 6 in DMSO-d6 (500 MHz) 
 






Figure S34. 13C{1H} NMR spectrum of compound 7 in DMSO-d6 (125 MHz) 
 






Figure S36. 1H-1H COSY spectrum of compound 7 in DMSO-d6 
 






Figure S38. 1H NMR spectrum of compound 8 in CDCl3 (500 MHz) 
 






Figure S40. HSQC spectrum of compound 8 in CDCl3 
 







Figure S42. 1H NMR spectrum of compound 10 in DMSO-d6 (500 MHz) 
 






Figure S44. HSQC spectrum of compound 10 in DMSO-d6 
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Abstract
Accumulation of two benzoyl esters in Aspergillus ustus after feeding with alcohols was reported 30 years ago. To the best of 
our knowledge, the biosynthesis for these esters has not been elucidated prior to this study. Here, we demonstrate that these 
compounds are artifical products of the phenethyl polyketide ustethylin A biosynthestic pathway. In addition, four aditional 
benzoyl esters with different methylation levels were also isolated and identified as shunt products. Feeding experiments 
provided evidence that the enzyme-bound polyketide acyl intermediates are hijacked by externally fed MeOH or EtOH, 
leading to the formation of the benzoyl esters.
Graphic abstract
Keywords Benzoyl esters · Biosynthesis · Aspergillus ustus · Alcohols feeding · Polyketides
Introduction
Secondary metabolites play an important role in ecological 
fitness of microorganisms, such as for protection from UV 
damage, toxic natural products and other microorganisms 
(Keller 2019). Polyketides with diverse biological and phar-
macological activities are the most abundant fungal natural 
products (Keller et al. 2005; Ran and Li 2020). These com-
pounds are biosynthesized by the well-studied multidomain 
proteins—polyketide synthases (PKSs). Based on the reduc-
tion status of their products, fungal PKSs can basically be 
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divided into three class: nonreducing, partially reducing and 
highly reducing PKSs (Cox 2007). The typical nonreducing 
PKSs contain starter unit ACP transacylase (SAT), ketosyn-
thase (KS), malonyl-CoA–ACP transacylase (MAT), product 
template (PT), acyl-carrier protein (ACP) and thioesterase 
(TE) domains (Crawford and Townsend 2010).
A study in 1987 reported the accumulation of 2,4-dihy-
droxy-3-methyl-6-ethyl benzoyl methyl and ethyl ester 
after feeding an Aspergillus ustus culture with MeOH and 
EtOH, respectively. Isotope incorporation was observed 
for both methyl groups of the aryl acid after feeding with 
[methyl-13C]-l-methionine, indicating their origin from 
methylation. Isotope labeling experiments also proved that 
other carbons are derived from acetate (De Jesus et al. 1987). 
However, no further biosynthetic studies have been reported 
for these compounds.
Phenethyl-containing compounds are common micro-
bial metabolites. In fungi, the ethyl groups in phenethyl 
residue are derived from S-adenosyl l-methionine and 
usually catalyzed by the methyltransferase domain of pol-
yketide synthase (Zheng et al. 2020). Recently, we eluci-
dated the first biosynthetic pathway of fungal phenethyl 
derivatives, i.e., that of ustethylin A in A. ustus 3.3904 
(Zheng et al. 2020), a rare human pathogen fungus (Pi 
et al. 2015). In this pathway, the nonreducing PKS UttA 
is responsible for the formation of the key intermediate 
phenethyl benzoic acid. After reduction of the aryl car-
boxyl group to aldehyde by the NRPS-like enzyme UttJ, 
the methyl and ethyl groups are oxidized by the nonheme 
 FeII/2-oxoglutarate-dependent oxygenase UttH and the 
cytochrome  P450 enzyme UttC, respectively. Phenolic 
methylation is catalyzed by the methyltransferase UttF 
(Scheme 1). The final pathway product ustethylin A was 
detected as the predominantly accumulated metabolite 
(Fig. 1a).
Materials and methods
Strains, media and growth conditions
Aspergillus ustus 3.3904 was purchased from China Gen-
eral Microbiological Culture Collection Center (Beijing, 
China) and cultivated in PDB (potato dextrose broth, Sigma) 
medium at 230 rpm and 30 °C for secondary metabolite 
production. Construction of the A. ustus ΔuttA mutant has 
been reported previously (Zheng et al. 2020).
Alcoholic feeding experiments
1.5 mL (3%, v/v) of MeOH, EtOH or  CD3OD were added 
into the three day-old A. ustus cultures in 250 mL flask 
containing 50 mL PDB medium, which were further main-
tained at 230 rpm and 30 °C for five days. 1 mL culture was 
extracted with EtOAc for LC–MS analysis.
For large-scale fermentation, 15 mL of MeOH or EtOH 
were added to 500 mL PDB medium in 2 L flask and culti-
vated under the same condition as mentioned above.
Scheme 1.  Simplified biosynthetic pathway of ustethylin A with 1–6 as shunt products after alcoholic feeding
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Precursor feeding in ∆uttA mutant
Compound 9 was dissolved in MeOH at a concentration of 
18 mg/mL. 277 μL (5 mg) of this solution were added into 
the culture of the A. ustus ∆uttA mutant in 250 mL flask con-
taining 50 mL PDB medium after fermentation at 230 rpm 
and 30 °C for three days. Two days later, 1 mL culture was 
extracted with EtOAc for LC–MS analysis.
HPLC analysis and isolation
Extracts were analyzed on an Agilent HPLC series 1200 
(Agilent Technologies) equipped with an Agilent Eclipse 
XDB-C18 column (5 μm, 4.6 × 150 mm). A linear gradient 
from 10 to 90% ACN in  H2O in 20 min was used. The col-
umn was then washed with 100% ACN for 5 min and equili-
brated with 10% ACN in  H2O for another 5 min. Detection 
was carried out on a photodiode array detector and absorp-
tions at 254 nm are illustrated in this study.
A semi-preparative Multospher 120 RP-18 column (5 μm, 
10 × 250 mm) was used for isolation of the products for 
structural elucidation on the same HPLC system with the 
same solvents at a flow rate of 2 mL/min. Separation was 
done by isocratic elution with 25–70% ACN for 10–20 min.
Large‑scale fermentation, extraction and isolation 
of secondary metabolites
For isolation of compounds 1–3, large-scale fermentation 
of A. ustus 3.3904 with MeOH was carried out as described 
above. The supernatant was separated from mycelia by fil-
tration and extracted with equal volume of EtOAc for three 
times. The mycelia were extracted with acetone and con-
centrated under reduced pressure to afford an aqueous solu-
tion and then extracted with EtOAc for three times. Both 
EtOAc extracts were evaporated under reduced pressure to 
afford the crude extracts for further purification. The crude 
extract was separated on a silica gel column with  CHCl3/
MeOH (100:0–0:100) as elution solvents to give 8 fractions. 
Fraction 2 was purified on a semi-preparative HPLC (ACN/
H2O), leading to 8.0 mg of 1, 8.0 mg of 2 and 60.0 mg of 3. 
Similar procedure was used for product isolation after EtOH 
feeding. 6.5 mg of 4, 5.2 mg of 5 and 30.0 mg of 6 were 
obtained in high purity.
LC–MS and MS analysis
Extracts were also analyzed on an Agilent HPLC 1260 series 
system equipped with a Bruker microTOF QIII mass spec-
trometer using an Agilent Eclipse XDB C18 column (5 μm, 
4.6 × 150 mm). Separation was performed at a flow rate of 
0.5 mL/min with a 40 min linear gradient from 5 to 100% 
ACN in  H2O, both containing 0.1% (v/v) HCOOH. The col-
umn was then washed with 100% ACN for 5 min and equili-
brated for 5 min with 5% ACN in  H2O. The parameters of 
the spectrometer were set as the following: electrospray posi-
tive ion mode for ionization, capillary voltage with 4.5 kV, 
collision energy with 8.0 eV. Sodium formate was used in 
each run for mass calibration. The masses were scanned 
in the range of m/z 100–1500. Data were evaluated with 
the Compass DataAnalysis 4.2 software (Bruker Daltonik, 
Bremen, Germany).
NMR analysis
NMR spectra of the isolated products were recorded at room 
temperature on a JEOL ECA-500 (JEOL, Akishima, Tokyo, 
Japan). The samples were dissolved in  CDCl3 or  CD3OD. 
All spectra were processed with MestReNov.9.0.0 (Mestre-
lab Research, Santiago de Compostella, Spain).
Fig. 1  a HPLC analysis of the A. ustus extracts. UV detection was 
carried on a photodiode array detector and absorptions at 254 nm are 
illustrated. b Structures of 1–9 and 11 
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Physiochemical properties of the compounds 
described in this study
1: white needle crystal; 1H NMR data see Table S1; HRMS 
(ESI) m/z: [M + H]+ calcd. for  C10H13O4 197.0808; found 
197.0756.
2: white needle crystal; 1H NMR data see Table S1; 
HRMS (ESI) m/z: [M + H]+ calcd. for  C10H13O4 197.0808; 
found 197.0755.
3: white bulk crystal; 1H NMR data see Table S1, 13C 
NMR data see Table S2; HRMS (ESI) m/z: [M + H]+ calcd. 
for  C11H15O4 211.0965; found 211.0916.
4: white needle crystal; 1H NMR data see Table S1; 
HRMS (ESI) m/z: [M + H]+ calcd. for  C11H15O4 211.0965; 
found 211.0964.
5: white needle crystal; 1H NMR data see Table S1; 
HRMS (ESI) m/z: [M + H]+ calcd. for  C11H15O4 211.0965; 
found 211.0960.
6: white bulk crystal; 1H NMR data see Table S1; HRMS 
(ESI) m/z: [M + H]+ calcd. for  C12H17O4 225.1121; found 
225.1119.
Structural elucidation
The structures of the isolated products were elucidated by 
interpretation of their MS and NMR spectra (Figures S1–S9) 
and by comparison of these data with those described in the 
literature. 1 (Sher and Langer 2008), 2 (Schleich et al. 2006) 
3 (De Jesus et al. 1987), 4 (Schleich et al. 2006), 5 (Sher and 
Langer 2008) and 6 (De Jesus et al. 1987) were identified as 
known compounds.
Results and discussion
The aryl acids involved in the biosynthesis of ustethylins 
are the acyl components of the previously identified esters 
(De Jesus et al. 1987) (Fig. 1b). We speculated therefore 
that they are also derived from the ustethylin pathway. To 
prove our hypothesis, we repeated the feeding experiments 
with alcohols using three day-old cultures of A. ustus 3.3904 
wild-type and an uttA deficient mutant in PDB medium. As 
shown in Fig. 1a, HPLC analysis of the EtOAc extract of 
the wild-type revealed the presence of ustethylin A as the 
predominant metabolite (Fig. 1a), as reported previously 
(Zheng et al. 2020). In the extract of the culture with exter-
nally fed MeOH and EtOH, three metabolites each 1–3 
and 4–6 were detected, respectively. 3 as a major peak was 
accompanied by two minor ones 1 and 2 in the culture with 
MeOH. LC–MS analysis revealed that 3 has an additional 
methyl group than 1 and 2 (Fig. 2a). It is noteworthy that 
compounds 1, 2, 4 and 5 were not reported in the previous 
study (De Jesus et al. 1987).
For structural elucidation, 1 – 3 were isolated from a 2 
L A. ustus culture after feeding with 60 mL MeOH. Com-
parison of the NMR data of the isolated products (Tables 
Fig. 2  LC–MS results (positive 
mode) of A. ustus extracts after 
feeding with MeOH (a) and 
 CD3OD (b). UV absorptions at 
254 nm are illustrated
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S1 and S2, Figures S1–S6) with those described in the lit-
erature confirmed 3 to be 2,4-dihydroxy-3-methyl-6-ethyl 
benzoyl methyl ester (De Jesus et al. 1987). NMR analy-
sis also proved that 1 and 2 are two congeners of 3 lack-
ing the C3-methyl group and replacing the C6-ethyl by a 
methyl group, respectively (Fig. 1b) (De Jesus et al. 1987; 
Schleich et al. 2006; Sher and Langer 2008). In analogy, 
the major peak 6 and the two minor ones 4 and 5 were also 
isolated from the culture fed with EtOH and identified as 
ethyl esters of the corresponding aryl acids (De Jesus et al. 
1987; Schleich et al. 2006; Sher and Langer 2008) (Fig. 1b, 
Table S1, Figures S7–S9).
The isotopic feeding experiments in the previous 
study proved that the O-methyl group in compound 3 is 
not derived from methionine (De Jesus et al. 1987). The 
O-methyl groups in 1–3 originate likely from MeOH. To 
confirm this,  CD3OD was fed into the Aspergillus ustus cul-
ture and the EtOAc extract was analyzed via HPLC–MS. 
Detection of [M + H]+ ion of 3 at m/z 214.1161 after feeding 
with  CD3OD, 3 Daltons larger than that after feeding with 
MeOH at m/z 211.0916 (Fig. 2), proved the incorporation 
of the  CD3 group into the structure of 3. Similar MS pattern 
changes were also observed for compounds 1 and 2 (Fig. 2).
As reported previously (Zheng et al. 2020), the PKS UttA 
from the ustethylin biosynthetic pathway is responsible for 
the formation of the aryl acids 7–9 (Fig. 1b), the acyl moie-
ties of 1–3 and 4–6. To prove its function, uttA was replaced 
with a hygromycin B resistance cassette in our former study 
(Zheng et al. 2020). HPLC analysis of the culture extract 
of the ΔuttA mutant revealed the abolishment of ustethy-
lin A production. Feeding this ΔuttA mutant with MeOH 
did not lead to an accumulation of 1–3 (Fig. 1a). Similar 
results were also observed after feeding the ΔuttA mutant 
with EtOH (data not shown). This proved unequivocally the 
involvement of UttA in the formation of 1–6.
To figure out whether the ester formation is from free 
acids in A. ustus, 9 in MeOH was fed to the culture of ΔuttA 
mutant. As shown in Fig. 1a, no trace of 3 was detected. 
Instead, 9 was converted to the corresponding benzal-
dehyde 10 (ustethylin D) and a dimeric metabolite 11, as 
described previously (Zheng et al. 2020). In addition, 3 was 
not detected after incubation of 9 with MeOH at 37 °C for 
16 h (data not shown). These results indicated that the ester 
formation in 1–6 requires activation of the acidic precursors.
In the previous study, we proposed that the PKS UttA 
utilizes malonyl-CoA as both starter and extension unit. 
Two methylation steps, at C-3 of the benzene ring and the 
C6-methyl group, are involved in the formation of the aryl 
acyl-ACP molecules (Scheme 1), which are then released 
as free aryl acids and modified by tailoring enzymes. Our 
results in this study provide evidence that after the phenyl 
ring formation catalyzed by UttA, the acyl-ACP molecules 
can be hijacked by alcohols for ester formation, as depicted 
in Scheme 1. The formation of the minor products 1 and 
2 after feeding with MeOH as well as 4 and 5 after feed-
ing with EtOH confirmed the incomplete methylation steps 
by UttA, as observed in the previous study (Zheng et al. 
2020). In vivo assays in our aforementioned study verified 
that reduction of the acid 9 to the benzaldehyde 10 by the 
NRPS-like enzyme UttJ is a prerequisite for further modifi-
cation (Zheng et al. 2020). Therefore, the esters 1–6 cannot 
be further metabolized by the tailoring enzymes of the Utt 
pathway and were accumulated as artificial products.
Feeding n-PrOH to the culture of A. ustus wild-type led to 
the detection of trace amount of the corresponding ester by 
HPLC–MS analysis, which could not be isolated in substan-
tial amount for structural identification. No ester formation 
was observed after feeding with i-PrOH or n-BuOH (data not 
shown). These results indicated that the ester formation is 
preferred for small alcohols. Ester bonds are commonly pre-
sent in natural products and are usually formed during chain 
release in the polyketide (Wang et al. 2009) or nonriboso-
mal peptide biosynthesis and by Baeyer–Villiger monooxy-
genases (Tsakos et al. 2015). However, spontaneous ester 
formation has also been described for carboxylic acids by 
incubation in alcoholic solvents at room temperature (Fan 
et al. 2020). Therefore, it cannot be concluded whether the 
formation of 1–6 is an enzymatic or nonenzymatic event 
(Scheme 1).
Conclusions
In conclusion, we demonstrated in this study that the aryl 
acyl esters from A. ustus 3.3904 are shunt products of the 
ustethylin biosynthetic pathway as response for the exter-
nally fed alcohols. It will be interesting to investigate the 
physiological relevance of this response.
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Figure S1. 1H NMR spectrum of compound 1 in CD3OD (500 MHz) 
 
 



























































































































Figure S3. 1H NMR spectrum of compound 3 in CDCl3 (500 MHz) 
 
 








































































































































Figure S5. HSQC spectrum of compound 3 in CDCl3 
 
 



























































Figure S7. 1H NMR spectrum of compound 4 in CDCl3 (500 MHz) 
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Oxepinamide F biosynthesis involves enzymatic D-
aminoacyl epimerization, 3H-oxepin formation, and
hydroxylation induced double bond migration
Liujuan Zheng1,3, Haowen Wang1,3, Aili Fan 2 & Shu-Ming Li 1✉
Oxepinamides are derivatives of anthranilyl-containing tripeptides and share an oxepin ring
and a fused pyrimidinone moiety. To the best of our knowledge, no studies have been
reported on the elucidation of an oxepinamide biosynthetic pathway and conversion of a
quinazolinone to a pyrimidinone-fused 1H-oxepin framework by a cytochrome P450 enzyme
in fungal natural product biosynthesis. Here we report the isolation of oxepinamide F from
Aspergillus ustus and identification of its biosynthetic pathway by gene deletion, heterologous
expression, feeding experiments, and enzyme assays. The nonribosomal peptide synthase
(NRPS) OpaA assembles the quinazolinone core with D-Phe incorporation. The cytochrome
P450 enzyme OpaB catalyzes alone the oxepin ring formation. The flavoenzyme OpaC
installs subsequently one hydroxyl group at the oxepin ring, accompanied by double bond
migration. The epimerase OpaE changes the D-Phe residue back to L-form, which is essential
for the final methylation by OpaF.
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Oxepinamides are a class of oxepins with a fused pyr-imidinone ring and were mainly found in fungi. Forexample, oxepinamides F, G, and H were isolated from
Aspergillus puniceus1,2, varioloid A and varioxepine A from Paeci-
lomyces variotii3,4, dihydrocinereain from Aspergillus carneus5, cir-
cumdatin A/B from Aspergillus ochraceus6, and versicoloid A/B
from Aspergillus versicolor7 (Fig. 1a). Some oxepinamides show high
affinity to liver X receptors (LXRs) and are potential agents for the
treatment of Alzheimer’s disease, atherosclerosis, diabetes, and
inflammation1,2. Oxepinamides are usually derived from quinazo-
linones with an anthranilyl (Ant) residue in common. They differ
from each other by incorporation of two other varying amino acids
and additional modifications. Until now, four trimodular non-
ribosomal peptide synthases (NRPSs) for assembling quinazoli-
nones containing Trp, Ala, and Gly have been functionally
characterized (Fig. 1b). In comparison to AldpA8 and CtqA8,
TqaA9 and FmqA10 have an additional epimerization (E) domain
in the Trp module, which is responsible for the conversion of L- to
D- tryptophan in fumiquinazoline (FQF). As shown in Fig. 1a,
phenylalanine, valine, leucine, and isoleucine residues are often
found in the oxepinamide structures. To the best of our knowledge,
genes responsible for quinazolinones with these amino acids have
not been reported prior to this study.
In comparison to 1H-oxepins with three C=C in the oxepin
ring, varioxepine A, varioloid A, oxepinamide F and G feature a
3H-oxepin structure with two C=C in the ring and one exo C=N
bond (Fig. 1a). To the best of our knowledge, despite the intri-
guing structural features and biological activities, studies on the
biosynthesis of oxepinamides, especially the formation of the 3H-
oxepin ring, have not been reported yet.
We identify in this study an oxepinamide (opa) biosynthetic
gene cluster (BGC) in Aspergillus ustus by bioinformatic analysis.
Gene deletion, heterologous expression, feeding experiments, and
in vitro assays with purified enzymes prove the biosynthetic steps
and the 3H-oxepin formation by consecutive ring expansion and
regio- and stereospecific hydroxylation. Furthermore, the D-
phenylalanyl epimerase OpaE converts the D-Phe residue back to
L-form for the last methylation step to form oxepinamide F.
Results
Identification of the opa BGC. Oxepinamide F (1) was isolated,
together with its nonmethylated congener oxepinamide E (2)
from a rice culture of A. ustus 3.3904. Their structures were
confirmed by mass spectrometry (MS), nuclear magnetic reso-
nance (NMR), optical rotation, and circular dichroism (CD)
analyses (NMR data are listed in Supplementary Tables 5–8 and
spectra in Supplementary Figs 7–30. CD spectra are given in
Supplementary Fig. 3)1. Typical NMR signals for 3H-oxepins
were observed at δH 6.7 (d, 7.3 Hz), δH 5.5 (t, 7.1 Hz), δH 6.2 (dd,
10.0, 7.0 Hz), and δH 5.8 ppm (d, 10.1 Hz), as well as δC 144, 104,
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Fig. 1 Oxepinamides and backbone enzymes. a Examples of fungal oxepinamides including 1H-oxepins and 3H-oxepins. b Known NRPSs for quinazolinone
assembling.
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To find the biosynthetic genes of 1, we sequenced the A. ustus
3.3904 genome, carried out prediction for putative BGCs by using
AntiSMASH11, and compared them with the published data12.
The core structure of 1 is proposed to be assembled from Ant,
Phe, and Ile by a NRPS containing at least three A-T-C (A:
adenylation, T: thiolation, C: condensation) modules13. 1 differs
from 2merely in the methyl group at OH-12, implying that an O-
methyltransferase (O-MeT) should be involved in its biosynthesis.
Comprehensive sequence analysis revealed the presence of at least
11 genes for putative NRPSs. Two of them, KIA75458 and
KIA75688, contain three A-T-C modules. Furthermore, a gene
coding for a putative O-MeT (KIA75453) was only found
neighboring to the gene for KIA75458. Thus, the KIA75458-
related BGC was the best candidate for the 1 and 2 biosynthesis.
Inspection of the genomic neighborhood of these candidate
genes in A. ustus revealed the presence of a putative BGC
containing six genes opaA–opaF, coding for the putative proteins
KIA75458–KIA75453 in the database (Fig. 2a). Sequence analysis
and comparison suggested their functions as putative cytochrome
P450 enzyme (OpaB, KIA75457), FAD-dependent oxygenase
(OpaC, KIA75456), transporter (OpaD, KIA75455), epimerase
(OpaE, KIA75454), and O-MeT (OpaF, KIA75453) (Supplemen-
tary Table 1).
Further sequence analysis revealed that KIA75458, named
OpaA in this study, has a domain architecture of A-T-C-A-T-E-
C-A-T-C (Fig. 2a). To prove its function, opaA in A. ustus was
replaced with a hygromycin B resistance cassette by using a split
marker gene replacement protocol14. The generated mutants were
verified by PCR (Supplementary Fig. 1) and cultivated in rice
media. High-performance liquid chromatography (HPLC) ana-
lysis of the culture extract of the ΔopaA mutant revealed the
abolishment of both 1 and 2 production (Fig. 2b), proving its
involvement in their biosynthesis. Deletion of opaF abolished 1,
but not 2 production, indicating that OpaF acts as a methyl-
transferase for the conversion of 2 to 1 (Fig. 2b). Based on above
results, the opa gene cluster is indeed responsible for biosynthesis
of 1 and 2.
The oxepin ring in 1 and 2 was proposed to be formed by
oxidative benzene ring expansion1,15. However, it is unknown
whether the P450 enzyme OpaB, the oxidase OpaC or both are
responsible for this conversion. To figure out their functions, we
firstly deleted opaB from A. ustus genome. Deletion of opaB led to
the abolishment of 1 and 2, together with the accumulation of a
new peak 3 at 16.2 min with a [M+H]+ ion at m/z 362.189
(Fig. 2b). Typical signals for oxepins were not observed in the
NMR spectra of 3. Extensive interpretation of the spectroscopic
data including NMR and CD spectra and comparison with
known compounds16 proved 3 to be protuboxepin K, a
quinazolinone derivative of Ant, D-Phe, and L-Ile (Fig. 3)17.
Bioinformatic analysis and comparison with known proteins
revealed that OpaA consists of a deduced AAnt-T1-C1-APhe-T2-E-
C2-AIle-T3-CT domain structures, similar to CtqA, AldpA, FmqA,
and TqaA. OpaA has the same AAnt domain for anthranilic acid
activation (Fig. 1b). As aforementioned, the E domain in FmqA
and TqaA is responsible for incorporation of a D-Trp residue in
FQF. In analogy, the presence of an E domain in the second
module of OpaA and the D-Phe residue in 3 imply that the second
A domain is for activating of L-Phe, which is then converted to D-
form by the E domain. The third A domain is responsible for L-Ile
activation and the terminal CT domain for cyclization and
releasing the NRPS product. Thus, OpaA is a quinazolinone
synthase using different amino acids from those listed in Fig. 1b,
which expands clearly quinazolinone structure diversity.
OpaB functions as an oxepinase. The results from deletion
experiments provide unambiguous evidence that OpaB is respon-
sible for the expansion of the benzene to the oxepin ring. For
further understanding of its function, opaB was amplified from
genomic DNA and cloned into pYH-gpdA-afpyrG18 via homo-
logous recombination in yeast19 for heterologous expression in
Aspergillus nidulans. The obtained plasmid pLZ61 was linearized by
SwaI and integrated into the genome of A. nidulans LO803020
(Supplementary Fig. 2). Feeding 3 in the obtained overexpression
R = H,     oxepinamide E (2)



















































































15-epi -oxepinamide E (5)
400 nm
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Fig. 2 Biosynthetic genes of oxepinamide F and intermediates. a The oxepinamide biosynthetic gene cluster (opa) from A. ustus 3.3904. b HPLC analysis
at 254 nm of the extracts after 7 day cultivation. c Structures of oxepinamide F (1), E (2), and 15-epi-oxepinamide E (5), as well as the CD spectra of 2 and 5
(200–400 nm). Blue double-headed arrows represent NOESY interactions.
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strain A. nidulans LZ61 led to the detection of compound 4, which
was not observed in a negative control. 4 was confirmed to be
protuboxepin A by NMR analysis and by comparison of its optical
rotation value with that reported in literature21. This confirmed that
OpaB alone is responsible for the oxepin ring formation (Fig. 3a).
Sequence alignment indicated that the conserved P450 motif
ExxR is present as ETMR in OpaB (Fig. 3b and Supplementary
Table 9)22–24. In analogy to other P450 catalyzed alkane hydro-
xylations and alkene epoxidations25,26, we postulated the electro-
philic oxoferryliron (FeIV=O) as the active oxygen intermediate in
the OpaB reaction. Attacking of the oxoferryliron species by the
nucleophilic benzene double bond in 3 would result in the for-
mation of an arene oxide, which is in rapid spontaneous equili-
brium with the oxepin 4 through 6π electrocyclic ring opening
(Fig. 3c)15,27. The oxepin form is expected to be more stable at
room temperature than its arene oxide27,28. Only the 1H-oxepin 4
was detected as OpaB poduct in this study, which differs from an
oxepin intermediate important for both phenylacetate degradation
and tropone biosynthesis. In those cases, the isomerase PaaG forms
a stable 3H-oxepin from a labile 1H-oxepin29. On the other hand,
both 1H- and 3H-oxepin derivatives listed in Fig. 1 were isolated as
stable fungal metabolites. Phylogenetic analysis of OpaB with 51
known P450 enzymes from bacteria and fungi indicates clearly the
presence of different clades (Supplementary Fig. 4). The bacterial
P450 enzymes catalyzing diverse reactions, including the two
hydroxylases P450cin and P450cam with trace oxepin formation
activity28, build a distinct clade from fungal enzymes. The majority
of the fungal P450s in the phylogenetic tree catalyzes hydroxylations
of diverse substrates. OpaB is located near to the epoxidase AtaY,
but far away from the oxepinase AtaF, both involved in the bio-
synthesis of acetylaranotin in Aspergillus terreus30.
OpaC catalyzes hydroxylation accompanied by double bond
migration. Comparing the planar structures, 2 differs from 4 in
the OH-12 and two different double bonds. Sequence analysis
suggested OpaC to be a FAD-containing monooxygenase and
could be a good candidate for a consecutive hydroxylation at C12
of the oxepin ring. The double bonds could be shifted during the
hydroxylation reaction. To verify its function biochemically, opaC
was amplified from complementary DNA (cDNA) and cloned
into pET28a (+) for overexpression in Escherichia coli. The
recombinant N-terminally His6-tagged protein was purified to
near homogeneity with a yield of 3.5 mg per liter culture (Fig. 4b).
To our surprise, one product peak 5 at 13.3 min, instead of 2 at
12.8 min, was detected in the incubation mixture of 4 with the
purified OpaC in the presence of NADPH (Fig. 4a). 5 shares the
same UV visible light absorption and mass spectral features with
2. NMR data and CD data supported that 5 and 2 are diaster-
eomers and differ from each other merely in the configuration at
C15. 5 was, therefore, named 15-epi-oxepinamide E (Fig. 2c).
Deletion of opaC from the A. ustus genome led indeed to the
accumulation of 5 (Fig. 2b). Biochemical characterization
revealed that OpaC also used NADH as a cofactor, but with a
significantly reduced activity (Fig. 4a). No substrate consumption
was observed in the incubation mixture of 3 and OpaC (Sup-
plementary Fig. 5), proving the prerequisite of the oxepin ring for
an acceptance by OpaC. The kinetic data of the OpaC reaction
with 4 in the presence of NADPH fit well to a typical velocity
equation with substrate inhibition31,32. An apparent KM value at
0.43 ± 0.04 mM, a turnover number (kcat) at 0.16 ± 0.01 s−1, the
catalytic efficiency (kcat/Km) at 0.37 mM−1 s−1 and a substrate
inhibition constant (Ki) at 0.39 ± 0.03 mM (Fig. 4c) were calcu-
lated by using the software GraphPad Prism 6.0.
Based on these results, a mechanism with a C4a-
hydroperoxyflavin intermediate33 was postulated for the OpaC
reaction (Fig. 4d). The oxidized flavin Flox is converted to its
reduced form Flred by external electron donor NADPH.
Subsequent reaction of Flred with O2 produces the electrophilic








































































(i) A. nidulans (wA ::PgpdA-opaB :afpyrG) +3
(ii) A. nidulans (wA ::PgpdA:afpyrG) +3
(iii) A. nidulans (wA ::PgpdA-opaB :afpyrG)
(iv) A. nidulans (wA ::PgpdA:afpyrG)
5
Fig. 3 Functional verification of the oxepinase OpaB. a HPLC analysis of the conversion of 3 to 4 in the opaB expression strain of A. nidulans at 254 nm.
b A sequence logo for the conserved EXXR motif in OpaB using sequences of 96 P450 enzymes (Supplementary Table 9). c Proposed mechanism for
oxepin formation catalyzed by OpaB (SH: substrate).
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C3 in 4 results in the double bond migration and attack on the
C4a-hydroperoxyflavin, leading to the formation of 5 and C4a-
hydroxyflavin. The latter one is then regenerated to Flox by
removal of one water molecule for the next reaction cycle.
Sequence analysis and biochemical investigation revealed that
OpaC belongs to the well-studied class A flavin-dependent
monooxygenases34. Phylogenetic analysis of representatives from
this group (Supplementary Fig. 6) indicates the presence of at
least three clades. OpaC is located closely together with AspB in
the biosynthesis of asperlicins and PhqK in that of paraherqua-
mides. AspB catalyzes the hydroxylation at C3 of an indole
moiety, resulting in the formation of a hexahydropyrrolo[2, 3-b]
indole framework35. PhqK converts an indole ring to a 2-keto
indoline ring via a postulated arene oxide intermediate36. In both
cases, the C4a-hydroperoxyflavin species was proposed to serve as
oxygen transferring agent, consistent with other class A flavin
monooxygenases and our mechanistic proposal.
D-Phenylalanyl epimerization catalyzed by OpaE. As afore-
mentioned, 2 differs from 5 only in the configuration at C15. The
S-configuration at this position in 2 corresponds to that of L-Phe,
which was epimerized to R-configuration by the E domain of
OpaA in 3. Conversion of 5 to 2 would need an epimerase like
OpaE. Deletion of opaE led indeed to the abolishment of 1 and 2
production and main accumulation of 5 with a trace amount of a
methylated product 6 (15-epi-oxepinamide F, Fig. 2b). To prove
OpaE function in vitro and to understand the epimerization
mechanism, the coding region of opaE was cloned and over-
expressed as described for OpaC. HPLC analysis of the reaction
mixture of 5 with the recombinant OpaE revealed 2 as the mere
product peak (Fig. 5), proving unequivocally its function as an
epimerase. Configuration change at C15 is a prerequisite for fur-
ther methylation to the final product 1, because only trace amounts
of 5 were converted to its methylated product 6 in ΔopaE mutant
(Fig. 2b). Determination of the kinetic parameters of the OpaE
reaction with 5 via Michaelis–Menten equation gave a KM value of
1.41 ± 0.05mM, a turnover number (kcat) of 0.28 ± 0.01 s−1 and the
catalytic efficiency (kcat/KM) at 0.20mM−1 s−1 (Fig. 5c).
Incubation of 5 and OpaE in Tris-HCl buffer containing D2O/
H2O (9:1) and subsequent analysis on liquid chromatography–
mass spectrometry (LC–MS) led to detection of the shifted
[M+H]+ isotopic pattern of 2 ([M+H]+ 395.184), which is
1 Da larger than that in H2O ([M+H]+ 394.177) (Fig. 5d).
Incubation of 2 in Tris-HCl buffer containing D2O/H2O (9:1) did
not change the isotopic pattern. These results proved the
involvement of an enol intermediate in the OpaE-catalyzed
epimerization, as proposed in Fig. 5e37.
Discussion
Taken together, we identified the opa cluster for the oxepinamide F
biosynthesis. OpaA was proven to activate Ant, L-Ile, and L-Phe,
change the configuration of L-Phe to D-Phe by an epimerase
domain, and assemble the quinazolinone 3. The benzene ring in
the Ant residue of 3 was expanded to an oxepin ring in 4 by the
P450 enzyme OpaB alone. The regio- and stereospecific hydro-
xylation of 4 catalyzed by OpaC was accompanied by double bond
migration from C4-N5 and C6-C12 in 4 to C3-C4 and N5-C6 in 5,
leading to the conversion of 1H-oxepin to 3H-oxepin system. The
R-configuration in 5 was changed to S-configuration by the single
epimerase OpaE for the final methylation of the OH-12 by the O-
methyltransferase OpaF, to the end product 1 (Fig. 6).
Oxepin rings also play important roles in the bacterial degra-
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Fig. 4 Proof of the OpaC function. a HPLC analysis of in vitro assays
of 4 with OpaC at 254 nm. b SDS-PAGE analysis of the purified
OpaC. The experiments were repeated twice. c Determination of the
kinetic parameters of the OpaC reaction. The error bars represent
standard errors of velocity and the standard errors of mean (SEMs) are
given as ±values (n= six independent experiments). d Proposed
mechanism for the OpaC reaction with a C4a-peroxyflavin as a key
intermediate.
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Fig. 5 In vitro verification of OpaE as a d-phenylalanyl epimerase. a HPLC analysis of in vitro assays with OpaE at 254 nm. b SDS-PAGE analysis of the
purified OpaE. The experiments were repeated twice. c Determination of the kinetic parameters for OpaE with 5.The error bars represent standard errors of
velocity and SEMs are given as ± values (n= six independent experiments). d LC–MS monitoring of the OpaE reactions in D2O/H2O and negative controls.
e Proposed mechanism for the OpaE reaction.
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natural products that both depend on the multicomponent
epoxidase PaaABCE and oxepin isomerase PaaG29,38. Stok et al.28
observed the formation of a simple oxepin derivative as a minor
side product in the hydroxylation of tert-butyl benzene by two
bacterial P450 enzymes, which usually use the monoterpenes
camphor and 1, 8-cineole as natural substrates, respectively.
Wang and coworkers reported the formation of a dihydrooxepin
ring in the biosynthesis of an epipolythiodioxopiperazine by three
enzymes, the epoxidase AtaF, the acetyltransferase AtaH, and the
cyctochrome P450 enzyme AtaY30. The oxepin ring was formed
from an acetoxylated cyclohexan-diene structure.
In peptide biosynthesis, conversion of L- to D-form amino acids
during the peptide biosynthesis is usually catalyzed by epimerase
domains of NRPSs or by radical S-adenosylmethionine-depen-
dent enzymes in microoganisms39,40. No single enzyme was
reported to catalyze the conversion of D- to L-form of an amino
acid residue. To the best of our knowledge, an oxepinamide
biosynthetic gene cluster that includes the characterization of
involved biosynthetic enzymes and reactions steps has not been
reported before. Furthermore, conversion of an amino acid resi-
due from L- to D-configuration and then back to the L-config-
uration by two different epimerases for structural modification
has not been described in literature.
Methods
Genome sequencing and sequence analysis. The genome of A. ustus 3.3904 was
sequenced by Genewiz (Suzhou, China) using Nova-seq6000/X-ten (Illumina).
Initial prediction and analysis of biosynthetic gene clusters were carried out by
using AntiSMASH41. Prediction of the enzyme function was performed with the
online BLAST programmer (http://blast.ncbi.nlm.nih.gov). The genomic DNA
sequence of the opa cluster (Supplementary Table 1) reported in this study cor-
responds well to that depicted at GenBank under accession number:
JOMC01000153.1.
The phylogenetic trees were created by MEGA version 7.0 (http://www.
megasoftware.net). Protein sequence alignments were performed with the program
ClustalW (https://www.genome.jp/tools-bin/clustalw) to identify strictly conserved
amino acid residues.
Strains, media, and growth conditions. Escherichia coli DH5α and BL21(DE3)
cells were grown in LB medium (1% NaCl, 1% tryptone, and 0.5% yeast extract) at
37 °C. In all, 50 μg mL−1 ampicillin or 50 μg mL−1 kanamycin were supplemented
for cultivation of recombinant strains.
Saccharomyces cerevisiae HOD114-2B cells were grown in YPD medium
(1% yeast extract, 2% peptone and 2% glucose, 1.5% agarose was used for plate).
The SC-uracil medium (6.7 g L−1 yeast nitrogen base with ammonium sulfate,
650 mg L−1 CSM-His-Leu-Ura (MP Biomedicals), 20 mg L−1 His and 60 mg L−1
Leu, pH 6.2− 6.3, 1.5% agarose was used for plate) with 2.0% glucose was used for
selection.
Fungal strains used in this study are listed in Supplementary Table 2. Aspergillus
ustus 3.3904 was purchased from China General Microbiological Culture
Collection Center (Beijing, China) and cultivated in rice medium (20 g Alnatura
long-grain rice with 30 mL H2O in 250 mL flask) at 25 °C for of secondary
metabolite production.
Aspergillus nidulans LO8030 and derivatives were grown at 37 °C on GMM
medium (1.0% glucose, 50mL L−1 salt solution, 1 mL L−1 trace element solution, and
1.6% agar) for sporulation and transformation with appropriate nutrition as required.
The salt solution comprises (w/v) 12% NaNO3, 1.04% KCl, 1.04% MgSO4 ∙ 7H2O, and
3.04% KH2PO4. The trace element solution contains (w/v) 2.2% ZnSO4 ∙ 7H2O, 1.1%
H3BO3, 0.5%MnCl2 ∙ 4H2O, 0.16% FeSO4 ∙ 7H2O, 0.16% CoCl2 ∙ 5H2O, 0.16% CuSO4
∙ 5H2O, 0.11% (NH4)6Mo7O24 ∙ 4H2O, and 5% Na4EDTA.
Genomic DNA isolation. The A. ustus 3.3904 and A. nidulans mycelia were dried
on filter paper and transferred into 2 mL Eppendorf tubes. After addition of 400 μL
LETS buffer (10 mM Tris-HCl pH 8.0, 20 mM EDTA pH 8.0, 0.5% SDS, and 0.1 M
LiCl) and four glass beads (2.85 mm in diameter), the tubes were vigorously mixed
for 4 min. After addition of another 300 μL LETS buffer, the mixtures were treated
with 700 μL phenol: chloroform: isoamyl alcohol (25: 24: 1). The genomic DNA in
the aqueous phase was precipitated by addition of 900 μL absolute EtOH, followed
by centrifugation at 17,000 x g for 30 min and washing with 70% EtOH. The
obtained DNA as pellet was dried at 55 °C for 15 min and dissolved in 50–100 μL
distilled H2O.
RNA isolation from A. ustus 3.3904 and cDNA synthesis. For this purpose, A.
ustus 3.3904 was cultivated in rice medium at 25 °C for 7 days. The mycelia were
collected by washing with 50 mL H2O and subsequent centrifugation. Fungal RNA
Mini kit (VWR OMEGA bio-tek E.Z.N.A) was used for RNA extraction following
the standard protocol provided by the manufacturer. For cDNA synthesis, the
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Fig. 6 Proposed biosynthetic pathway for oxpinamide F in Aspergillus ustus. Ant, L-Phe and L-Ile are assembled to protuboxepin K (3) by the NRPS OpaA
with epimerization at the phenylalanyl residue. The oxepinase OpaB catalyzes the oxepin ring formation in protuboxepin A (4). The regio- and
stereospecific hydroxylation of 4 by OpaC is accompanied by a double bond migration, leading to the conversion of a 1H-oxepin to a 3H-oxepin system in 5.
The D-Phe configuration in 5 is changed to L-Phe in 2 by the single epimerase OpaE. The O-methyltransferase OpaF catalyzes the conversion of 2 to the end
product 1 by methylation of the hydroxyl group at C-12.
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The deduced polypeptide from the coding region of opaC obtained from cDNA
comprises 457 amino acids, lacking the five residues from 248 to 252 in KIA75456:
PCR amplification, gene cloning, and plasmid construction. Primers and plas-
mids used in this study are listed in Supplementary Tables 3 and 4, respectively.
Seqlab GmbH (Göttingen, Germany) synthesized the PCR primers. Phusion®
High-Fidelity DNA polymerase from New England Biolabs (NEB) were used for
PCR amplification, which was carried out on a T100TM Thermal cycler from Bio-
Rad by following the manufacturer´s suggestion for temperature profiles.
Genetic manipulation in A. ustus 3.3904 and cultivation of deletion mutants.
To get germlings for protoplast preparation, fresh spores of A. ustus 3.3904 were
inoculated in a 250 mL flask containing 50 mL LMM medium and incubated at
230 rpm and 30 °C. After 11 h, the germlings were harvested by centrifugation at
2280 x g in 4 °C for 15 min and washed with distilled H2O. The pellets were sus-
pended in 10 mL osmotic buffer (1.2 M MgSO4 in 10 mM sodium phosphate, pH
5.8) containing 40 mg lysing enzyme from Trichoderma harzianum (Sigma) and
30 mg yatalase from Corynebacterium sp. OZ-21 (OZEKI Co., Ltd.) and incubated
at 100 rpm and 30 °C for 10 h. The formation of protoplasts was monitored by
controlling under microscope. The mixture was then transferred into a 50 mL
falcon tube and overlaid gently with 10 mL of trapping buffer (0.6 M sorbitol in 0.1
M Tris-HCI, pH 7.0). The protoplasts appeared as an interface between the two
buffer systems after centrifugation at 2280 x g and 4 °C for 15 min. This interface
was transferred carefully into a 15 mL falcon tube. The protoplasts in this phase
were collected by centrifugation at 2280 x g, and resuspended in 100 μL of STC
buffer (1.2 M sorbitol, 10 mM CaCl2 in 10 mM Tris-HCI, pH 7.5).
For transformation, the obtained protoplasts were incubated with DNA samples
(2–3 μg in 8–10 μL) on ice for 50 min. 1.25 mL of PEG solution (60% PEG 4000, 50
mM CaCl2, 50 mM Tris-HCI, pH 7.5) was then added, gently mixed and incubated
at room temperature for 30 min. In all, 5 mL STC buffer were added into the
mixture and spread on plates with SMM bottom medium (1.0% glucose, 50 mL L−1
salt solution, 1 mL L−1 trace element solution, 1.2 M sorbitol and 1.6% agar)
containing 100 µg mL−1hygromycin B. The plates were overlaid softly by SMM top
medium (1.0% glucose, 50 mL L−1 salt solution, 1 mL L−1 trace element solution,
1.2 M sorbitol, and 0.8% agar) containing 50 µg mL−1hygromycin B. After
cultivating at 30 °C for 3–4 days, the fungal colonies were transferred on fresh PDA
plates (PD medium with 3% agar) containing 100 µgmL−1 hygromycin B for
selection. The potential transformants were verified via PCR amplification
(Supplementary Fig. 1), cultivated in rice medium at 25 °C for 7 days and extracted
with EtOAc. After evaporation, the extracts were dissolved in dimethyl sulfoxide
(DMSO) and subjected to LC–MS for analysis.
Heterologous expression in A. nidulans. In this study, we used A. nidulans
LO803042 as expression host. The protoplast preparation procedure was similar to
that for A. ustus 3.3904 as mentioned above. The germlings were shaken with 40
mg lysing enzyme from Trichoderma harzianum (Sigma) and 20 mg yatalase from
Corynebacterium sp. OZ-21 (OZEKI Co., Ltd.) at 100 rpm and 37 °C for 3 h. pLZ61
containing the cytochrome P450 gene opaB was transformed into A. nidulans
LO8030 to create the expression strain LZ61. The transformants were verified by
PCR (Supplementary Fig. 2) and cultivated for biotransformation with protubox-
epin K (3).
Overproduction and purification of OpaC and OpaE. The opaC and opaE
expression plasmids pLZ62 and pLZ63 were transferred separately into E. coli BL21
(DE3).Terrific Broth (TB) medium (2.4% yeast extract, 2.0% tryptone, 0.4% gly-
cerol, 0.1 M phosphate buffer, pH 7.4) was used for cultivation. OpaC over-
production was induced with 0.5 mM IPTG at 16 °C for 16 h, and OpaE with 1 mM
IPTG at 20 °C for 20 h. The recombinant His6-tagged proteins were purified by Ni-
NTA affinity chromatography (Qiagen, Hilden). The protein concentration was
determined on a Nanodrop 2000c spectrophotometer (Thermo Scientific,
Braunschweig, Germany) and analyzed by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) (Figs. 4b and 5b). Protein yields of 3.5 and 20 mg
per liter bacterial culture were calculated for OpaC and OpaE, respectively.
In vitro assays of OpaC and OpaE. To test the enzyme activity of OpaC, the
reaction mixtures (50 μL) containing 50 mM Tris-HCl (pH 7.5), 5 mM NADPH, 1
mM protuboxepin A (4), 10 μg (3.9 µM) of the purified recombinant OpaC were
incubated at 30 °C for 30 min. The reactions were terminated by addition of 50 μL
methanol.
For OpaE, the reaction mixtures (50 μL) containing 50 mM Tris-HCl (pH 7.5),
1 mM 15-epi-oxepinamide E (5), 5 μg (3.2 μM) of the purified recombinant OpaE
were incubated at 37 °C for 30 min. The reactions were terminated by addition of
50 μL methanol.
For deuterium labeling experiment with OpaE, the stock solutions of the assay
components in H2O were diluted with D2O to a final D2O/H2O ratio of 9:1 in
50 mM Tris-HCl. The reaction mixtures were incubated and analyzed on LC–MS
as described for standard assays.
Determination of kinetic parameters. Enzyme assays for determination of the
kinetic parameters for OpaC (50 μL) contained 50 mM Tris-HCl (pH 7.5), 5 mM
NADPH, 4 μg (1.6 μM) of the purified recombinant OpaC and protuboxepin A (4)
at final concentrations from 0.025 to 2.5 mM. The incubations were carried out at
30 °C for 30 min. After extraction of the reaction mixtures with EtOAC and eva-
poration of the solvent to dryness, the residues were dissolved in DMSO and
analyzed on HPLC.
For OpaE, 50 μL reaction mixtures contained 50 mM Tris-HCl (pH 7.5), 2 μg
(1.3 μM) of the purified recombinant OpaE and compound 15-epi-oxepinamide E
(5) at final concentrations from 0.02 to 2 mM. The incubations were carried out at
37 °C for 30 min. After addition of MeOH and centrifugation, the supernatants
were analyzed on HPLC. The data presented in Figs. 4c and 5c were obtained from
six independent experiments. SEMs are given as ± values (n= six independent
experiments).
Kinetic parameters were determined by nonlinear regression using the software
GraphPad Prism 6.0 via substrate inhibition velocity equation for OpaC and
Michaelis–Menten equation for OpaE.
Large-scale fermentation, extraction, and isolation of secondary metabolites.
The strains were cultivated in 0.75 kg rice (1.75 L) for isolation. The rice culture
was extracted with equal volume of EtOAc for three times. The EtOAc extracts
were concentrated under reduced pressure to afford the crude extracts for further
purification.
To isolate oxepinamide F (1) and E (2), the crude extract of A. ustus wildtype
was subjected to silica gel (230‒400 mesh) column chromatography, by using a
gradient of CH2Cl2/CH3OH (100:0‒0:100) to give eight fractions (Fr.1‒Fr.8). Fr.4
was purified on a semi-preparative HPLC (ACN/H2O), leading to 38.42 mg of
oxepinamide F (1), 57.24 mg of oxepinamide E (2). Similarly, 77.68 mg
protuboxepin K (3) was obtained from a culture of the ΔOpaB mutant, 79.24 mg
protuboxepin A (4) from a culture of the ΔOpaC mutant, 23.88 mg 15-epi-
oxepinamide E (5) 16.88 mg 15-epi-oxepinamide F (6) from a culture of the ΔOpaE
mutant and 15.78 mg oxepinamide E (2) from a culture of the ΔOpaF mutant.
Feeding experiments in the opaB expression strain A. nidulans LZ61. To figure
out the function of the cytochrome P450 enzyme OpaB, opaB was overexpressed in
A. nidulans with the gpdA promoter from A. fumigatus18. Ten milliliter PDB with
75 μL 0.5 mgmL−1 riboflavin and 10 μL 0.5 mgmL−1pyridoxine in a 25 mL
erlenmeyer flask were inoculated at 230 rpm and 30 °C. One milligram of protu-
boxepin K (3) (8 mgmL−1DMSO) was added into 3 days old culture of the
transformant A. nidulans LZ61. 16 h later, 1 mL culture was extracted with 1 mL
EtOAc. The extracts were dried and dissolved in 100 μL DMSO for LC–MS ana-
lysis. Strain LZ61 without feeding protuboxepin K (3) and A. nidulans assembled
empty vector with or without feeding protuboxepin K (3) were used as negative
controls.
HPLC analysis and metabolite isolation. Fungal extracts were analyzed on an
Agilent HPLC series 1200 (Agilent Technologies) by using an Eclipse XDB-C18
column (Agilent Technologies, 5 μm, 4.6 × 150 mm) and ACN/H2O as elution
solvents. A linear gradient from 10 to 90% ACN in H2O containing 0.1% (v/v)
HCOOH in 20 min was used. After washing with 100% ACN for 5 min, the column
was equilibrated with 10% ACN for another 5 min. A photodiode array detector
was used for detection and the absorptions at 254 nm are illustrated in this study.
For product isolation, a Multospher 120 RP-18 column (5 μm, 10 × 250mm)
was used on the same HPLC system, with the same elution solvents at a flow rate of
2 mLmin−1. Separation was performed by isocratic elution with 45–70% ACN in
H2O containing 0.1% (v/v) HCOOH for 10–20 min, and.
LC–MS and MS analysis. Extracts were also analyzed on an Agilent HPLC
1260 series system equipped with a Bruker microTOF QIII mass spectrometer by
using a Multospher 120 RP-18-5μ column (5 μm, 250 × 2mm). Separation was
accomplished in a 40 min linear gradient from 5 to 100% ACN in H2O, both
containing 0.1% (v/v) HCOOH at a flow rate of 0.25 mLmin−1. The column was
then washed with 100% ACN for 5 min followed by equilibration with 5 % ACN
for 10 min. Positive ions were scanned in the range of m/z 100–1500 under the
following conditions: capillary voltage with 4.5 kV, collision energy with 8.0 eV and
electrospray ionization. Mass calibration was achieved by using sodium formate in
each run. Data collection and analysis were carried out with the Compass
DataAnalysis 4.2 software (Bruker Daltonik, Bremen, Germany).
NMR analysis. Samples in high purity were dissolved in DMSO-d6 or CDCl3 and
subjected to JEOL ECA-500 or ECA-400 (JEOL, Akishima, Tokyo, Japan) for
taking NMR spectra. MestReNov.9.0.0 (Mestrelab Research, Santiago de Com-
postella, Spain) was used for spectral processing.
CD spectroscopic analysis. The samples were dissolved in CH3OH and measured
in the range of 200–400 nm by using a 1 mm path length quartz cuvette (Hellma
Analytics, Müllheim, Germany) on a J-815 CD spectrometer (Jasco Deutschland
GmbH, Pfungstadt, Germany). The CD spectra are shown in Supplementary Fig. 3.
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Measurement of optical rotations. Jasco DIP-370 at 25 °C equipped with the D-
line of the sodium lamp at λ= 589.3 nm was utilized to measure the optical
rotations of the isolated compounds in CHCl3 or CH3OH. The polarimeter was
calibrated with the respective solvent before the measurement.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The information of opa gene cluster can be obtained from JOMC01000153.1 in the NCBI
database. The authors declare that all relevant data supporting the finding of this study
are available within the paper and its Supplementary Information files. All data are
available from the corresponding author on reasonable request. Source data are provided
with this paper.
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entary Table 1. Putative functions of the genes from




























































































Supplementary Table 2. Strains used in this study 
Stains Genotype 
Wild type A. ustus 3.3904 
ΔopaA ΔopaA::hph in A. ustus 3.3904 
ΔopaB ΔopaB::hph in A. ustus 3.3904 
ΔopaC ΔopaC::hph in A. ustus 3.3904 
ΔopaE ΔopaE::hph in A. ustus 3.3904 
ΔopaF ΔopaF::hph in A. ustus 3.3904 
A.nidulans  
LO8030  pyroA4, riboB2, pyrG89, nkuA::argB 
 
sterigmatocystin cluster (AN7804-AN7825)Δ, 
emericellamide cluster (AN2545-AN2549)Δ, 
 asperfuranone cluster (AN1039-AN1029)Δ, 
 monodictyphenone cluster (AN10023-AN10021)Δ, 
 terrequinone cluster (AN8512-AN8520)Δ, 
 austinol cluster part 1 (AN8379-AN8384)Δ, 
 austinol cluster part 2 (AN9246-AN9259)Δ, 
 F9775 cluster (AN7906-AN7915)Δ, 
 asperthecin cluster (AN6000-AN6002)Δ 
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Supplementary Table 5. The 1H and 13C NMR spectroscopic data of oxepinamide F 


























































































solvents DMSO-d6 DMSO-d6 CDCl3 
Position δH(multi., J) δC δH(multi., J) δC δH(multi., J) δC 
1  165.3  165.0  167.9 
2 9.89, s  9.73, s  7.08, s  
3  123.4  122.1 2.64, d, 2.8 58.6 
4  115.1  115.7  156.3 
6  151.8  153.3  163.1 
8 6.74, d, 7.3 144.4 6.72, d, 7.3 144.2 6.04, d, 5.8 143.3 
9 5.48, t, 7.1 104.0 5.49, t, 7.1 104.1 5.64, t, 5.8 117.3 
10 6.24, dd, 10.0, 7.0 130.8 6.18, dd, 10.2, 7.0 129.6 6.17, dd, 11.2, 5.8 128.1 
11 5.77, d, 10.0 127.0 5.89, d, 10.2 130.0 6.78, d, 11.2 125.6 









13  163.4  166.2  161.0 
15 5.18, dd, 7.9, 5.7 55.8 5.03, dd, 6.9, 5.5 56.3 5.45, t, 4.7 57.0 
16 2.88, m 36.4 2.96, dd, 13.7, 5.5 36.3 3.39 – 3.40, m 36.7 
 3.12, dd, 13.7, 5.6  3.05, dd, 13.7, 6.9  3.39 – 3.40, m  
17 2.91, m 32.1 2.82, m 31.9 2.27, m 37.1 
18 1.31, m 25.6 1.18, m 25.5 0.99 – 1.04, m 23.2 
19 0.73, t, 7.4 12.1 0.62, t, 7.6 11.9 0.74, t, 7.5 12.0 
20 0.95, d, 7.2 17.8 0.90, d, 7.3 17.5 0.85, d, 7.3 15.8 
1´  135.1  135.4  134.4 
2´, 6´ 7.08, d, 6.9 129.6 7.06, dd, 8.2 129.3 6.94, dd, 8.4, 1.5 129.8 
3´, 5´ 7.24, t, 7.3 128.3 7.24, tt, 7.0, 1.6 128.2 7.24, tt, 7.0, 1.5 129.0 
4´ 7.18, d, 7.3 126.8 7.20,d,7.1 126.7 7.30, t, 7.0 128.2 






Supplementary Table 6. The 1H and 13C NMR spectroscopic data with key HMBC, 








































Position δH(multi., J) δC HMBC NOESY 
1  168.8   
3 2.76, d, 2.2 58.4 C-4, C-16, C-17, C-19 H-15, H-16, H-19 
4  150.3   
6  147.1   
7 7.62, br d, 8.3 127.5 C-6, C-8, C-9, C-11 H-8, H-9, H-10 
8 7.78, ddd, 8.3, 7.2, 1.2 134.8 C-6, C-10, C-11 H-7, H-9, H-10 
9 7.52, ddd, 8.0, 7.2, 1.2 127.2 C-6, C-7, C-8, C-11 H-7, H-8, H-10 
10 8.34, dd, 8.0, 1.2 126.9 C-6, C-7, C-8, C-12 H-8, H-9, H-2´,6´, H-3´,5´ 
11  120.1   
12  160.9   
14 5.64, br t, 4.7 57.1 C-1, C-4, C-1´, C-15, C-12 H-15, H-2´,6´ 
15 
3.47, dd, 13.8, 5.5 37.3 C-1, C-1´, C-14, C-2´,6´ H-3, H-14, H-2´,6´ 
3.44, dd, 13.8, 4.0    
16 2.47, m 36.5 C-4, C-17, C-18, C-19 H-3, H-17, H-18, H-19 
17 1.19, m 23.3 C-3, C-16, C-18, C-19 H-16, H-18, H-19 
 1.04, m  H-16, H-18, H-19 
18 0.77, t, 7.4 12.3 C-16, C-17 H-16, H-17, H-19 
19 0.91, d, 7.3 15.8 C-3, C-16, C-17 H-3, H-16, H-17, H-18 
1´  135.1   
2´, 6´ 6.92, dd, 8.2, 1.4 129.9 C-1, C-4, C-1´, C-4´, C-2´,6´, C-14, C-15 H-10, H-14, H-15, H-3´,4´,5´ 
3´, 5´ 7.18, t, 7.5 128.8 C-1´, C-3´,5´ H-10, H-2´,4´,6´ 
4´ 7.27, t, 7.5 128.0 C-1´, C-2´,6´ H-2´,6´, H-3´,5´ 




Supplementary Table 7. The 1H and 13C NMR spectroscopic data with key HMBC, 













































δC HMBC NOESY 
1  164.9   
2 9.64, s  C-1, C-3, C-4, C-15, C-17 H-20, H-3´,4´,5´ 
3  120.7   
4  116.2   
6  153.5   
8 6.64, d, 7.2 144.0 C-6, C-10, C-9, C-11 H-9, H-10, H-11, H-2´,6´, H-3´,5´ 
9 5.49, t, 7.2 105.3 C-8, C-11 H-8, H-10, H-11, H-2´,6´, H-3´,5´ 
10 6.12, dd, 10.4, 6.8 128.6 C-8, C-12 H-8, H-9, H-2´,6´, H-3´,5´ 




69.6 C-6, C-11, C-12  
13  165.5   
15 5.19, t, 5.1 55.7 C-1, C-1´, C-4, C-16 H-11 
16 3.01, dd, 13.7, 5.3 36.5 C-1, C-1´, C-2´,6´, C-15 H-17 
 3.13, dd, 13.7, 5.0   H-17 
17 2.82, m 31.5 C-3, C-4, C-18, C-19, C-20 H-16, H-18, H-19, H-20 
18 1.40, m 25.7 
 
C-3, C-17, C-19, C-20 H-17, H-18b, H-19, H-20 
 1.30, m  H-17, H-18a, H-19, H-20 
19 0.67, t, 7.4 11.9 C-17, C-18 H-17, H-18, H-20 
20 0.63, d, 7.1 17.0 C-3, C-17, C-18 HN-2, H-17, H-18, H-19 
1´  135.0   
2´, 6´ 7.00, dd, 7.0, 2.9 129.6 C-4´, C-2´,6´, C-16 H-8, H-9, H-10, H-3´,4´,5´ 
3´, 5´ 7.20, m 128.1 C-1´, C-3´,5´, C-2´,6´ HN-2, H-8, H-9, H-10, H-2´,6´ 





Supplementary Table 8. The 1H and 13C NMR spectroscopic data with key HMBC, 













































δC HMBC NOESY 
1  165.0   
2 9.75, s  C-1, C-3, C-4, C-15, C-17 H-18, H-20, H-3´,5´, H-2´,6´, H-4´ 
3  122.0   
4  115.9   
6  151.3   
8 6.67, d, 7.2 144.3 C-6, C-10, C-9, C-11 H-9, H-10, H-11, H-2´, 6´ 
9 5.50, t, 7.2 105.4 C-8, C-10, C-11 H-8, H-10, H-11, OCH3-12, H-15 
10 6.21, dd, 10.4, 6.8 128.7 C-8, C-12 H-8, H-9, H-11, H-2´,6´, H-3´,5´ 
11 5.64, d, 10.4 130.0 C-6, C-8, C-9, C-12, C-13 H-8, H-9, H-10, H-15 




52.8 C-12 H-9, H-15 
13  163.0   
15 5.24, t, 5.2 55.9 C-1, C-1´, C-4, C-13, C-16 H-9, H-11, OCH3-12, H-16a 
16 3.01, dd , 14.1, 5.3 36.4 C-1, C-1´, C-2´,6´, C-15 H-15, H-16b, H-17 
 3.14, dd, 14.1, 5.1   H-16a, H-17 
17 2.84, m 31.6 C-3, C-18, C-20 H-16a, H-16b, ,H-18a, H-20 
18 1.41, m 25.8 
 
C-17, C-19 HN-2, H-17, H-18b, H-19, H-20 
 1.30, m C-3, C-17, C-19, C-20 HN-2, H-18a, H-19, H-20 
19 0.66, t, 7.4 11.7 C-3, C-17, C-18 H-18, H-20 
20 0.66, d, 7.0 16.9 C-3, C-17, C-18 HN-2, H-17, H-18, H-19 
1´  134.9   
2´, 6´ 6.99, dd, 7.0,  3.0 129.6 C-4´, C-2´,6´, C-16 HN-2, H-8, H-10, H-3´,5´, H-4´ 
3´, 5´ 7.20, m 128.2 C-1´, C-3´,5´, C-2´,6´ HN-2, H-10, H-2´,6´, H-4´ 
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Supplementary Figure 1. PCR verification of deletion mutants of A. ustus 3.3904. 
PCR amplification for three different fragments from genomic DNA of WT and deletion mutants was used to prove the 
presence/absence of the target gene and the integration site of the selection marker with up- and downstream regions. The 








Supplementary Figure 2. PCR verification of opaB heterologous expression transformant 
A. nidulans-pYH-gpdA-opaB-pyrG (HE-opaB). A fragment of 1.5 kb within the target gene was amplified from the primers 














Supplementary Figure 4. Phylogenetic analysis of OpaB and functionally characterized P450s from bacteria and 
























Supplementary Figure 6. Phylogenetic analysis of class A flavin monooxygenases. OpaC, AspB and PhqK are 







Supplementary Figure 7. 1H NMR spectrum of oxepinamide F (1) in DMSO-d6 (500 MHz) 
 





























































Supplementary Figure 9. 1H NMR spectrum of oxepinamide E (2) in DMSO-d6 (500 MHz) 
 





























































Supplementary Figure 11. 1H NMR spectrum of protuboxepin K (3) in CDCl3 (500 MHz) 
 



























































Supplementary Figure 13. HSQC spectrum of protuboxepin K (3) in CDCl3 
 





































Supplementary Figure 15. HMBC spectrum of protuboxepin K (3) in CDCl3 
 
















Supplementary Figure 17. 1H NMR spectrum of protuboxepin A (4) in CDCl3 (500 MHz) 
 

























































Supplementary Figure 19. 1H NMR spectrum of 15-epi-oxepinamide E (5) in DMSO-d6 (500 MHz) 
 





























































Supplementary Figure 21. HSQC spectrum of 15-epi-oxepinamide E (5) in DMSO-d6 
 







































Supplementary Figure 23. HMBC spectrum of 15-epi-oxepinamide E (5) in DMSO-d6 
 


















Supplementary Figure 25. 1H NMR spectrum of 15-epi-oxepinamide F (6) in DMSO-d6 (500 MHz) 
 





























































Supplementary Figure 27. HSQC spectrum of 15-epi-oxepinamide F (6) in DMSO-d6 
 







































Supplementary Figure 29. HMBC spectrum of 15-epi-oxepinamide F (6) in DMSO-d6 
 



















Supplementary Note 1 
 
Physiochemical properties of the compounds described in this study. 
Oxepinamide F (1): orange oil; [α]25D +480 ( c 0.25 , CHCl3 ) ; 1H and 13C NMR data see Supplementary Table 5; HRMS 
(ESI) m/z: [M + H]+ calcd. for C23H25N3O4 408.192; found 408.192 . 
Oxepinamide E (2): red brown power; [α]25D +517 ( c 0.25 , CHCl3 ) ; 1H and 13C NMR data see Supplementary Table 5; 
HRMS (ESI) m/z: [M + H]+ calcd. for C22H23N3O4 394.176; found 394.177.  
Protuboxepin K (3): yellow oil; [α]25D -236 ( c 0.1 , CHCl3 ) ; 1H, 13C NMR, HMBC, and NOESY data see Supplementary 
Table 6; HRMS (ESI) m/z: [M + H]+ calcd. for C22H23N3O2 362.186; found 362.189. 
Protuboxepin A (4): orange oil; [α]25D -362 ( c 0.35 , MeOH ) ;  1H and 13C NMR data see Supplementary Table 5; HRMS 
(ESI) m/z: [M + H]+ calcd. for C22H23N3O3 378.181; found 378.182. 
15-epi-oxepinamide E (5): red brown power; [α]25D +10 ( c 0.23 , CHCl3 ); 1H, 13C NMR, HMBC, and NOESY data see 
Supplementary Table 7; HRMS (ESI) m/z: [M + H]+ calcd. for C22H23N3O4 394.176; found 394.176. 
15-epi-oxepinamide F (6): red brown power; [α]25D +10 ( c 0.15 , CHCl3 ); 1H, 13C NMR, HMBC, and NOESY data see 
Supplementary Table 8; HRMS (ESI) m/z: [M + Na]+ calcd. for C23H25N3O4 408.192; found 408.192. 
Structural elucidation. 
The structures of oxepinamide F (1), E (2), protuboxepin K (3), and protuboxepin A (4) were elucidated by comprehensive 
interpretation of their MS, optical rotation, and NMR data (Supplementary Table 5, Supplementary Table 6, 
Supplementary Figures 7-18) and comparison with those reported in the literature.1-3 
15-epi-oxepinamide E (5) shares the same [M + H]+ ion and similar NMR data with oxepinamide E (2) (Supplementary 
Table 7, Supplementary Figures 19-24), but exhibit different cotton effects in their CD spectra. Correlation of H-17 to H-16 
in NOESY spectrum of 5 proved the 15S configuration. 
15-epi-oxepinamide F (6) shares the same [M + H]+ ion and similar NMR data with oxepinamide F (1). Correlation of H-17 
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4.4 Oxepin formation in fungi implies specific and 
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ABSTRACT: Oxepinamides are fungal oxepine−pyrimidinone−
ketopiperazine derivatives. In this study, we elucidated the
biosynthetic pathway of oxepinamide D in Aspergillus ustus by
gene deletion, heterologous expression, feeding experiments, and
enzyme assays. We demonstrated that the cytochrome P450
enzymes catalyzed highly specific and stereoselective oxepin ring
formation.
Several important drugs are fungal peptides or derivativesthereof, e.g., the well-known β-lactam antibiotics, the
immunosuppressant cyclosporine A, and the antifungal agent
echinocandin.1,2 These compounds or their precursors are
usually biosynthesized by nonribosomal peptide synthetases
(NRPSs). The chemical logic of the NRPS assembly lines,
together with enzymatic modifications, including epimeriza-
tion, methylation, hydroxylation, and oxidative cross-linking, is
significant and intriguing to both organic chemists and
biochemists.3
Oxepine−pyrimidinone−ketopiperazine (OPK) scaffolds
(Figure 1A) are assembled by NRPSs from anthranilate
(Ant) and two additional amino acids and identified as a key
structural feature in fungal metabolites, mainly found in
Aspergillus and Penicillium species, with broad biological
activities. Since 1988, more than 37 OPK derivatives including
oxepinamides were identified.4,5 Interestingly, oxepinamides
consisting of different amino acids were often isolated from the
same strains.6,7 This phenomenon raised the question if they
are products of one or more biosynthetic gene clusters
(BGCs). Despite the structural diversity of OPKs, only one
biosynthetic pathway, i.e., that of oxepinamide F from
Aspergillus ustus, has been recently reported by our group.8
A. usuts 3.3904 is a rare pathogenic fungus and produces
different secondary metabolites, e.g., ustethylin A (1)9 and
oxepinamides E (2) and F (3) (Figures 1B and 2i).8
Oxepinamide F is an O-methylated product of oxepinamide
E. In their biosynthetic pathway, the NRPS OpaA with a
domain architecture of A-T-C-A-T-E-C-A-T-C (A, adenyla-
tion; T, thiolation; C, condensation; E, epimerization) utilizes
Ant, Phe, and Ile to assemble a fused quinazolinone derivative.
Afterward, the cytochrome P450 enzyme OpaB inserts an
oxygen atom into the Ant residue to form the OPK backbone.
Subsequent hydroxylation by OpaC, epimerization by OpaE,
and methylation by OpaF lead to the formation of
oxepinamide F. During the biosynthesis, the configuration at
the Phe residue is first changed to the D-form by the E domain
of OpaA and then back to the L-form by OpaE. The second
change in configuration was essential for the methylation step.
However, the reason for the first configuration change is
unknown.
In this study, we identified an additional OPK derivative,
oxepinamide D [4 (Figures 1B and 2i)], in A. usuts 3.3904.
Gene deletion, heterologous expression, feeding experiments,
and enzyme assays proved that oxepinamide D and
Received: January 15, 2021
Published: March 3, 2021
Figure 1. (A) OPK backbones. (B) opa cluster for oxepinamides E
and F and opa2 cluster for oxepinamide D.
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oxepinamide F are products of two similar BGCs. More
importantly, the two cytochrome P450 enzymes for the oxepin
ring formation, OpaB2 identified in this study and OpaB
reported previously, show high substrate specificity and stereo
selectivity.
4 was detected at 21.0 min in the HPLC chromatogram of a
rice culture (Figure 2i) and has a [M + H]+ ion at m/z
352.1301 with a deduced molecular formula of C19H17N3O4.
Its UV spectrum is similar to those of oxepinamides E and F.
The 1H and 13C NMR spectra of 4 also show the typical
oxepin signals (Table S5 and Figures S8 and S9). Together
with CD spectrum, 4 was identified as oxepinamide D, isolated
previously from Aspergillus puniceus.10 4 belongs to type A of
OPK, while 2 and 3 are members of type B (Figure 1A). Based
on the structure, 4 can be speculated as a derivative of Ant, Ala,
and Phe.
Deletion of opaA from A. ustus genome abolished the
production of 2 and 3, but not that of 4 (Figure 2ii), proving
the involvement of another biosynthetic pathway for 4.
Genome mining in A. ustus and sequence analysis identified
a gene encoding a trimodular NRPS KIA75688 (termed
herewith OpaA2) with a domain architecture of A-T-C-A-T-E-
C-A-T-C. OpaA2 shares a sequence identity of 48% with
OpaA. Inspection of the genomic neighborhood of opaA2
indicated the presence of a putative BGC containing three
additional genes, opaB2−opaD2 (Figure 1B and Table S1).
Sequence analysis suggested their functions as a putative
cytochrome P450 enzyme (OpaB2, KIA75687), a FAD-
dependent oxygenase (OpaC2, KIA75686), and a transporter
(OpaD2, KIA75689) (Table S1). To prove its function, opaA2
was replaced with a hygromycin B resistance cassette by using
a split marker gene replacement protocol.11 The obtained
ΔopaA2 mutant was verified by PCR (Figure S1) and
cultivated in rice media. LC-MS analysis of the culture extract
confirmed the abolishment of the production of 4, but not that
of 2 and 3 (Figure 2i,iii), proving its involvement only in the
biosynthesis of 4.
To identify the NRPS product, opaA2 was cloned into pYH-
gpdA-pyrG via homologous recombination in yeast12 for
expression in Aspergillus.13 The obtained plasmid pLZ65 was
linearized by SmaI and integrated into the Aspergillus nidulans
genome (Figure S2). Compared with that of the negative
control carrying the empty vector, two additional peaks, 5 and
6, with the same [M + H]+ ions at m/z 320.139 ± 0.005 were
detected in the opaA2 overexpression strain (Figure 3). The
ratio of 5 and 6 was estimated to be 1:4. Typical signals for the
oxepin ring were not observed in their NMR spectra (Tables
S5 and S6 and Figures S10−S16). Detailed spectroscopic
analysis led to the identification of 5 and 6 as diastereomeric
quinazolinones derived from Ant, Ala, and Phe. They differ
from each other just in the configuration at C-3.
Figure 2. LC-MS analysis of the A. ustus extracts. UV absorptions at
254 nm in black and EICs in blue.
Figure 3. LC-MS analysis of A. nidulans opaA2 and opaA strains with
UV (254 nm, black) and EIC detection (blue and pink).
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Plasmid pLZ64 containing opaA from the oxapinamide F
BGC was constructed in a parallel fashion and expressed in A.
nidulans following the same procedure for opaA2. As expected,
protuboxepin K (8) with a D-Phe residue was detected by LC-
MS (Figures 3 and 4B), proving the E domain in the second
OpaA module for L-phenylalanine epimerization.
The presence of a D-Ala residue in 5 and 6 can be explained
by the existence of the E domain in the second module in
OpaA2, as in the case of OpaA. However, for the D-Phe residue
in 5, no redundant epimerization domain in OpaA2 was
predicted. To prove the possibility that 5 is a non-enzymatic
product of 6, 5 and 6 were incubated at 37 °C and different pH
values for 20 h (Figure S3A). HPLC analysis showed that both
5 and 6 were stable under acid conditions. In contrast, 6 was
much more easily converted to 5 at pH 10. This is very likely
via a keto−enol tautomeric event with the involvement of a
two-double bond migration mechanism in the fused
quinazolinone ring (Figure S3B).
As reported previously, OpaB from the oxapinamide F BGC
catalyzed the formation of the oxepin ring in the OPK
backbone.8 Although OpaB2 shares only a sequence identity of
30% with OpaB, it could still be responsible for oxepin ring
formation in oxepinamide D. Deletion of opaB2 from the A.
ustus genome led indeed to the abolishment of 4 and the
accumulation of two tripeptide derivatives, 5 and 6 (Figure
2iv), the same products after opaA2 expression in A. nidulans
(Figure 3i). Again, 6 was detected as the predominant product.
The pH value of the culture was changed from 6.0 at the
beginning to 8.2 at day 8. It seems that 6 was converted by
non-enzymatic diastereomerization during the cultivation
process.
To understand its catalytic role, opaB2 was amplified from
genomic DNA and expressed in A. nidulans following the same
procedure for opaA2 expression. The resulted transformants
were verified by PCR (Figure S2). Feeding 6 in the opaB2
overexpression strain led to the detection of compound 7,
which was not observed in a negative control [Figure 4A(i)]. 7
shows an [M + H]+ ion at m/z 336.1354, 16 Da larger than
that of 6, indicating insertion of one oxygen atom into 6.
Interpretation of NMR data (Table S7 and Figures S17−S22)
led to the identification of 7 as a precursor of 4 without the
hydroxyl group at C-3 (Figure 4B). Feeding 5 into the A.
nidulans opaB2 culture did not lead to any conversion (Figure
4A), indicating the absolute importance of the stereochemistry
at the quinazolinone core for the OpaB2 reaction.
As mentioned above, the E domain of OpaA changes the
configuration of the Phe residue from the L- to D-form during
the formation of the quinazolinone derivative (14R)
protuboxepin K (8), the substrate of another oxapinase
OpaB. To determine whether this change in configuration is
essential for the oxepin ring formation catalyzed by OpaB,
(14S)-epi-protuboxepin K (9) was chemically synthesized
according to the methods reported previously14,15 and fed into
Figure 4. (A) HPLC results of feeding experiments in opaB and opaB2 overexpression strains with detection at 254 nm. (B) Structures of
compounds 8−10. (C) Mechanism of OPK formation catalyzed by OpaB2.
Figure 5. (A) HPLC analysis of in vitro assays of 7 with UV detection
at 254 nm. (B) Proposed mechanism for OpaC2 reaction.
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the culture of an A. nidulans opaB transformant created in the
previous study.8 As shown in Figure 4A, no product was
detected by HPLC analysis. In contrast, almost complete
conversion of the natural substrate protuboxepin K (8) to
protuboxepin A (10) was observed after feeding into the A.
nidulans opaB culture. This proves the stereoselective proper-
ties of the OpaB reaction and the necessity of the change in the
configuration during the NRPS assembly line. Feeding 5 and 6
into the A. nidulans opaB transformant did not lead to any
consumption. Similar results were also obtained after feeding
of 8 and 9 into the A. nidulans opaB2 transformant (Figure
4A). All of these results prove the high substrate specificity and
stereoselectivity of the ring expansion reactions catalyzed by
the two oxepinases, OpaB and OpaB2.
Epimerization in microbial peptides is usually catalyzed by
the E domain in NRPSs16 and essential for the availability of
the correct intermediates.17 In the tyrocidine biosynthesis in
Bacillus, the C5 domain utilizes only the E4 domain product, D-
Phe-L-Pro-L-Phe-D-Phe-PCP, as a substrate for condensation.18
In the biosynthesis of acetylaszonalenin from the fungus
Neosartorya f ischeri, <1% of the cyclodipeptide Ant-L-Trp was
detected after deletion of the E domain, in comparison to the
amount of the cyclodipeptide Ant-D-Trp produced by the wild
type. However, in the fumiquinazoline F biosynthesis in
Penicillium aethiopicum, the CT utilizes not only Ant-D-Trp-L-
Ala-S-CoA but also Ant-L-Trp-L-Ala-S-CoA to form the cyclic
tripeptide derivative.19 In the absence of the E domain, the
truncated CtqA and AldpA20 still produce quinazolinone
derivatives, indicating that the epimerization might not be
essential for the tripeptide assembly lines. Bioinformatic
analysis showed that both OpaA and OpaA2 contain an E
domain in the second module. We proved here that the E
domains in these NRPSs are responsible for the formation of
products with correct stereochemistry for oxepin ring
formation catalyzed by oxepinases.
4 differs from 7 just by an additional hydroxyl group at C-3.
OpaC2 shares a sequence identity of 61% with OpaC. Deletion
of opaC2 from the A. ustus genome led indeed to the
abolishment of the production of 4 and the accumulation of 7
(Figure 2v), proving the involvement of OpaC2 in the
conversion of 7 to 4. To characterize OpaC2 biochemically,
opaC2 was amplified from A. ustus cDNA and cloned into
pET28a(+) for overexpression in Escherichia coli. The
recombinant N-terminally His6-tagged protein was purified to
near homogeneity with a yield of 1.6 mg/L of culture (Figure
S5). 4 was detected as the sole product in the incubation
mixture of 7 with the purified OpaC2 in the presence of
NADPH. Comparison of the CD spectra of 7 and 4 indicated
that the orientation of the phenyl ring at C-3 has been changed
(Figure 5B and Figure S4). These results provide unambiguous
evidence that OpaC2 catalyzes the regio- and stereospecific C3
hydroxylation of 7 with retaining the 1H-oxepin system. In
comparison, OpaC installs a hydroxyl group at C-12 with the
change from the 1H- to 3H-oxepin system. Similar to OpaC,
OpaC2 also utilized NADH as a cofactor, but with an
obviously decreased activity (Figure 5A). Hydroxylations
catalyzed by flavin-dependent monooxygenases usually take
places at the sp2 carbon.21 We propose therefore that the
substrate of OpaC2 is the keto−enol intermediate with a C-
3C-4 bond (Figure 5B). The kinetic data of the reaction of
OpaC2 with 7 in the presence of NADPH fit well to a
Michaelis−Menten velocity equation. An apparent Km value of
0.14 ± 0.01 mM, a turnover number (kcat) of 0.085 ± 0.002
s−1, and a catalytic efficiency (kcat/Km) of 607 M
−1 s−1 (Figure
S6) were calculated by using GraphPad Prism 6.0.
To test the substrate flexibility, 10 and 7 were incubated
with OpaC2 and OpaC, respectively. No product formation
was detected in either case (Figure S7), being in agreement
with the in vivo results of the ΔopaC and ΔopaC2 mutants and
proving their high substrate specificity. Together with the
aforementioned feeding results in the opaB and opaB2
transformants, we can conclude that there is no crosstalk
between the two BGCs.
In summary, we identified in this study the second
oxepinamide BGC opa2 in A. ustus, being responsible for the
biosynthesis of the 1H-oxepin oxepinamide D carrying a C3-
hydroxyl group. The 3H-oxepin oxepinamide F as the final
product of the previously reported BGC opa has a methoxyl
group at C-12. Both compounds also differ from each other in
the third amino acid for backbone formation. However, both
clusters share a NRPS (OpaA and OpaA2) for a quinazolinone
skeleton and P450 (OpaB and OpaB2) for oxepin formation.
The two flavin-dependent monooxygenases OpaC and OpaC2
install hydroxyl groups at different positions. Two additional
enzymes complete afterward the oxepinamide F biosynthesis
(Scheme 1). In addition, we demonstrated in this study that
the E domains in OpaA and OpaA2 are responsible for the
epimerization of phenylalanine and alanine, respectively, which
is a prerequisite for the ring expansion catalyzed by oxepinases
OpaB and OpaB2.
Scheme 1. Comparative Illustration of the Biosynthetic Pathways for Oxepinamides D and F in A. ustus
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The reagents used in this study were purchased from Fischer Scientific, Roth, VWR or Sigma-Aldrich. 
(14S)-epi-protuboxepin K (9) was synthesized by using anthranilic acid, Boc-L-Ileu, and 
triphenylphosphite as reactants following the previously described methods.1,2  
2. Genome sequencing and sequence analysis 
The genome of Aspergillus ustus 3.3904 was sequenced by Genewiz (Suzhou, China) using Nova-
seq6000/X-ten (Illumina). Initial prediction and analysis for biosynthetic gene clusters were carried out 
by using AntiSMASH.3 Prediction of the enzyme function was performed with the online BLAST program 
(http://blast.ncbi.nlm.nih.gov). The genomic DNA sequence of the opa2 cluster (Table S1) reported in 
this study corresponds to that depicted at GenBank under accession number: JOMC01000058.1. 
3. Strains, media and growth conditions 
Fungal strains used in this study are listed in Table S2. A. ustus 3.3904 was purchased from China 
General Microbiological Culture Collection Center (Beijing, China) and cultivated in rice medium (20 g 
Alnatura long-grain rice with 30 mL H2O in 250 mL flask) at 25°C and 7 days for secondary metabolite 
production. 
Aspergillus nidulans LO8030 and derivatives were grown at 37°C on GMM medium (1.0% glucose, 50 
mL/L salt solution, 1 mL/L trace element solution, and 1.6% agar) for sporulation and transformation with 
appropriate nutrition as required. The salt solution comprises (w/v) 12% NaNO3, 1.04% KCl, 1.04% 
MgSO4∙7H2O, and 3.04% KH2PO4. The trace element solution contains (w/v) 2.2% ZnSO4∙7H2O, 1.1% 
H3BO3, 0.5% MnCl2∙4H2O, 0.16% FeSO4∙7H2O, 0.16% CoCl2∙5H2O, 0.16% CuSO4∙5H2O, 0.11% 
(NH4)6Mo7O24∙4H2O, and 5% Na4EDTA.  
Escherichia coli DH5α and BL21(DE3) cells were grown in LB medium (1% NaCl, 1% tryptone, and 0.5% 
yeast extract) at 37°C. 50 μg/mL ampicillin or 50 μg/mL kanamycin were supplemented for cultivation of 
recombinant strains. 
Saccharomyces cerevisiae HOD114-2B cells were grown in YPD medium (1% yeast extract, 2% peptone 
and 2% glucose. 1.5% agarose were used for plates. The SC-uracil medium (6.7 g/L yeast nitrogen base 
with ammonium sulfate, 650 mg/L CSM-His-Leu-Ura (MP Biomedicals), 20 mg/L His, and 60 mg/L Leu, 
pH 6.2-6.3) with 2.0% galactose was used for selection. 1.5% agarose were used for plates. 
4. Genomic DNA isolation 
The mycelia of A. ustus 3.3904 and A. nidulans were handled with filter paper to remove the media and 




(10 mM Tris-HCl pH 8.0, 20 mM EDTA pH 8.0, 0.5% SDS, and 0.1 M LiCl) were added to the tubes. 
After vigorous mixing for 4 min, 300 μL LETS buffer were added. The solution was then treated with 700 
μL phenol: chloroform: isoamyl alcohol (25: 24: 1). Genomic DNA was precipitated by addition of 900 μL 
absolute EtOH. After centrifugation at 13,000 rpm for 30 min and washing with 70% EtOH, the obtained 
DNA was dissolved in 50 ‒ 100 μL distilled H2O. 
5. RNA isolation and cDNA synthesis 
A. ustus 3.3904 was cultivated in rice medium at 25°C for 7 days and the cells were collected by adding 
50 mL H2O and centrifugation. RNA extraction was performed by using Fungal RNA Mini kit (VWR 
OMEGA bio-tek E.Z.N.A) according to the standard manufacturer´s instruction. The ProtoScript II First 
Strand cDNA Synthesis kit (BioLabs) was used for cDNA synthesis with Oligo-dT primers.  
6. PCR amplification, gene cloning and plasmid construction 
Plasmids and primers used in this study are listed in Tables S3 and S4, respectively. Primers were 
synthesized by Seqlab GmbH (Göttingen, Germany). PCR amplification was carried out by using 
Phusion® High-Fidelity DNA polymerase from New England Biolabs (NEB) on a T100TM Thermal cycler 
from Bio-Rad. PCR reaction mixtures and thermal profiles were set as recommended by the 
manufacturer´s instruction. 
To construct the plasmids for gene deletion, a 1.2 − 1.5 kbp PCR fragment containing downstream 
sequence of the target gene was amplified from the genomic DNA of A. ustus. The vector p3YG (Table 
S3) was linearized by the restriction enzymes SalI and SlaI. Both DNA fragments were then transferred 
into E.coli DH5α for homologous recombination.4 In analogy, the vector p5HY was linearized by NotI and 
BglII and used for homologous recombination with the upstream sequence of the target gene. 
The vector pYH-gpda-pyrG with flanking sequences of the A. nidulans wA gene (Table S3) was used for 
heterologous expression of opaA, opaA2, and opaB2 in A. nidulans. The target genes were PCR 
amplified from the genomic DNA of A. ustus and cloned via homologous recombination in yeast5 into the 
vector, which had been linearized by SmaI or SwaI. 
To construct the plasmid for overproduction of OpaC2 in E.coli, the coding region of OpaC2 was amplified 
by PCR from cDNA of A. ustus with the primers in Table S4. The vector pET-28a(+) was linearized by 
BamHI and EcoRI and used for homologous recombination with opaC2,4 yielding the expression plasmid 
pLZ67. 
7. Genetic manipulation in A. ustus 3.3904 and cultivation of deletion mutants 
Protoplast preparation and transformation of A. ustus 3.3904 for deletion were carried out as described 




verify the integrity via PCR amplification (Figure S1). After cultivation in rice medium at 25°C for 7 days, 
the cultures were extracted with EtOAc, dissolved in DMSO, and subjected to HPLC and HPLC-MS 
analyzes. 
8. Heterologous expression in A. nidulans 
A. nidulans LO80307 was used as the expression host. Protoplast preparation and transformation were 
performed as described previously.8 pLZ64 – 66 containing the NRPS genes opaA and opaA2 as well 
as the cytochrome P450 gene opaB2, were transformed into A. nidulans LO8030 to create expression 
strains. The transformants were verified by PCR (Figure S2) and were cultivated in rice media for 
metabolite production.  
9. Overproduction and purification of OpaC and OpaC2 
OpaC was overproduced and purified as described previously.6 The opaC2 expression plasmid pLZ67 
was transferred into E. coli BL21(DE3). The recombinant strain was cultivated in Terrific Broth (TB) 
medium (2.4% yeast extract, 2.0% tryptone, 0.4% glycerol, 0.1 M phosphate buffer, pH 7.4). OpaC2 
overproduction was induced with 0.5 mM IPTG at 16°C for 16 h. The recombinant His6-tagged protein 
was purified by Ni-NTA affinity chromatography (Qiagen, Hilden) and analyzed by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE, Figure S5). The protein concentration was 
determined on a Nanodrop 2000c spectrophotometer (Thermo Scientific, Braunschweig, Germany). 
Protein yield of 1.6 mg per liter bacterial culture was calculated. 
10. In vitro assays of OpaC and OpaC2 
To test the enzyme activity of OpaC and OpaC2, the reaction mixtures (50 μL) containing 50 mM Tris-
HCl (pH 7.5), 5 mM NADPH or NADH, 1 mM 7 or 10, 10 μg of the purified recombinant OpaC or OpaC2 
were incubated at 30 °C for 30 min. The reactions were terminated by addition of 50 μL methanol. The 
HPLC results of the enzyme assays are given in Figures 5 and S7. 
11. Determination of kinetic parameters 
Enzyme assays for determination of the kinetic parameters for OpaC2 (50 μL) contained 50 mM Tris-
HCl (pH 7.5), 5 mM NADPH, 4 μg of the purified recombinant OpaC2 and 7 at final concentrations from 
0.025 to 2 mM. Incubations were carried out at 30 °C for 30 min. After addition of MeOH and 
centrifugation, the supernatants were analyzed on HPLC. The reaction product 4 was used as 
authentic standard for quantification. 




The fungal strains were cultivated in 0.75 kg rice (1.75 L) for isolation. The rice culture was extracted 
with equal volume of EtOAc for 3 times. The EtOAc extracts were concentrated under reduced pressure 
to afford the crude extracts for further purification. 
To isolate oxepinamide D (4), the crude extract of A. ustus wildtype was subjected to silica gel (230 ‒ 
400 mesh) column chromatography, by using a gradient of CH2Cl2/CH3OH (100:0 ‒ 0:100) to give nine 
fractions (Fr. 1 ‒ Fr. 9). Fr. 7 was purified on a semi-preparative HPLC (ACN/H2O), leading to 89.2 mg 
of oxepinamide D (4). Similarly, 6.9 mg of 5 and 5.1 mg of 6 were obtained from a culture of the ΔopaB2 
mutant, 21.91 mg of 7 from a culture of the ΔopaC2 mutant. 
13. Feeding experiments in the opaB and opaB2 expression strains A. nidulans LZ61 and LZ66 
To figure out the catalytic characters of the oxepinases OpaB and OpaB2. 10 mL PDB with 75 μL 0.5 
mg/mL riboflavin and 10 μL 0.5 mg/ml pyridoxine in a 25 ml flask were cultivated at 230 rpm and 30°C. 
0.5 mg of precursor was added into 3 days old culture of the transformant A. nidulans LZ61 (opaB) and 
A. nidulans LZ66 (opaB2). 16 h later, 1 mL culture was extracted with 1 mL EtOAc. The extracts were 
dried and dissolved in 100 μL DMSO for LC-MS analysis. Strains without fed precursors and A. nidulans 
assembled empty vector with or without feeding of precursors were used as controls. 
14. HPLC analysis and metabolite isolation  
Extracts were analyzed on an Agilent HPLC series 1200 (Agilent Technologies) equipped with an Agilent 
Eclipse XDB-C18 column (5 μm, 4.6 × 150 mm). A linear gradient from 10 to 90 % ACN in H2O, containing 
0.1% (v/v) HCOOH, in 20 min was used. The column was then washed with 100% ACN for 5 min and 
equilibrated with 10 % ACN in H2O for another 5 min. Detection was carried out on a photodiode array 
detector and absorptions at 254 nm were illustrated in this study. 
A semi-preparative Multospher 120 RP-18 column (5 μm, 10 × 250 mm) was used for product isolation 
on the same HPLC system with the same solvents at a flow rate of 2 mL/min. Separation was done by 
isocratic elution with 45 ‒ 70% ACN in H2O containing 0.1% (v/v) HCOOH, for 10-20 min. 
15. LC-HRMS analysis 
Extracts were also analyzed on an Agilent HPLC 1260 series system equipped with a quadrupole mass 
spectrometer microTOF QIII (Bruker Daltonics, Bremen, Germany) by using a Multospher 120 RP18-5μ 
column (5 μm, 250 × 2 mm). Separation was performed at a flow rate of 0.25 mL/min with a 40 min linear 
gradient from 5 to 100% ACN in H2O, both containing 0.1% (v/v) HCOOH. The column was then washed 
with 100% ACN for 5 min and equilibrated for 10 min. The parameters of the mass spectrometer were 
set as following: electrospray positive ion mode for ionization, capillary voltage with 4.5 kV, collision 




scanned in the range of m/z 100 – 1500. The data were analyzed by using the DataAnalysis 4.2 software 
(Bruker Daltonik, Bremen, Germany).  
16. NMR analysis 
NMR spectra of the isolated products were recorded at room temperature on a JEOL ECA-500 or ECX-
400S spectrometer (JEOL, Akishima, Tokyo, Japan). The samples were dissolved in DMSO-d6 or CDCl3. 
All spectra were processed with MestReNov.9.0.0 (Mestrelab Research, Santiago de Compostella, 
Spain). 
17. Circular dichroism (CD) spectroscopic analysis  
CD spectra were measured on a J-815 CD spectrometer (Jasco Deutschland GmbH, Pfungstadt, 
Germany). The samples were dissolved in methanol and measured in the range of 200 – 400 nm by 
using a 1 mm path length quartz cuvette (Hellma Analytics, Müllheim, Germany). The CD spectra are 
given in Figure S4. 
18. Measurement of optical rotations  
The optical rotation was measured on the polarimeter Jasco DIP-370 at 25°C using the D-line of the 
sodium lamp at  = 589.3 nm. Prior to the measurement, the polarimeter was calibrated with CH3Cl or 
CH3OH as solvents. 
19. Physiochemical properties of the compounds described in this study 
Oxepinamide D (4): orange oil; see Table S5 for 1H and 13C NMR data; HRMS (ESI) m/z: [M + H]+ calcd. 
for C19H17N3O4 352.1291; found 352.1301 . 
Compound (5): yellow oil; [α]25 D  -53.33 ( c 0.15 , CHCl3 ); see Table S5 for 1H and 13C NMR data; HRMS 
(ESI) m/z: [M + H]+ calcd. for C19H17N3O2 320.1393; found 320.1399.  
Compound (6): orange oil; [α]25 D  -42.58 ( c 0.14 , CHCl3 ); see Table S6 for 1H, 13C NMR, HMBC, and 
NOESY data; HRMS (ESI) m/z: [M + H]+ calcd. for C19H17N3O2 320.1393; found 320.1392. 
Compound (7): aureate solid; see Table S7 for 1H and 13C NMR data; HRMS (ESI) m/z: [M + H]+ calcd. 
for C19H17N3O3 336.1342; found 336.1354. 
20. Structural elucidation 
The structures of oxepinamide D (4) and compound 5 were elucidated by comprehensive interpretation 
of their MS, optical rotation, and NMR data (Table S5, Figures S8 − S11) and comparison with those 
reported in the literature.9-11 The typical oxepin signals were clearly observed in the 1H and 13C NMR 
spectra of 4 at δH 6.59 (d, 11.1 Hz), δH 5.81 (t, 5.6 Hz), δH 6.21 (dd, 11.1, 5.6 Hz), and δH 6.29 ppm (d, 




Compound 6 shares the same [M + H]+ ion with compound 5, but different NMR data (Table S6, Figures 
S12 − S16). The chiral center of compound 6 was determined by comparison with that of compound 7. 
Correlation of H-3 to H-16 in NOESY spectrum of 7 confirmed the 3S configuration. 
Compound 7 has a [M + H]+ ion at m/z 336.1354 and similar NMR data with compound 6 (Table S7, 
Figures S17 − S22). Intensive interpretation of its NMR spectra including 1H, 13C, HMQC, and HMBC 
revealed the presence of typical oxepin signals at δH 6.59 (d, 11.1 Hz), δH 5.78 (t, 5.6 Hz), δH 6.23 (d, 
5.6 Hz), and δH 6.19 ppm (dd, 11.1, 5.6 Hz) as well as δC 125.2, 117.2, 143.2, and 127.9 ppm, which 












cover/identity, homologous protein, A. ustus 
3.3904 
Putative function 
OpaA2 KIA75688 3905 




OpaB2 KIA75687 522 91/32, Oxepinase OpaB (KIA75457) P450, Oxepin formation 
OpaC2 KIA75686 462 
91/61, Flavin-dependent monooxygenase, 
OpaC (KIA75456) 
hydroxylase 
OpaD2 KIA75689 587 







Table S2. Strains used in this study 
Strains Genotype 
Wild type A. ustus 3.3904 
ΔopaA2 ΔopaA2::hph in A. ustus 3.3904 
ΔopaB2 ΔopaB2::hph in A. ustus 3.3904 
ΔopaC2 ΔopaC2::hph in A. ustus 3.3904 
A. nidulans  
LO8030  
pyroA4, riboB2, pyrG89, nkuA::argB 
 
sterigmatocystin cluster (AN7804-AN7825)Δ, 
emericellamide cluster (AN2545-AN2549)Δ, 
 asperfuranone cluster (AN1039-AN1029)Δ, 
 monodictyphenone cluster (AN10023-AN10021)Δ, 
 terrequinone cluster (AN8512-AN8520)Δ, 
 austinol cluster part 1 (AN8379-AN8384)Δ, 
 austinol cluster part 2 (AN9246-AN9259)Δ, 
 F9775 cluster (AN7906-AN7915)Δ, 
 asperthecin cluster (AN6000-AN6002)Δ 
LZ61 gpdA::opaB::AfpyrG in A. nidulans LO8030 
LZ64 gpdA::opaA::AfpyrG in A. nidulans LO8030 
LZ65 gpdA::opaA2::AfpyrG in A. nidulans LO8030 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table S5. The 1H and 13C NMR spectroscopic data of oxepinamide D (4) in DMSO-d6 
and compound 5 in CDCl3 
 
 
Oxepinamide D (4) 
 
Compound 5 
 500 MHz 125 MHz 400 MHz 100 MHz 
Position δH(multi., J) δC δH(multi., J) δC 
1  165.0  168.7 
2 9.19, s  6.40, t, 4.9  
3/3-OH 7.09, s 84.3 4.81, dt,9.9, 3.8 51.9 
4  157.7  147.3 
6  162.3  149.8 
7   7.71, dd, 8.3, 1.5 127.3 
8 6.29, d, 5.6 143.6 7.81, ddd, 8.3, 7.1, 1.5 135.0 
9 5.81, t, 5.6 117.3 7.52, ddd, 8.1, 7.1, 1.2 127.9 
10 6.21, dd, 11.1, 5.6 128.3 8.30, dd, 8.1, 1.2 127.0 
11 6.59, d, 11.1 125.1  120.3 
12  109.8  160.6 
13  159.6   
14   5.24, q, 2.1 58.2 
15 4.45, q, 6.9 51.5 1.51, d, 7.1 19.0 
16 0.38, d, 6.9 17.7 3.48, dd, 13.5, 3.8 44.4 
   3.16, dd, 13.5, 9.9  
17 3.08, d, 12.9 46.4   
 3.54, d, 12.9    
1´  134.5  135.3 
2´, 6´ 7.08, m 130.6 7.24, m 129.3 
3´, 5´ 7.25, t, 7.3 128.4 7.36, m 129.8 
4´ 7.19, t, 7.3 127.3 7.30, m 127.0 
 
The NMR data of 4 and 5 correspond well to those of oxepinamide D,9 and (+)-(1S,4S)-1-Benzyl-





Table S6. The 1H (400 MHz) and 13C NMR (125 MHz) spectroscopic data of compound 





Position δH(multi., J) δC HMBC 
1  169.2  
2 5.82, s  C-4 
3 4.82, dd, 10.6, 3.6 54.1  
4  149.7  
6  147.0  
7 7.74, dd, 8.2, 1.5 127.6 C-9, C-11 
8 7.81, ddd, 8.2, 7.1, 1.5 134.9 C-6, C-10 
9 7.54, ddd, 8.1, 7.1, 1.2 127.6 C-7, C-11 
10 8.31, dd, 8.1, 1.2 127.0 C-6, C-8, C-12 
11  120.7  
12  160.5  
14 5.46, dd, 7.2, 0.8 52.3 C-1, C-4, C-16 
15a 2.98, dd, 14.4, 3.6 38.2 C-3, C-2´,6´, C-3´,5´ 
15b 4.15, dd, 14.4, 10.6 38.2  
16 1.62, d, 7.2 17.1 C-1, C-14 
1´  135.5  
2´, 6´ 7.32, d, 7.5 129.4 C-4´, C-15 
3´, 5´ 7.42, br. t, 7.5 129.7 C-1´, C-3´,5´ 






Table S7. The 1H (500 MHz) and 13C NMR (125 MHz) spectroscopic data of compound 
7 in DMSO-d6 with key HMBC, COSY and NOESY correlations  
 
   
Position δH(multi., J) δC HMBC NOESY 
1  167.2   
2 8.53, s  C-3, C-4, C-15 H-3 
3 5.15, t, 4.7 53.6 C-1´, C-4, C-17 H-2, H-16, H-17 
4  156.1   
6  161.7   
8 6.23, d, 5.6 143.2 C-6, C-9, C-10 H-9, H-10 
9 5.78, t, 5.6 117.2 C-8, C-11 H-8, H-10 
10 
6.19, dd, 11.1, 
5.6 
127.9 C-8, C-12 H-8, H-9, H-11 
11 6.59, d, 11.1 125.2 C-6, C-9 H-9, H-10 
12  109.3   
13  159.9   
15 4.63, q, 7.1 51.8 C-1, C-4, C-16 H-16 
16 
17 
1.44, d, 7.1 16.8 C-1, C-15 H-3, H-15 
Overlapping 
with H2O signal 
36.4 C-1´, C-3´,5´, C-3, C-4 H-3, H-2´,6´ 
1´  135.8   
2´, 6´ 7.25-7.24, m 129.9 C-1´, C-2´,6´, C-3´,5´ H-3´,4´,5´ 
3´, 5´ 7.25-7.24, m 127.9 C-1´, C-2´,6´, C-3´,5´ H-2´,4´,6´ 








Figure S1. PCR verification of deletion mutants of A. ustus 3.3904 
PCR amplification for three different fragments from genomic DNA of WT and deletion 
mutants was used to prove the presence/absence of the target gene and the integration 
site of the selection marker with up- and downstream regions. The PCR primers are given 








Figure S2. PCR verification of heterologous expression transformants 
For A. nidulans-pYH-gpdA-opaA-pyrG (HE-opaA), A. nidulans-pYH-gpdA-opaA2-pyrG 
(HE-opaA2), and A. nidulans-pYH-gpdA-opaA-pyrG (HE-opaB2), fragments of 1556 bp, 
1541 bp, and 1465 bp within the target genes were amplified from genomic DNA by using 
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Figure S5. SDS-PAGE analysis of the purified OpaC2 
 
The proteins were separated on a 12% polyacrylamide gel and stained with Coomassie 
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Figure S6. Determination of the kinetic parameters of OpaC2 toward compound 7 in 
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Figure S8. 1H NMR spectrum of oxepinamide D (4) in DMSO-d6 (500 MHz) 
 





Figure S10. 1H NMR spectrum of compound (5) in CDCl3 (500 MHz) 
 





Figure S12. 1H NMR spectrum of compound 6 in CDCl3 (500 MHz) 
 





Figure S14. HSQC spectrum of compound 6 in CDCl3 
 





Figure S16. HMBC spectrum of compound 6 in CDCl3 
 






Figure S18. 13C{1H} NMR spectrum of compound 7 in DMSO-d6 (125 MHz) 
 





Figure S20. COSY spectrum of compound 7 in DMSO-d6 
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Switching a regular tryptophan
C4-prenyltransferase to a reverse tryptophan-
containing cyclic dipeptide C3-prenyltransferase
by sequential site-directed mutagenesis†
Liujuan Zheng,‡ Peter Mai,‡ Aili Fan§ and Shu-Ming Li *
FgaPT2 from Aspergillus fumigatus catalyzes a regular C4- and its mutant K174A a reverse C3-prenyla-
tion of L-tryptophan in the presence of dimethylallyl diphosphate. FgaPT2 also uses tryptophan-con-
taining cyclic dipeptides for C4-prenylation, while FgaPT2_K174A showed almost no activity toward
these substrates. In contrast, Arg244 mutants of FgaPT2 accept very well cyclic dipeptides for regular
C4-prenylation. In this study, we demonstrate that FgaPT2_K174F, which catalyzes a regular C3-preny-
lation on tyrosine, can also use cyclo-L-Trp-L-Ala, cyclo-L-Trp-L-Trp, cyclo-L-Trp-Gly, cyclo-L-Trp-L-
Phe, cyclo-L-Trp-L-Pro, and cyclo-L-Trp-L-Tyr as substrates, but only with low activity. Combinational
mutation on Lys174 and Arg244 increases significantly the acceptance of these cyclic dipeptides. With
the exception of cyclo-L-Trp-L-Trp, the tested dipeptides were much better accepted by
FgaPT2_K174F_R244X (X = L, N, Q, Y) than FgaPT2, with an increase of two- to six-fold activity. In com-
parison to FgaPT2_K174F, even two- to ten-fold conversion yields were calculated for the double
mutants. Isolation and structural elucidation of the enzyme products revealed stereospecific reverse
C3-prenylation on the indole ring, resulting in the formation of syn–cis configured hexahydropyrroloin-
dole derivatives. The results presented in this study highlight the convenience of site-directed mutagen-
esis for creating new biocatalysts.
Introduction
Cyclic dipeptides (CDPs) and derivatives are widely distributed
in microorganisms and exhibit diverse biological and pharma-
cological activities.1–3 In nature, these dipeptides are bio-
synthesized by bimodular non-ribosomal peptide synthetases
or cyclodipeptide synthases.4–6 Due to the various modification
possibilities on the indole ring, tryptophan-containing CDPs
are the richest precursors of natural products with pharma-
ceutical interest.2,3 These dipeptides are frequently modified
by methylation, hydroxylation, prenylation, dimerization, and
further cyclization.2,3,7,8 Chart 1 lists several examples of CDP
derivatives such as the antitumor active rugulosuvine A from
Penicillium species,9 the sterol O-acyltransferase inhibitor
amauromine from Nocardiopsis sp.,10,11 and the two myco-
toxins roquefortine C and acetylaszonalenin from different
fungal strains.3,12,13 They are modification products of CDPs
obtained by tailoring enzymes including prenyltransferases
(PTs).3,14
Chart 1 Examples of CDP derivatives.
†Electronic supplementary information (ESI) available: Primers and constructs,
NMR data and spectra as well as determination of kinetic parameters. See DOI:
10.1039/c8ob01735b
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Prenyltransferases belong to one of the important modify-
ing enzymes of CDPs and catalyze the transfer reactions of
prenyl units (n × C5, n = 1, 2, 3, 4 etc.) from prenyl dipho-
sphates to different aliphatic and aromatic acceptors.14
Members of the most biochemically and structurally investi-
gated PT group share meaningful sequence identities with the
dimethylallyltryptophan synthase in the biosynthesis of ergot
alkaloids and are therefore termed DMATS enzymes.8,14–16
Most PTs of the DMATS superfamily use dimethylallyl dipho-
sphate (DMAPP) as a donor and L-tryptophan or tryptophan-
containing cyclic dipeptides as acceptors and are involved in
the biosynthesis of diverse indole alkaloids.8,14 The dimethyl-
allyl moieties are attached to N-1, C-2, C-3, C-4, C-5, C-6, or C-7
of the indole ring in a regular or reverse manner. For the
regular prenylation, DMAPP was proposed to form a dimethyl-
allyl cation/pyrophosphate ion pair. The primary center of
DMAPP is attacked by the electron-rich aromatic ring with a
concerted displacement of pyrophosphate to form the arenium
ion intermediate, which re-aromatizes by deprotonation to
form the final product.17–19 For the reverse prenylation, the
nucleophilic attack takes place at the tertiary center instead of
the primary center of the dimethylallyl carbocation. Reverse
prenylation on the indole ring takes place mainly at C-2 and
C-3 of the cyclic dipeptides, like those of cyclo-L-Trp-L-Pro cata-
lyzed by NotF and BrePT,20,21 cyclo-L-Trp-L-Ala by EchPT1,22
cyclo-L-Trp-Ant by AnaPT,12 and cyclo-L-Trp-L-Leu by
CdpC3PT.23 L-Tryptophan is usually regularly prenylated at C-4,
C-5, C-6, and C-7, as demonstrated for FgaPT2,24 5-DMATS,25
6-DMATS,26 and 7-DMATS, respectively.27
FgaPT2 from Aspergillus fumigatus was identified as a
C4-DMATS, which initiates the biosynthesis of the ergot alka-
loids fumigaclavines.24 The crystal structure of FgaPT2 con-
tains a rare β/α fold (PT barrel) and serves as a basis for under-
standing the prenylation mechanism and for enzyme
design.18,19 Structure-based molecular modelling and site-
directed mutagenesis revealed that Lys174 facilitates the
entrance of substrates in the reactive center and Ile80, Leu81,
Tyr191, and Arg244 anchor the polar side chain of
L-tryptophan.19
Mutation of Lys174 to Phe switches FgaPT2 to a tyrosine
C3-prenyltransferase FgaPT2_K174F.28 Arg244 mutants
enhance significantly the catalytic ability of FgaPT2 toward
tryptophan-containing CDPs and keep the prenylation position
at C-4.29 Luk et al.30 demonstrated that FgaPT2_K174A can
prenylate L-tryptophan at both C-3 and C-4 positions and pro-
posed the C4-prenylated derivative to be the result of the
Cope rearrangement of a C3-prenylated derivative.
Acceptance of tryptophan-containing CDPs by FgaPT2_K174A
has not been tested before, while FgaPT2 was also demon-
strated to prenylate these compounds at C-4, i.e. the same
position as for the natural substrate L-tryptophan (Scheme 1).
All these results proved FgaPT2 as an excellent model for
enzyme design by site-directed mutagenesis. In this study, we
describe the creation of a reverse C3-prenyltransferase for
tryptophan-containing CDPs by two step-mutations on
Lys174 and Arg244.
Results and discussion
Acceptance of tryptophan-containing cyclic dipeptides by
FgaPT2_K174F
To prove the acceptance toward tryptophan-containing CDPs,
we constructed the plasmid pLZ1 for overproduction of
FgaPT2_K174A (Table S1†). One predominant protein band
with the expected size was detected using SDS-PAGE analysis
for the purified FgaPT2_K174A (Fig. S1†), which was used for
incubation with L-tryptophan and DMAPP. LC-MS analysis of
the reaction mixture revealed the presence of two product
peaks at 7.3 and 8.0 min. The peak at 8.0 min was identified
as the C4-prenylated derivative by comparison of its retention
time, UV (λmax 278 nm), and MS data with those of the FgaPT2
product (Fig. S2†). The peak at 7.3 min showed the same [M +
H]+ ion, but a clearly different UV spectrum (λmax at 240 and
294 nm) as the peak at 8.0 min. These data would correspond
to those of the C3-prenylated L-tryptophan reported for
FgaPT2_K174A.30 After proof of its functionality, the overpro-
duced FgaPT2_K174A was incubated with six L-tryptophan-con-
taining cyclic dipeptides, i.e. cyclo-L-Trp-L-Ala (1), cyclo-L-Trp-L-
Trp (2), cyclo-L-Trp-Gly (3), cyclo-L-Trp-L-Phe (4), cyclo-L-Trp-L-
Pro (5), and cyclo-L-Trp-L-Tyr (6) in the presence of DMAPP at
37 °C for 3 h. HPLC analysis of the incubation mixtures indi-
cated no product formation in all enzyme assays under the
tested conditions (Fig. 1). LC-MS analysis with EIC detection
for the [M + H]+ ion of monoprenylated products showed
product peaks with very low intensity (Fig. S3†).
In contrast, the cyclic dipeptides 1–6 were accepted by the
wildtype FgaPT2 with product yields in the range from 6.6 to
29.5% (Fig. 1). With the exception for 2, one product peak
each (1a or 3a–6a) was observed. These products showed a
typical UV λmax peak at 278 nm for the indole system and have
[M + H]+ ions, which are 68 Daltons larger than the respective
substrate (Fig. S3†), indicating the presence of an indole
chromophore and corresponding to the C4-prenylation of
cyclic dipeptides by FgaPT2 (Scheme 1).31 In the case of 2, two
products 2a and 2a* were detected, with [M + H]+ ions, which
are 68 and 136 Daltons larger than that of 2, indicating a
mono- and diprenylation, respectively (Fig. S3†).
In a previous study, we demonstrated that Lys174 also plays
an important role in aromatic substrate selection.
Scheme 1 Prenylation of cyclic dipeptides by FgaPT2 and its mutants.
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FgaPT2_K174F accepts L-tryptophan only with a 240-fold
decreased activity compared to FgaPT2, while its catalytic
ability for L-tyrosine increased 28-fold.28 We proved therefore
its behavior toward cyclic dipeptides 1–6 under the same con-
ditions used for FgaPT2_K174A. As shown in Fig. 1, all six sub-
strates were accepted by FgaPT2_K174F with product yields of
2.5 to 6.5%. Detailed inspection of the HPLC chromatograms
revealed the presence of one product each (1b–6b) with slightly
Fig. 1 HPLC analysis of incubation mixtures of FgaPT2 and its mutants with cyclic dipeptides.
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delayed retention times and clear different UV spectra com-
pared to 1a–6a.
The UV absorption maxima of 1b–6b at 240 and 294 nm
indicated the disruption of the indole and the presence of a
hexahydropyrroloindole system by C3-prenylation.
LC-ESI-HRMS analysis of the incubation mixtures of
FgaPT2_K174F with 1–6 confirmed the monoprenylation in
1b–6b by detection of [M + H]+ ions, which are 68 Daltons
larger than those of the respective substrates (Fig. S3†). We
speculated that 1–6 were converted to C3-prenylated derivatives
by FgaPT2_K174F. However, the conversion yields are too low
to be used as convenient biocatalyst for CDP prenylation.10,30
In the case of 2, a diprenylated product was also detected
using LC-MS analysis (Fig. S3†).
Enhancing the conversion of tryptophan-containing cyclic
dipeptides by combinational mutation on Lys174 and Arg244
We demonstrated previously that Arg244 mutants, especially
R244N, R244Q, R244Y, and R244L, showed strongly increased
activities toward tryptophan-containing cyclic dipeptides,
while L-tryptophan was less accepted by these mutants than
the wildtype FgaPT2.29 The prenylation position remained at
C-4 of the indole ring. To increase the conversion yields of
cyclic dipeptides for potential C3-prenylation, we created
double mutants by site-directed mutagenesis of Lys174 to Phe
and Arg244 to Leu, Asn, Gln, and Tyr, resulting in the four
double mutants FgaPT2_K174F_R244L, FgaPT2_K174F_R244N,
FgaPT2_K174F_R244Q, and FgaPT2_K174F_R244Y (Table S1†).
The overproduced proteins with yields of 1.2 –2.3 mg per liter
culture were purified to apparent homogeneity (Fig. S1†) and
exploited to enzyme assays with 1–6 under the conditions used
for FgaPT2_K174F.
HPLC analysis of the reaction mixtures delivered remark-
able results (Fig. 1 and 2). (i) Product formation was detected
in all the enzyme assays (Fig. 1, for simplification, only the
result of the best mutant for a given substrate is illustrated).
(ii) All double mutants exhibited increased activities toward all
the tested substrates (Fig. 2). Total product yields of 20.3 to
41.4% were calculated for the best mutant with a given
substrate, i.e. FgaPT2_K174F_R244N for 1–4 and
FgaPT2_K174F_R244L for 5 and 6. This means an activity
increase of two- to ten-fold, in comparison with those with
FgaPT2_K174F. (iii) The products have the same retention
times and UV spectra as those of the FgaPT2_K174F for a
given substrate (1b–6b). (iv) The corresponding products also
have almost the same [M + H]+ ions from LC-MS analysis
(Fig. S3†). In the case of 2, the additional peak 2b* with a [M +
H]+ ion for a diprenylated derivative was detected. All these
data underline successful mutational combinations for accep-
tance of tryptophan-containing CDPs.
Structure elucidation of the enzyme products with
FgaPT2_K174F_R244X
To elucidate the structures, the enzyme products of 1–4 were
isolated from incubation mixtures with FgaPT2_K174F_R244N
and those of 5 and 6 with FgaPT2_K174F_R244L. HRMS data
(Table 1) confirmed the monoprenylation in 1b–6b and dipre-
nylation in 2b*. Inspection of the 1H NMR spectra of 1b–6b
(Fig. S4–S9†) revealed the presence of signals for a reverse
prenyl moiety each at δh 4.97–5.13 (dd, 1H), 5.05–5.09 (dd, 1H),
5.76–5.98 (dd, 1H), 0.93–1.11 (s, 3H), and 0.79–1.01 (s, 3H)
Fig. 2 Yields of 1b–6b with Lys174 and Arg244 mutants. The com-
ponents and incubation conditions are identical to those of Fig. 1.




1b C19H24N3O2 326.1858 326.1863 1.5
2b C27H29N4O2 441.2292 441.2285 −1.6
2b* C32H36N4O2 509.2927 509.2911 −3.1
3b C18H22N3O2 312.1719 312.1707 −3.8
4b C25H28N3O2 402.2187 402.2176 −2.7
5b C21H26N3O2 352.2029 352.2020 −2.6
6b C25H28N3O3 418.2138 418.2125 −3.1
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ppm (Table S2†). The signals of H-2 at the original indole
rings are significantly up-field shifted to 5.32–5.55 ppm, indi-
cating the disruption of the indole and formation of a hexahy-
dropyrroloindole system caused by a C3-prenylation.10,23 The
signals of H-11 appear as double doublets of doublets with
coupling constants of approximately 11, 6.0, and 2.0 Hz,
proving the 3β-prenylation of the L-configured tryptophanyl
moiety, i.e. syn–cis configuration (2S, 3R, 11S).10 A literature
search confirmed the structures 1b–6b (Scheme 1) as reported
previously.10,23 They were obtained as enzyme products of the
prenyltransferase CdpC3PT from Neosartorya fischeri.10,23 In
the case of 2b*, the structure cannot be confirmed using NMR
analysis, due to the low quantity. We speculated here C3-preny-
lation at both the indole rings, as observed for other C3-prenyl-
transferases with cyclo-L-Trp-L-Trp.14
To get detailed insights into the reaction mechanism, we
carried out molecular docking using the program AutoDock
Vina.32 The models of FgaPT2_K174A, FgaPT2_K174F, and
FgaPT2_K174F_R244L were created from the FgaPT2 structure
(PDB code: 3I4X) using SWISS-MODEL. The tested cyclic di-
peptides and DMAPP were docked in silico into the models of
FgaPT2 and its mutants. Unfortunately, the observed enzyme
activities and prenylation positions can be explained neither by
the distances of C-1/C-3 of DMAPP to C-3/C-4 of the indole ring
of the cyclic dipeptides, nor by π–π or van der Waals force inter-
action (data not shown). Therefore, crystal structures of the
mutants are needed for understanding the observed results pre-
sented in this study, which should be explored in the near future.
Determination of kinetic parameters
Kinetic parameters including Michaelis Menten constants (KM)
and turnover numbers (kcat) were determined at pH 7.5 for
the two best mutants in the presence of DMAPP, i.e.
FgaPT2_K174F_R244N with 1–4 as well as
FgaPT2_K174F_R244L with 5 and 6. The reactions catalyzed by
both mutants apparently followed the Michaelis Menten kine-
tics (Fig. S10–S15†). With the exception of 3, KM values in the
range of 0.15 to 0.79 mM were determined (Table 2). The high
catalytic efficiencies of FgaPT2_K174F_R244N for 4 and
FgaPT2_K174F_R244L for 5 and 6 confirmed their high con-
versions illustrated in Fig. 1.
Experimental
Chemicals
DMAPP was synthesized according to the method described
for geranyl diphosphate reported previously.33 Substrates used
for the enzyme assays were purchased from Bachem
(Bubendorf, Switzerland) or synthesized as described
previously.34
Bacterial strains, plasmids, and culture conditions
E. coli BL21 (DE3) pLysS (Invitrogen, Karlsruhe, Germany) and
SoluBL21 (Novagen, Darmstadt, Germany) were used for
expression experiments. pIU18 was used as a DNA template for
the creation of FgaPT2_K174A. pES26 containing the mutation
for FgaPT2_K174F28 was used as a template for the cons-
truction of the double mutants FgaPT2_K174F_R244L,
FgaPT2_K174F_R244N, FgaPT2_K174F_R244Q, and
FgaPT2_K174F_R244Y. E. coli cells harboring plasmids were
grown in liquid Lysogeny Broth (LB) or Terrific Broth (TB)
medium and on solid LB medium with 2% (w/v) agar at 37 °C.
Kanamycin (50 μg mL−1) was used for the selection of recombi-
nant E. coli strains.
Site-directed mutagenesis, overproduction and purification of
the recombinant proteins
The Expand™ Long Template PCR system (Roche Diagnostic,
Mannheim, Germany) was used for the construction of plas-
mids listed in Table S1.† The primers are given in Table S1.†
The obtained plasmids were sequenced by Seqlab Sequence
Laboratories (Göttingen, Germany) to confirm the desired
mutations in the respective constructs. FgaPT2 and its
mutated derivatives were overproduced and purified as
described previously.28,35
Enzyme assays with purified recombinant proteins
To test the enzyme activity, the reaction mixtures (50 μL) con-
taining 50 mM Tris-HCl (pH 7.5), 10 mM CaCl2, 0.5 mM cyclic
dipeptide, 1 mM DMAPP, and 10 μg of the purified recombi-
nant protein were incubated at 37 °C for 3 h. The reactions
were terminated by the addition of 50 μL methanol. After
removal of the precipitated protein by centrifugation at
13 000g for 30 min, 20 μL supernatant was subjected to HPLC
or LC-HRMS analysis.
Enzyme assays for the determination of kinetic
parameters (50 μL) contained 1 mM DMAPP, 5–10 µg
FgaPT2_K174F_R244N or FgaPT2_K174F_R244L and the aro-
matic substrates at final concentrations from 0.025 to 5 mM.
The incubations were carried out at 37 °C for 30 min. After
addition of MeOH and centrifugation, the supernatants were
analyzed on a HPLC system.
HPLC analysis of enzyme assays
Enzyme assays were analyzed on an Agilent HPLC series 1200
system (Agilent Technologies) equipped with an Agilent
Eclipse XDB-C18 column (5 μm, 4.6 × 150 mm). A linear gradi-
ent from 10 to 90% CH3CN in H2O in 20 min was used. The
















1 0.36 0.012 33.3 — — —
2 0.79 0.13 164.6 — — —
3 3.10 0.19 61.3 — — —
4 0.15 0.03 200.0 — — —
5 — — — 0.41 0.15 365.9
6 — — — 0.62 0.25 403.2
S: substrate.
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column was then washed with 100% CH3CN for 5 min and
equilibrated with 10% CH3CN in H2O for another 5 min.
Detection was carried out with a photodiode array detector
and absorptions at 254 nm were illustrated in this study.
Isolation of the enzyme products
For isolation of the enzyme products, the assays (10 mL)
contained 50 mM Tris-HCl (pH 7.5), 5 mM CaCl2, 1 mM
cyclic dipeptide, 1 mM DMAPP, and 0.2–0.5 mg mL−1 recom-
binant protein. After incubation at 37 °C for 24 h, the reac-
tion mixtures were extracted with equal volume of EtOAc for
three times. The extracts were concentrated on a rotating
vacuum evaporator at 30 °C and the residues are dissolved
in 1 mL MeOH for isolation on a HPLC system. A semipre-
parative Multospher 120 RP-18 column (5 μm, 10 × 250 mm)
was used for isolation of the enzyme products on the same
HPLC system mentioned above with the same solvents at a
flow rate of 2.5 mL min−1. Separation was done by isocratic
elution with 40–70% CH3CN for 10–20 min. The fractions of
interest were collected, combined, and concentrated to
dryness on a rotating vacuum evaporator at 30 °C. The iso-
lated enzyme products were then subjected to NMR and MS
analyses.
LC-MS and MS analysis
Enzyme products were also analyzed on an Agilent HPLC 1260
series system equipped with a Bruker microTOF QIII mass
spectrometer using the Multospher 120 RP-18 column (5 μm,
2 × 250 mm). Separation was performed at a flow rate of
0.5 mL min−1 with a 10 min linear gradient from 5 to 100%
CH3CN in H2O, both containing 0.1% (v/v) formic acid. The
column was then washed with 100% CH3CN for 5 min and
equilibrated for 5 min. The parameters of the spectrometer
were set as the following: electrospray positive ion mode for
ionization, capillary voltage with 4.5 kV, collision energy with
8.0 eV.
NMR analysis
NMR spectra of the isolated enzyme products were recorded
at room temperature on a JEOL ECA-500 system (JEOL,
Akishima, Tokyo, Japan). The samples were dissolved in
DMSO-d6 or CDCl3. All spectra were processed with
MestReNov.6.1.0 (Mestrelab Research, Santiago de
Compostella, Spain).
Conclusions
In summary, we demonstrated that FgaPT2_K174F catalyzes a
reverse C3-prenylation of cyclic dipeptides, instead of C4-pre-
nylation by the non-mutated enzyme, but only with low
activity. Significant increase of the reaction velocity was
achieved by additional mutation on Arg244. Our results
provide an excellent example of protein engineering by site-
directed mutagenesis on the basis of structural information.
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no δH, mult., (J in Hz) δH, mult, (J in Hz) δH, mult, (J in Hz) 
2 5.50, s 5.55, s 5.55, s 
4 7.16, dd (7.5, 0.7) 7.14 a  7.16, ddd (7.5, 1.2, 0.5) 
5 6.77, td (7.5, 1.0) 6.75, td (7.5, 1.0) 6.77, td (7.5, 1.0) 
6 7.11, td (7.5, 1.0) 7.11a 7.11, td (7.6, 1.0) 
7 6.58, d (7.8) 6.61, d (7.8) 6.59, ddd (7.6, 1.0, 0.5) 
10 2.47, dd (12.7, 11.0) 2.42, dd (12.5, 11.2) 2.45, dd (12.7, 11.2) 
 2.55, dd (12.8, 6.5) 2.52, dd (12.5, 6.2) 2.56, dd (12.7, 6.2) 
11 3.96, ddd (10.9, 6.4, 1.7) 3.92, ddd(10.9, 6.3, 1.7) 3.95, ddd (11.2, 6.2, 1.6) 
14 4.05, qd (6.9, 1.6) 4.31, ddd (10.9, 3.6, 1.8) 4.04, dd (17.0, 2.0) 
 - - 3.87, dd (17.0, 4.1) 
15 - 5.65, s - 
17 1.46, d (6.9) 3.75, ddd (15.2, 3.7, 0.9) - 
 - 2.97, dd (15.1, 11.0) - 
19 - 7.11a - 
20 - 8.13, s - 
22 - 7.39, dt (8.3, 0.9) - 
23 - 7.23, td (7.7, 0.9) - 
24 - 7.13 a - 
25 - 7.55, d (7.9) - 
1' 5.13, dd (10.8, 1.1) 5.13, dd (10.8, 1.1) 5.13, dd (10.8, 1.1) 
 5.08, dd (17.4, 1.1) 5.08, dd (17.4, 1.1) 5.09, dd (17.4, 1.1) 
2' 5.98, dd (17.4, 10.8) 5.97, dd (17.4, 10.8) 5.98, dd (17.4, 10.8) 
4' 1.12, s 1.11, s 1.12, s 
























































































no. δH, mult., (J in Hz) δH, mult., (J in Hz) δH, mult., (J in Hz) 
2 5.54, s 5.46, s 5.32, d (1.1) 
4 7.14, d (7.5) 7.16, dd, (7.5, 1.0) 7.09, d (7.0) 
5 6.76, d (7.5) 6.77, td, (7.5, 1.0) 6.59, t (7.4) 
6 7.11, t (7.7) 7.11, td (7.5,1.0) 6.98, t (7.4) 
7 6.59, d (7.7) 6.59, d (7.5) 6.49, d (7.0) 
10 2.40, t (1.9) 2.49, dd (12.9, 10.8) 2.50b 
 2.52,dd (12.8, 6.2) 2.54, dd (12.9, 6.7)  
11 3.93, ddd (11.3, 6.2, 1.8) 3.98, dd (10.8, 6.7) 3.67, ddd (11.6, 5.7, 1.8) 
14 4.21, ddd (10.8, 3.6, 1.8) 4.05, t (8.3) 4.07, m 
15 5.50, s  - 
 - 2.12, m - 
16 - 3.56, m - 
 - 3.50, m - 
17 3.60, dd (14.4, 3.6) 2.04, m 3.06, dd (14.0, 3.8) 
 2.78, dd (14.4, 10.8) 1.89, m 2.84, dd (14.0, 5.0) 
18  2.32, dtd (9.1, 6.7, 2.5)  
19 7.19, d (7.1) - 7.01, d (8.4) 
20 7.34, t (7.3) - 6.66, m (8.4) 
21 7.29, t (7.4) - 9.17, s (OH) 
22 7.34, t (7.3) - 6.66, m (8.4) 
23 7.19, d (7.1) - 7.01, d (8.4) 
1' 5.13 ,dd (10.8, 1.0) 5.07, dd (17.4, 1.1) 4.97, dd (17.3, 1.4) 
 5.08, dd (17.4, 10) 5.05, dd (10.8, 1.1) 5.05, dd (10.8, 1.4) 
2' 5.96, dd (17.3, 10.8) 5.99, dd (17.4, 10.8) 5.76, dd (17.3, 10.8) 
4' 1.11, s 1.11, s 0.93, s 
5' 1.01, s 1.00, s 0.79, s 
a Signals overlapping with each other. b signals overlapping with those of solvent. The data of 1b – 6b correspond 







Fig. S1 SDS-PAGE analysis of the purified proteins. 
The proteins were separated on a 12% polyacrylamide gel and stained with 







Fig. S2 LC-HRMS analysis of FgaPT2 and FgaPT2_K174A reactions with 







Fig. S3  LC-MS analysis of the incubation mixtures of cyclic dipeptides with 































































































































Fig. S10 Determination of the kinetic parameters of the FgaPT2_K174F_R244N 
reaction toward 1 in the presence of DMAPP. 
 
 
Fig. S11 Determination of the kinetic parameters of the FgaPT2_K174F_R244N 





























Fig. S12 Determination of the kinetic parameters of the FgaPT2_K174F_R244N 





Fig. S13 Determination of the kinetic parameters of the FgaPT2_K174F_R244N 


















Fig. S14 Determination of the kinetic parameters of the FgaPT2_K174F_R244L 




Fig. S15 Determination of the kinetic parameters of the FgaPT2_K174F_R244L 







References and Notes 
 
 (1)  Steffan, N.; Unsöld, I. A.; Li, S.-M. Chembiochem 2007, 8, 1298-1307. 
 (2)  Fan, A.; Zocher, G.; Stec, E.; Stehle, T.; Li, S.-M. J. Biol. Chem. 2015, 290, 
1364-1373. 
 (3)  Yin, W.-B.; Yu, X.; Xie, X.-L.; Li, S.-M. Org. Biomol. Chem. 2010, 8, 
2430-2438. 
 (4)  Yu, X.; Zocher, G.; Xie, X.; Liebhold, M.; Schütz, S.; Stehle, T.; Li, S.-M. 





5. CONCLUSIONS AND FUTURE PROSPECTS 
 
5. Conclusions and future prospects 
In this thesis, BGCs for secondary metabolites from A. ustus have been investigated via multiple 
approaches. The identified PKS-containing utt BGC and two similar NRPS-containing opa and opa2 
BGCs from the same fungus A. ustus demonstrated clearly the large fungal potential for natural product 
production and new enzyme discovery. In addition, site-directed mutagenesis for a fungal PT led to the 
functional switching with enhanced conversion yields, indicating that site-directed mutagenesis is an 
effective tool to increase the structural diversity of natural products. 
In the biosynthesis of ustethylin A, isotopic feeding and heterologous expression experiments confirmed 
that the PKS UttA is responsible for assembling the phenethyl core structure with methylation as key 
reactions. The in vivo results proved that the NRPS_like enzyme UttJ catalyzes reduction of the aryl acid 
to aldehyde and the nonheme FeII/2-oxoglutarate dependent oxygenase UttH performs the subsequent 
hydroxylation at the benzyl group. After methylation by the O-MeT UttF, the cytochrome P450 enzyme 
UttC catalyzes the hydroxylation of the phenethyl residue to form the product ustethylin A. Deletion of 
uttD coding for a regulator completely abolished product formation, proving its role in regulating the 
expression of utt BGC. The feeding experiments of MeOH and EtOH to A. ustus and the mutants revealed 
that the pathway for ustethylin A can be shunted in the stage of enzyme-bound polyketide acyl 
intermediates, leading to the production of benzoyl ester derivatives. 
For the biosynthesis of oxepinamide F, the heterologous expression results proved that the NRPS OpaA 
assembles the quinazolinone backbone. The in vivo experiments revealed that the cytochrome P450 
enzyme OpaB alone catalyzes the ring expansion in quinazolinone to form the OPK backbone. The in 
vitro assays proved that the flavin-dependent enzyme OpaC is responsible for the regio- and 
stereospecific hydroxylation, which is accompanied by a double bond migration leading to the conversion 
of a 1H-oxepin to a 3H-oxepin system. Subsequently, the epimerase OpaE converts the configuration of 
Phe residue from R- to S- configuration, which is essential for the final methylation of the OH-12 by the 
O-Met OpaF to form oxepinamide F. In analogy, an additional NRPS containing BGC is involved in the 
biosynthesis of oxepinamide D. Gene deletion, heterologous expression as well as in vitro assays proved 
that the NRPS OpaA2 assembles the quinazolinone skeleton, the cytochrome P450 enzyme OpaB2 is 
responsible for the conversion of quinazolinone to OPK backbone, and the flavin-dependent 
monooxygenase OpaC2 performs the last hydroxylation in the OPK backbone to form the oxepinamide 
D. Feeding experiments in the opaB and opaB2 transformants as well as the results of the enzyme assays 
with OpaC and OpaC2 demonstrated that there is very likely no crosstalk between the opa and opa2 
BGCs 
247 
5. CONCLUSIONS AND FUTURE PROSPECTS 
 
Mutation of the key residues Lys174 and Arg244 in the fungal PT FgaPT2 was also performed in this 
thesis. The combined mutations of these two sites i.e. FgaPT2_K174F_R244X (X=L, N, Q, Y) show much 
better acceptance for cyclo-L-Trp- L-Ala, cyclo- L-Trp- L-Trp, cyclo- L-Trp-Gly, cyclo- L-Trp- L-Phe, cyclo- 
L-Trp- L-Pro, and cyclo- L-Trp- L-Tyr as substrates for reverse C3-prenylation. These results demonstrated 
that site-directed mutagenesis is a powerful tool to increases the structural diversity of natural products. 
For future prospects, the following works can be performed: 
➢ Investigation of the functions of the unknown enzymes UttB, UttE, and UttI in the utt BGC via 
in vivo and in vitro experiments. 
➢ prove if ustethylin A can be further metabolized by other enzymes, e.g. UttB, UttE, and UttI. 
➢ Based on the opa and opa2 BGC, mining more similar BGCs with NRPS bearing a domain 
structure of A-T-C-A-T-E-C-A-T-CT and a P450 enzyme next to the NRPS in other fungi. 
➢ Site-directed mutagenesis with OpaC and OpaC2 to understand the molecular basis of the 
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